Giancarlo Comi
#84,915
Most Influential Person Now
Researcher
Giancarlo Comi's AcademicInfluence.com Rankings
Giancarlo Comibiology Degrees
Biology
#3644
World Rank
#5536
Historical Rank
Molecular Biology
#243
World Rank
#247
Historical Rank
Neuroscience
#347
World Rank
#363
Historical Rank
Download Badge
Biology
Giancarlo Comi's Degrees
- PhD Neuroscience University of Milan
- Masters Biology University of Milan
- Bachelors Biology University of Milan
Similar Degrees You Can Earn
Why Is Giancarlo Comi Influential?
(Suggest an Edit or Addition)Giancarlo Comi's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria (2017) (3544)
- Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis (2011) (2511)
- Defining the clinical course of multiple sclerosis (2014) (2372)
- Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis. (2010) (2040)
- Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis (2013) (1170)
- Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis (2017) (1170)
- Ocrelizumab versus Interferon Beta‐1a in Relapsing Multiple Sclerosis (2017) (1107)
- Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis (2003) (1089)
- Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study (2001) (1072)
- Oral fingolimod (FTY720) for relapsing multiple sclerosis. (2006) (854)
- Randomized trial of oral teriflunomide for relapsing multiple sclerosis. (2011) (845)
- Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism (2005) (771)
- European/Canadian multicenter, double‐blind, randomized, placebo‐controlled study of the effects of glatiramer acetate on magnetic resonance imaging–measured disease activity and burden in patients with relapsing multiple sclerosis (2001) (753)
- A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis. (2010) (708)
- Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility (2019) (589)
- Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy (2001) (572)
- Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study (2018) (559)
- White matter damage in Alzheimer's disease assessed in vivo using diffusion tensor magnetic resonance imaging (2002) (545)
- Autoantibodies to glutamic acid decarboxylase in a patient with stiff-man syndrome, epilepsy, and type I diabetes mellitus. (1988) (539)
- Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial (2000) (499)
- Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial (2009) (499)
- Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial (2014) (448)
- Association between pathological and MRI findings in multiple sclerosis (2012) (418)
- Early Hemorrhagic Transformation of Brain Infarction: Rate, Predictive Factors, and Influence on Clinical Outcome: Results of a Prospective Multicenter Study (2008) (414)
- 250 μg or 500 μg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study (2009) (401)
- Magnetization transfer changes in the normal appering white matter precede the appearance of enhancing lesions in patients with multiple sclerosis (1998) (394)
- A randomized, double‐blind, placebo‐controlled, parallel‐group, enriched‐design study of nabiximols * (Sativex®), as add‐on therapy, in subjects with refractory spasticity caused by multiple sclerosis (2011) (378)
- A Magnetization Transfer Imaging Study of Normal-Appearing White Matter in Multiple Sclerosis (1995) (369)
- Delayed post-ischaemic neuroprotection following systemic neural stem cell transplantation involves multiple mechanisms. (2009) (354)
- Placebo-controlled trial of oral laquinimod for multiple sclerosis. (2012) (350)
- Diffusion tensor magnetic resonance imaging in multiple sclerosis (2001) (347)
- Functional Magnetic Resonance Imaging Correlates of Fatigue in Multiple Sclerosis (2002) (343)
- ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis (2018) (319)
- Inflammation Triggers Synaptic Alteration and Degeneration in Experimental Autoimmune Encephalomyelitis (2009) (317)
- Default-mode network dysfunction and cognitive impairment in progressive MS (2010) (300)
- Brain Gray Matter Changes in Migraine Patients With T2-Visible Lesions: A 3-T MRI Study (2006) (299)
- Teriflunomide versus subcutaneous interferon beta-1a in patients with relapsing multiple sclerosis: a randomised, controlled phase 3 trial (2014) (298)
- Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes (2010) (295)
- Disease‐Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis (2021) (287)
- Secondary progressive multiple sclerosis: current knowledge and future challenges (2006) (272)
- Brain atrophy and lesion load predict long term disability in multiple sclerosis (2013) (265)
- Myeloid microvesicles are a marker and therapeutic target for neuroinflammation (2012) (264)
- Clinical characteristics, course and prognosis of relapsing Devic’s Neuromyelitis Optica (2004) (259)
- Typical and atypical pathology in primary progressive aphasia variants (2017) (257)
- Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study (2015) (255)
- Oral teriflunomide for patients with a first clinical episode suggestive of multiple sclerosis (TOPIC): a randomised, double-blind, placebo-controlled, phase 3 trial (2014) (255)
- Interferon beta-1a for brain tissue loss in patients at presentation with syndromes suggestive of multiple sclerosis: a randomised, double-blind, placebo-controlled trial (2004) (253)
- Cortical adaptation in patients with MS: a cross-sectional functional MRI study of disease phenotypes (2005) (249)
- Cladribine and progressive MS (2000) (234)
- Autologous Transplantation of Muscle-Derived CD133+ Stem Cells in Duchenne Muscle Patients (2007) (233)
- Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study (2016) (231)
- Evolving concepts in the treatment of relapsing multiple sclerosis (2017) (231)
- ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis (2018) (224)
- Persistent inflammation alters the function of the endogenous brain stem cell compartment (2008) (224)
- Comparison of fingolimod with interferon beta-1a in relapsing-remitting multiple sclerosis: a randomised extension of the TRANSFORMS study (2011) (224)
- Ofatumumab versus Teriflunomide in Multiple Sclerosis. (2020) (220)
- Assessment of normal-appearing white and gray matter in patients with primary progressive multiple sclerosis: a diffusion-tensor magnetic resonance imaging study. (2002) (216)
- Cognitive dysfunction in patients with mildly disabling relapsing–remitting multiple sclerosis: an exploratory study with diffusion tensor MR imaging (2002) (214)
- Human neural stem cells ameliorate autoimmune encephalomyelitis in non‐human primates (2009) (207)
- Caspase-1 regulates the inflammatory process leading to autoimmune demyelination. (1999) (206)
- Cognitive and psychosocial features of childhood and juvenile MS (2008) (203)
- Oral fingolimod (FTY720) in multiple sclerosis (2009) (202)
- Transplanted neural stem/precursor cells instruct phagocytes and reduce secondary tissue damage in the injured spinal cord. (2012) (202)
- Intrathecal Delivery of IFN-γ Protects C57BL/6 Mice from Chronic-Progressive Experimental Autoimmune Encephalomyelitis by Increasing Apoptosis of Central Nervous System-Infiltrating Lymphocytes1 (2001) (201)
- Quantification of brain gray matter damage in different MS phenotypes by use of diffusion tensor MR imaging. (2002) (201)
- A voxel-based morphometry study of grey matter loss in MS patients with different clinical phenotypes (2008) (200)
- Adaptive functional changes in the cerebral cortex of patients with nondisabling multiple sclerosis correlate with the extent of brain structural damage (2002) (199)
- Treatment of cognitive impairment in multiple sclerosis: position paper (2013) (196)
- Microglia convert aggregated amyloid-β into neurotoxic forms through the shedding of microvesicles (2013) (195)
- Physiopathology and treatment of fatigue in multiple sclerosis (2001) (195)
- Comparison of two dosing frequencies of subcutaneous interferon beta-1a in patients with a first clinical demyelinating event suggestive of multiple sclerosis (REFLEX): a phase 3 randomised controlled trial (2012) (194)
- Safety and efficacy of cladribine tablets in patients with relapsing–remitting multiple sclerosis: Results from the randomized extension trial of the CLARITY study (2018) (193)
- Repeatability of surface EMG variables during voluntary isometric contractions of the biceps brachii muscle. (1999) (193)
- Brain MRI correlates of cognitive impairment in primary and secondary progressive multiple sclerosis (1995) (192)
- Effect of oral cladribine on time to conversion to clinically definite multiple sclerosis in patients with a first demyelinating event (ORACLE MS): a phase 3 randomised trial (2014) (191)
- Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension (2018) (190)
- Assessment of system dysfunction in the brain through MRI-based connectomics (2013) (189)
- High frequency of intestinal TH17 cells correlates with microbiota alterations and disease activity in multiple sclerosis (2017) (180)
- Loss of glial fibrillary acidic protein (GFAP) impairs Schwann cell proliferation and delays nerve regeneration after damage (2006) (180)
- Quantitative assessment of MRI lesion load in multiple sclerosis. A comparison of conventional spin-echo with fast fluid-attenuated inversion recovery. (1996) (180)
- Multiple sclerosis: effects of cognitive rehabilitation on structural and functional MR imaging measures--an explorative study. (2012) (180)
- Cognitive and psychosocial features in childhood and juvenile MS (2010) (178)
- Cognitive impairment in Duchenne muscular dystrophy (1994) (176)
- The contribution of MRI in assessing cognitive impairment in multiple sclerosis (2010) (174)
- A Multicenter Study on the Prevalence of Diabetic Neuropathy in Italy (1997) (172)
- The contribution of voxel-based morphometry in staging patients with mild cognitive impairment (2006) (171)
- MRI and magnetization transfer imaging changes in the brain and cervical cord of patients with Devic’s neuromyelitis optica (1999) (169)
- Regional brain atrophy evolves differently in patients with multiple sclerosis according to clinical phenotype. (2005) (169)
- Gray matter damage predicts the accumulation of disability 13 years later in MS (2013) (166)
- Correlations between Structural CNS Damage and Functional MRI Changes in Primary Progressive MS (2002) (164)
- Neural progenitor cells orchestrate microglia migration and positioning into the developing cortex (2014) (158)
- Short-term brain volume change in relapsing-remitting multiple sclerosis: effect of glatiramer acetate and implications. (2001) (158)
- Nocturnal sleep study in multiple sclerosis: Correlations with clinical and brain magnetic resonance imaging findings (1994) (157)
- In vivo assessment of cervical cord damage in MS patients: a longitudinal diffusion tensor MRI study. (2007) (155)
- Magnetization transfer MRI metrics predict the accumulation of disability 8 years later in patients with multiple sclerosis. (2006) (154)
- The organization of intrinsic brain activity differs between genders: A resting‐state fMRI study in a large cohort of young healthy subjects (2013) (154)
- Large-scale neuronal network dysfunction in relapsing-remitting multiple sclerosis (2012) (153)
- Network-based multiple sclerosis pathway analysis with GWAS data from 15,000 cases and 30,000 controls. (2013) (149)
- Functional network connectivity in the behavioral variant of frontotemporal dementia (2013) (148)
- Phase II study of oral fingolimod (FTY720) in multiple sclerosis: 3-year results (2010) (145)
- Age-related changes in conventional, magnetization transfer, and diffusion-tensor MR imaging findings: study with whole-brain tissue histogram analysis. (2003) (144)
- Pregnancy and fetal outcomes after interferon-β exposure in multiple sclerosis (2010) (144)
- Animal Models of Ischemic Stroke. Part Two: Modeling Cerebral Ischemia (2010) (143)
- Inflammation in multiple sclerosis: the good, the bad, and the complex (2002) (143)
- White matter damage in frontotemporal lobar degeneration spectrum (2011) (143)
- Conventional and magnetization transfer MRI predictors of clinical multiple sclerosis evolution: a medium-term follow-up study. (2003) (143)
- Evidence for widespread movement-associated functional MRI changes in patients with PPMS (2002) (142)
- Evidence of thalamic gray matter loss in pediatric multiple sclerosis (2008) (141)
- Multimodal evoked potentials to assess the evolution of multiple sclerosis: a longitudinal study (2006) (140)
- Evidence for axonal pathology and adaptive cortical reorganization in patients at presentation with clinically isolated syndromes suggestive of multiple sclerosis (2003) (140)
- Fatigue in Multiple Sclerosis Is Associated with Abnormal Cortical Activation to Voluntary Movement—EEG Evidence (2001) (140)
- Mild cognitive impairment in Parkinson's disease is associated with a distributed pattern of brain white matter damage (2014) (139)
- Real‐life impact of early interferonβ therapy in relapsing multiple sclerosis (2009) (139)
- A randomised controlled trial of intravenous immunoglobulin in IgM paraprotein associated demyelinating neuropathy (2002) (138)
- Long-term (up to 4.5 years) treatment with fingolimod in multiple sclerosis: results from the extension of the randomised TRANSFORMS study (2015) (138)
- Thalamic damage and long-term progression of disability in multiple sclerosis. (2010) (138)
- Divergent brain network connectivity in amyotrophic lateral sclerosis (2013) (138)
- Association of Vitamin D Levels With Multiple Sclerosis Activity and Progression in Patients Receiving Interferon Beta-1b. (2015) (136)
- Immune Regulatory Neural Stem/Precursor Cells Protect from Central Nervous System Autoimmunity by Restraining Dendritic Cell Function (2009) (135)
- Validation of diagnostic magnetic resonance imaging criteria for multiple sclerosis and response to interferon β1a (2003) (135)
- Modulation of autoimmune demyelination by laquinimod via induction of brain-derived neurotrophic factor. (2012) (135)
- A multicenter assessment of cervical cord atrophy among MS clinical phenotypes (2011) (135)
- Comparison of triple dose versus standard dose gadolinium-DTPA for detection of MRI enhancing lesions in patients with MS (1996) (135)
- A conventional and magnetization transfer MRI study of the cervical cord in patients with MS (2000) (134)
- Brain network connectivity assessed using graph theory in frontotemporal dementia (2013) (134)
- Similar low frequency of anti-MOG IgG and IgM in MS patients and healthy subjects (2004) (130)
- Magnetic resonance techniques in multiple sclerosis: the present and the future. (2011) (130)
- Weekly diffusion-weighted imaging of normal-appearing white matter in MS (2000) (129)
- Mean diffusivity and fractional anisotropy histogram analysis of the cervical cord in MS patients (2005) (128)
- Using Smartphones and Wearable Devices to Monitor Behavioral Changes During COVID-19 (2020) (128)
- Tract-specific white matter structural disruption in patients with bipolar disorder. (2011) (128)
- Cell-based therapeutic strategies for multiple sclerosis (2017) (128)
- Brain structural and functional connectivity in Parkinson's disease with freezing of gait (2015) (127)
- Freedom from disease activity in multiple sclerosis (2010) (125)
- Intra- and inter-observer agreement of brain MRI lesion volume measurements in multiple sclerosis. A comparison of techniques. (1995) (125)
- Safety and efficacy of the selective sphingosine 1-phosphate receptor modulator ozanimod in relapsing multiple sclerosis (RADIANCE): a randomised, placebo-controlled, phase 2 trial (2016) (125)
- Intracortical lesions (2010) (124)
- A multi-centre longitudinal study comparing the sensitivity of monthly MRI after standard and triple dose gadolinium-DTPA for monitoring disease activity in multiple sclerosis. Implications for phase II clinical trials. (1998) (124)
- Altered functional and structural connectivities in patients with MS (2007) (123)
- Functional Basis of Memory Impairment in Multiple Sclerosis: A [18F]FDG PET Study (1996) (122)
- IL‐12 is involved in the induction of experimental autoimmune myasthenia gravis, an antibody‐ mediated disease (1998) (122)
- Magnetization transfer and diffusion tensor MRI show gray matter damage in neuromyelitis optica (2004) (122)
- Magnetic Resonance‐Based Tracking and Quantification of Intravenously Injected Neural Stem Cell Accumulation in the Brains of Mice with Experimental Multiple Sclerosis (2007) (120)
- Phenotypic clustering of lamin A/C mutations in neuromuscular patients (2007) (119)
- Vaccination with amyloid-beta peptide induces autoimmune encephalomyelitis in C57/BL6 mice. (2003) (119)
- Placebo-controlled trial of oral laquinimod in multiple sclerosis: MRI evidence of an effect on brain tissue damage (2013) (118)
- Structural and functional MRI correlates of Stroop control in benign MS (2009) (118)
- Assessment of cardiac safety during fingolimod treatment initiation in a real-world relapsing multiple sclerosis population: a phase 3b, open-label study (2013) (118)
- MRI and motor evoked potential findings in nondisabled multiple sclerosis patients with and without symptoms of fatique (2000) (117)
- Measurement error of two different techniques for brain atrophy assessment in multiple sclerosis (2004) (117)
- Brain involvement in systemic immune mediated diseases: magnetic resonance and magnetisation transfer imaging study (2000) (116)
- Vitamin D levels and risk of multiple sclerosis in patients with clinically isolated syndromes (2014) (115)
- Mitoxantrone for multiple sclerosis. (2005) (115)
- Safety and tolerability of cladribine tablets in multiple sclerosis: the CLARITY (CLAdRIbine Tablets treating multiple sclerosis orallY) study (2011) (114)
- Clinical and biochemical correlations in mitochondrial myopathies treated with coenzyme Q10 (1988) (114)
- Impaired functional integration in multiple sclerosis: a graph theory study (2014) (113)
- Loss of Dp140 dystrophin isoform and intellectual impairment in Duchenne dystrophy (2000) (113)
- Basal ganglia and thalamo‐cortical hypermetabolism in patients with spasmodic torticollis (1996) (113)
- The Multiple Sclerosis Genomic Map: Role of peripheral immune cells and resident microglia in susceptibility (2017) (113)
- Safety and efficacy of ozanimod versus interferon beta-1a in relapsing multiple sclerosis (SUNBEAM): a multicentre, randomised, minimum 12-month, phase 3 trial (2019) (113)
- Safety and efficacy of ozanimod versus interferon beta-1a in relapsing multiple sclerosis (RADIANCE): a multicentre, randomised, 24-month, phase 3 trial (2019) (112)
- Brain reserve and cognitive reserve in multiple sclerosis (2013) (111)
- Autosomal Dominant Frontotemporal Lobar Degeneration Due to the C9ORF72 Hexanucleotide Repeat Expansion: Late-Onset Psychotic Clinical Presentation (2013) (111)
- Breastfeeding is not related to postpartum relapses in multiple sclerosis (2011) (110)
- The Cortical Signature of Amyotrophic Lateral Sclerosis (2012) (108)
- iPSC-derived neural precursors exert a neuroprotective role in immune-mediated demyelination via the secretion of LIF (2013) (108)
- Setting a research agenda for progressive multiple sclerosis: The International Collaborative on Progressive MS (2012) (107)
- Fibroblast growth factor-II gene therapy reverts the clinical course and the pathological signs of chronic experimental autoimmune encephalomyelitis in C57BL/6 mice (2001) (107)
- Heterogeneity of autoantibodies in stiff‐man syndrome (1993) (106)
- A spinal cord MRI study of benign and secondary progressive multiple sclerosis (1995) (106)
- Pharmacological management of spasticity in multiple sclerosis: Systematic review and consensus paper (2016) (106)
- Cognitive impairment in multiple sclerosis is associated to different patterns of gray matter atrophy according to clinical phenotype (2011) (106)
- Diffusion-tensor magnetic resonance imaging detects normal-appearing white matter damage unrelated to short-term disease activity in patients at the earliest clinical stage of multiple sclerosis. (2005) (106)
- Corpus callosum damage and cognitive dysfunction in benign MS (2009) (105)
- Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis (2021) (103)
- Electroencephalographic coherence analysis in multiple sclerosis: correlation with clinical, neuropsychological, and MRI findings (2000) (103)
- Diffusion tensor MRI tractography and cognitive impairment in multiple sclerosis (2012) (102)
- Sensorimotor functional connectivity changes in amyotrophic lateral sclerosis. (2011) (102)
- Plasmapheresis in the treatment of stiff-man syndrome. (1989) (102)
- Progressive gray matter damage in patients with relapsing-remitting multiple sclerosis: a longitudinal diffusion tensor magnetic resonance imaging study. (2005) (102)
- Long-term follow-up of isolated optic neuritis: the risk of developing multiple sclerosis, its outcome, and the prognostic role of paraclinical tests (1999) (101)
- Microstructural changes and atrophy in brain white matter tracts with aging (2012) (100)
- Autoantibodies to glutamic acid decarboxylase in palatal myoclonus and epilepsy (1994) (100)
- Safety and Efficacy of Transcranial Direct Current Stimulation in Acute Experimental Ischemic Stroke (2013) (100)
- Short-term accrual of gray matter pathology in patients with progressive multiple sclerosis: an in vivo study using diffusion tensor MRI (2005) (99)
- Selective decreased grey matter volume of the pain-matrix network in cluster headache (2012) (99)
- Lifetime and actual prevalence of pain and headache in multiple sclerosis (2008) (99)
- Disease-modifying drugs in childhood-juvenile multiple sclerosis: results of an Italian co-operative study (2005) (99)
- Evaluation of Polyneuropathy Markers in Type 1 Diabetic Kidney Transplant Patients and Effects of Islet Transplantation (2007) (98)
- Dysfunctional brain circuitry in obsessive–compulsive disorder: Source and coherence analysis of EEG rhythms (2010) (98)
- Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis Risk (2018) (98)
- Prediction of a multiple sclerosis diagnosis in patients with clinically isolated syndrome using the 2016 MAGNIMS and 2010 McDonald criteria: a retrospective study (2017) (98)
- Occurrence and clinical relevance of an interleukin-4 gene polymorphism in patients with multiple sclerosis (1997) (97)
- Brain transcranial direct current stimulation modulates motor excitability in mice (2010) (97)
- Anti-JC virus antibody prevalence in a multinational multiple sclerosis cohort (2013) (96)
- Neuropsychological features in childhood and juvenile multiple sclerosis (2014) (96)
- Acute transverse myelopathy: spinal and cranial MR study with clinical follow-up. (1995) (96)
- Functional network connectivity abnormalities in multiple sclerosis: Correlations with disability and cognitive impairment (2018) (94)
- MR correlates of cerebral atrophy in patients with multiple sclerosis (2002) (94)
- Simple and complex movement‐associated functional MRI changes in patients at presentation with clinically isolated syndromes suggestive of multiple sclerosis (2004) (94)
- Pregnancy and fetal outcomes after Glatiramer Acetate exposure in patients with multiple sclerosis: a prospective observational multicentric study (2012) (93)
- Cortical abnormalities in patients with migraine: a surface-based analysis. (2013) (93)
- Evolving expectations around early management of multiple sclerosis (2010) (93)
- Influence of the topography of brain damage on depression and fatigue in patients with multiple sclerosis (2014) (92)
- MicroRNA and mRNA expression profile screening in multiple sclerosis patients to unravel novel pathogenic steps and identify potential biomarkers (2012) (92)
- Cognitive impairment and structural brain damage in benign multiple sclerosis (2008) (91)
- Cognitive Functions and White Matter Tract Damage in Amyotrophic Lateral Sclerosis: A Diffusion Tensor Tractography Study (2011) (90)
- Assessing response to interferon-β in a multicenter dataset of patients with MS (2016) (89)
- Relevance of interleukin 1 receptor antagonist intron 2 polymorphism in Italian MS patients (1999) (89)
- Effects of glatiramer acetate on relapse rate and accumulated disability in multiple sclerosis: meta-analysis of three double-blind, randomized, placebo-controlled clinical trials (2003) (89)
- The Brain Functional Networks Associated to Human and Animal Suffering Differ among Omnivores, Vegetarians and Vegans (2010) (88)
- Brain plasticity in Parkinson’s disease with freezing of gait induced by action observation training (2016) (87)
- Epidural analgesia and cesarean delivery in multiple sclerosis post-partum relapses: the Italian cohort study (2012) (87)
- Migrainous Vertigo: Results of Caloric Testing and Stabilometric Findings (2009) (87)
- Mitoxantrone prior to interferon beta-1b in aggressive relapsing multiple sclerosis: a 3-year randomised trial (2011) (87)
- Effects of early treatment with glatiramer acetate in patients with clinically isolated syndrome (2013) (87)
- Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticity (2016) (86)
- Comparison of triple dose versus standard dose gadolinium-DTPA for detection of MRI enhancing lesions in patients with primary progressive multiple sclerosis. (1995) (86)
- IL4 gene delivery to the CNS recruits regulatory T cells and induces clinical recovery in mouse models of multiple sclerosis (2008) (86)
- Physiopathology of fatigue in Multiple Sclerosis (2008) (85)
- Normal-appearing white and grey matter damage in MS (2007) (85)
- The use of quantitative magnetic-resonance-based techniques to monitor the evolution of multiple sclerosis (2003) (84)
- Optical Coherence Tomography Reveals Retinal Neuroaxonal Thinning in Frontotemporal Dementia as in Alzheimer's Disease. (2017) (84)
- Fingolimod versus intramuscular interferon in patient subgroups from TRANSFORMS (2013) (83)
- Structural brain correlates of cognitive and behavioral impairment in MND (2016) (83)
- Functional and morphological changes of the retinal vessels in Alzheimer’s disease and mild cognitive impairment (2019) (83)
- Paraplegia following coeliac plexus block (1993) (83)
- Central nervous system gene therapy with interleukin-4 inhibits progression of ongoing relapsing–remitting autoimmune encephalomyelitis in Biozzi AB/H mice (2001) (83)
- A pilot trial of low-dose naltrexone in primary progressive multiple sclerosis (2008) (82)
- The effect of interferon β-1b on quantities derived from MT MRI in secondary progressive MS (2003) (82)
- Safety of cladribine tablets in the treatment of patients with multiple sclerosis: An integrated analysis. (2019) (82)
- Regional but not global brain damage contributes to fatigue in multiple sclerosis. (2014) (81)
- Myeloid microvesicles in cerebrospinal fluid are associated with myelin damage and neuronal loss in mild cognitive impairment and Alzheimer disease (2014) (81)
- Safety and efficacy of natalizumab in children with multiple sclerosis (2010) (81)
- Spinal cord involvement in multiple sclerosis and neuromyelitis optica spectrum disorders (2019) (81)
- Guidelines for autologous blood and marrow stem cell transplantation in multiple sclerosis: a consensus report written on behalf of the European Group for Blood and Marrow Transplantation and the European Charcot Foundation (2000) (80)
- Pre-specified subgroup analyses of a placebo-controlled phase III trial (TEMSO) of oral teriflunomide in relapsing multiple sclerosis (2012) (80)
- Functional cortical changes of the sensorimotor network are associated with clinical recovery in multiple sclerosis (2008) (80)
- Cryoglobulinaemic neuropathy. A clinical, morphological and immunocytochemical study of 8 cases. (1988) (79)
- A functional magnetic resonance imaging study of patients with secondary progressive multiple sclerosis (2003) (79)
- EEG coherence in pathological conditions. (1999) (79)
- Resolution‐dependent estimates of lesion volumes in magnetic resonance imaging studies of the brain in multiple sclerosis (1995) (79)
- Magnetic resonance imaging outcomes from a phase III trial of teriflunomide (2013) (79)
- Neuromyelitis optica spectrum disorders: long-term safety and efficacy of rituximab in Caucasian patients (2016) (79)
- Deficits in memory and visuospatial learning correlate with regional hippocampal atrophy in MS (2013) (78)
- Mitoxantrone: benefits and risks in multiple sclerosis patients (2009) (78)
- Sensorimotor network rewiring in mild cognitive impairment and Alzheimer's disease (2009) (78)
- Late onset multiple sclerosis: clinical characteristics, prognostic factors and differential diagnosis (2004) (77)
- Brain network connectivity differs in early-onset neurodegenerative dementia (2017) (77)
- Acute Hyperglycemia and Early Hemorrhagic Transformation in Ischemic Stroke (2009) (77)
- Teriflunomide added to interferon-&bgr; in relapsing multiple sclerosis: A randomized phase II trial (2012) (77)
- Effects of oral glatiramer acetate on clinical and MRI-monitored disease activity in patients with relapsing multiple sclerosis: a multicentre, double-blind, randomised, placebo-controlled study (2006) (76)
- Acute promyelocytic leukemia following mitoxantrone as single agent for the treatment of multiple sclerosis (1998) (76)
- Metachromatic leukodystrophy – mutation analysis provides further evidence of genotype–phenotype correlation (2008) (76)
- Voxelwise Assessment of the Regional Distribution of Damage in the Brains of Patients with Multiple Sclerosis and Fatigue (2011) (76)
- Amelioration of nerve conduction velocity following simultaneous kidney/pancreas transplantation is due to the glycaemic control provided by the pancreas (1997) (76)
- Relative contributions of brain and cervical cord pathology to multiple sclerosis disability: a study with magnetisation transfer ratio histogram analysis (2000) (76)
- MRI markers of destructive pathology in multiple sclerosis-related cognitive dysfunction (2006) (75)
- Correlations between clinical and MRI involvement in multiple sclerosis: assessment using T1, T2 and MT histograms (1999) (75)
- Disruption of structural connectivity along the dorsal and ventral language pathways in patients with nonfluent and semantic variant primary progressive aphasia: A DT MRI study and a literature review (2013) (75)
- Fatigue and its relationships with cognitive functioning and depression in paediatric multiple sclerosis (2012) (74)
- fMRI changes in relapsing‐remitting multiple sclerosis patients complaining of fatigue after IFNβ‐1a injection (2007) (74)
- The Multiple Sclerosis Care Unit (2018) (74)
- Benign versus secondary-progressive multiple sclerosis: the potential role of proton MR spectroscopy in defining the nature of disability. (1998) (74)
- Peripheral levels of caspase-1 mRNA correlate with disease activity in patients with multiple sclerosis; a preliminary study (1999) (73)
- Irreversible disability and tissue loss in multiple sclerosis: a conventional and magnetization transfer magnetic resonance imaging study of the optic nerves. (2002) (73)
- Role of B Cells in Multiple Sclerosis and Related Disorders (2020) (73)
- Functional and structural connectivity of the motor network in pediatric and adult-onset relapsing-remitting multiple sclerosis. (2010) (73)
- Antiacquaporin 4 antibodies detection by different techniques in neuromyelitis optica patients (2009) (73)
- Effect of cladribine tablets on lymphocyte reduction and repopulation dynamics in patients with relapsing multiple sclerosis. (2019) (73)
- T Regulatory Cells Are Markers of Disease Activity in Multiple Sclerosis Patients (2011) (73)
- Fingolimod versus interferon beta/glatiramer acetate after natalizumab suspension in multiple sclerosis. (2015) (72)
- Structural brain MRI abnormalities in pediatric patients with migraine (2014) (72)
- Pooled safety and tolerability data from four placebo-controlled teriflunomide studies and extensions. (2016) (72)
- Interferon-β treatment in multiple sclerosis patients decreases the number of circulating T cells producing interferon-γ and interleukin-4 (2000) (72)
- Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone (2011) (72)
- Cost–utility analysis of intravenous immunoglobulin and prednisolone for chronic inflammatory demyelinating polyradiculoneuropathy (2003) (72)
- Dominant LMNA mutations can cause combined muscular dystrophy and peripheral neuropathy (2005) (72)
- IL12A, MPHOSPH9/CDK2AP1 and RGS1 are novel multiple sclerosis susceptibility loci (2010) (72)
- Intrahemispheric and interhemispheric structural network abnormalities in PLS and ALS (2014) (71)
- Postpartum relapses increase the risk of disability progression in multiple sclerosis: the role of disease modifying drugs (2014) (71)
- Motor Learning in Healthy Humans Is Associated to Gray Matter Changes: A Tensor-Based Morphometry Study (2010) (71)
- Autologous stem cell transplantation as rescue therapy in malignant forms of multiple sclerosis (2005) (71)
- Long-term safety and efficacy of teriflunomide (2016) (71)
- Late-onset cerebellar ataxia with hypogonadism and muscle coenzyme Q10 deficiency (2004) (71)
- The apolipoprotein E ϵ4 allele causes a faster decline of cognitive performances in Down's syndrome subjects (1997) (70)
- Is a preserved functional reserve a mechanism limiting clinical impairment in pediatric MS patients? (2009) (70)
- Disrupted brain connectome in semantic variant of primary progressive aphasia (2014) (70)
- Assessment of MRI abnormalities of the brainstem from patients with migraine and multiple sclerosis (2006) (70)
- Mitoxantrone for multiple sclerosis. (2013) (69)
- Pregnancy decision-making in women with multiple sclerosis treated with natalizumab (2018) (69)
- Intrinsic damage to the major white matter tracts in patients with different clinical phenotypes of multiple sclerosis: a voxelwise diffusion-tensor MR study. (2011) (69)
- Subventricular zone neural progenitors protect striatal neurons from glutamatergic excitotoxicity. (2012) (69)
- Method for intracellular magnetic labeling of human mononuclear cells using approved iron contrast agents. (1999) (68)
- Characteristics of chronic MS lesions in the cerebrum, brainstem, spinal cord, and optic nerve on T1‐‐‐weighted MRI (1998) (68)
- Cognitive learning is associated with gray matter changes in healthy human individuals: A tensor-based morphometry study (2009) (68)
- Long-term results of immunomodulatory treatment in children and adolescents with multiple sclerosis: the Italian experience (2009) (68)
- Cross-validation of biomarkers for the early differential diagnosis and prognosis of dementia in a clinical setting (2015) (68)
- Event‐Related desynchronization to contingent negative variation and Self‐Paced movement paradigms in Parkinson's disease (1998) (67)
- Clinical trials of multiple sclerosis monitored with enhanced MRI: new sample size calculations based on large data sets (2001) (67)
- A genome-wide association study in progressive multiple sclerosis (2012) (67)
- Neural Stem Cell Transplantation Induces Stroke Recovery by Upregulating Glutamate Transporter GLT-1 in Astrocytes (2016) (67)
- Oral laquinimod in patients with relapsing-remitting multiple sclerosis: 36-week double-blind active extension of the multi-centre, randomized, double-blind, parallel-group placebo-controlled study (2010) (66)
- A whole brain MR spectroscopy study from patients with Alzheimer's disease and mild cognitive impairment (2005) (66)
- Marchiafava-Bignami disease: longitudinal MR imaging and MR spectroscopy study. (2003) (66)
- ELECTROPHYSIOLOGIC STUDIES IN TARSAL TUNNEL SYNDROME: Diagnostic Reliability of Motor Distal Latency, Mixed Nerve and Sensory Nerve Conduction Studies (1994) (65)
- A magnetic resonance imaging voxel-based morphometry study of regional gray matter atrophy in patients with benign multiple sclerosis. (2008) (65)
- Gender Differences in Patients with Acute Ischemic Stroke (2010) (65)
- Moving toward earlier treatment of multiple sclerosis: Findings from a decade of clinical trials and implications for clinical practice. (2014) (64)
- Pregnancy decision-making in women with multiple sclerosis treated with natalizumab (2018) (64)
- Disease Modifying Therapies and COVID-19 Severity in Multiple Sclerosis (2020) (64)
- Ventral and dorsal visual streams in posterior cortical atrophy: A DT MRI study (2012) (64)
- Phase III dose‐comparison study of glatiramer acetate for multiple sclerosis (2011) (64)
- DMTs and Covid‐19 severity in MS: a pooled analysis from Italy and France (2021) (64)
- The ependymal route to the CNS: an emerging gene-therapy approach for MS. (2001) (63)
- Deep gray matter T2 hypointensity is present in patients with clinically isolated syndromes suggestive of multiple sclerosis (2010) (63)
- Obsessive compulsive disorder among idiopathic focal dystonia patients: an epidemiological and family study (2002) (63)
- Optical coherence tomography and visual evoked potentials: which is more sensitive in multiple sclerosis? (2014) (63)
- Quantitative volumetric analysis of brain magnetic resonance imaging from patients with multiple sclerosis (1998) (62)
- Corneal confocal microscopy reveals trigeminal small sensory fiber neuropathy in amyotrophic lateral sclerosis (2014) (62)
- Switching from natalizumab to fingolimod (2015) (61)
- Amyloid-β deposition and regional grey matter atrophy rates in dementia with Lewy bodies. (2016) (61)
- Patterns of Brain Structural Changes in First-Contact, Antipsychotic Drug-Naïve Patients with Schizophrenia (2014) (61)
- Action observation and motor imagery in performance of complex movements: Evidence from EEG and kinematics analysis (2015) (60)
- Magnetization transfer imaging of patients with definite MS and negative conventional MRI (1999) (60)
- Serial contrast-enhanced MR in patients with multiple sclerosis and varying levels of disability. (1997) (60)
- MRI metrics as surrogate markers for clinical relapse rate in relapsing-remitting MS patients (2002) (60)
- Clinical Features, Familial History, and Migraine Precursors in Patients With Definite Vestibular Migraine: The VM‐Phenotypes Projects (2018) (60)
- The topography of brain damage at different stages of Parkinson's disease (2013) (60)
- A preliminary study of magnetization transfer and diffusion tensor MRI of multiple sclerosis patients with fatigue (2002) (60)
- A preliminary diffusion tensor and magnetization transfer magnetic resonance imaging study of early-onset multiple sclerosis. (2004) (59)
- Changes in functional and structural brain connectome along the Alzheimer’s disease continuum (2018) (59)
- Chemotactic factors enhance myogenic cell migration across an endothelial monolayer. (2001) (59)
- Activated macrophages release microvesicles containing polarized M1 or M2 mRNAs (2014) (58)
- Natalizumab versus fingolimod in patients with relapsing-remitting multiple sclerosis non-responding to first-line injectable therapies (2016) (58)
- Natalizumab in pediatric multiple sclerosis: results of a cohort of 55 cases (2013) (58)
- The effect of cladribine on T1 ‘black hole’ changes in progressive MS (2000) (58)
- Posterior brain damage and cognitive impairment in pediatric multiple sclerosis (2014) (57)
- A functional MRI study of movement-associated cortical changes in patients with Devic's neuromyelitis optica (2004) (57)
- Cerebellar contribution to motor and cognitive performance in multiple sclerosis: An MRI sub-regional volumetric analysis (2017) (57)
- Central nervous system delivery of interleukin 4 by a nonreplicative herpes simplex type 1 viral vector ameliorates autoimmune demyelination. (1998) (57)
- Medications for neuropathic pain: current trends (2006) (57)
- Cerebral grey matter pathology and fatigue in patients with multiple sclerosis: a preliminary study (2002) (57)
- Delivery to the central nervous system of a nonreplicative herpes simplex type 1 vector engineered with the interleukin 4 gene protects rhesus monkeys from hyperacute autoimmune encephalomyelitis. (2001) (57)
- Enhancement frequency decreases with increasing age in relapsing-remitting multiple sclerosis (2001) (57)
- Mapping regional grey and white matter atrophy in relapsing–remitting multiple sclerosis (2012) (57)
- Hippocampal‐DMN disconnectivity in MS is related to WM lesions and depression (2015) (56)
- Long-term follow-up of patients treated with glatiramer acetate: a multicentre, multinational extension of the European/Canadian double-blind, placebo-controlled, MRI-monitored trial (2007) (56)
- Functional cortical changes in patients with multiple sclerosis and nonspecific findings on conventional magnetic resonance imaging scans of the brain (2003) (56)
- Cytokines and immunity in multiple sclerosis: the dual signal hypothesis (2000) (56)
- Treatment of early-onset multiple sclerosis with intramuscular interferonβ-1a: long-term results (2007) (56)
- The Topography of Brain Microstructural Damage in Amyotrophic Lateral Sclerosis Assessed Using Diffusion Tensor MR Imaging (2011) (56)
- Wake-up stroke within 3 hours of symptom awareness: imaging and clinical features compared to standard recombinant tissue plasminogen activator treated stroke. (2013) (56)
- Evidence for Cortical Functional Changes in Patients With Migraine and White Matter Abnormalities on Conventional and Diffusion Tensor Magnetic Resonance Imaging (2003) (55)
- Quantitative muscle strength assessment in duchenne muscular dystrophy: longitudinal study and correlation with functional measures (2011) (55)
- The Italian multiple sclerosis register (2018) (55)
- Clinical and neurophysiological assessment of immunoglobulin therapy in five patients with multifocal motor neuropathy. (1994) (55)
- Oxidative Stress Is Differentially Present in Multiple Sclerosis Courses, Early Evident, and Unrelated to Treatment (2014) (55)
- Disease-modifying treatments for progressive multiple sclerosis (2013) (55)
- European study on intravenous immunoglobulin in multiple sclerosis: results of magnetization transfer magnetic resonance imaging analysis. (2004) (55)
- Correlations between cognitive impairment, middle cerebral artery flow velocity and cortical glucose metabolism in the early phase of Alzheimer's disease. (1995) (55)
- HSV-1-mediated IL-1 receptor antagonist gene therapy ameliorates MOG35–55-induced experimental autoimmune encephalomyelitis in C57BL/6 mice (2007) (54)
- Proinflammatory cytokines regulate antigen‐independent T‐cell Activation by two separate calcium‐signaling pathways in multiple sclerosis patients (1998) (54)
- Patients with migraine do not have MRI-visible cortical lesions (2012) (54)
- The brief neuropsychological battery for children: a screening tool for cognitive impairment in childhood and juvenile multiple sclerosis (2009) (54)
- A functional MRI study of cortical activations associated with object manipulation in patients with MS (2004) (54)
- Impaired Short-term Motor Learning in Multiple Sclerosis: Evidence From Virtual Reality (2007) (54)
- Efficacy and tolerability of natalizumab in relapsing–remitting multiple sclerosis patients: a post-marketing observational study (2010) (53)
- Interferon-γ and interferon-β affect endogenous catecholamines in human peripheral blood mononuclear cells: Implications for multiple sclerosis (2005) (53)
- Complementary and alternative medicine (CAM) use in an Italian cohort of pediatric headache patients: the tip of the iceberg (2014) (53)
- The Role of T1-Weighted Derived Measures of Neurodegeneration for Assessing Disability Progression in Multiple Sclerosis (2017) (53)
- Measuring evoked responses in multiple sclerosis (1999) (53)
- Early treatment (2006) (53)
- Cortical lesions in children with multiple sclerosis (2011) (52)
- The topographical distribution of tissue injury in benign MS: A 3T multiparametric MRI study (2008) (52)
- Autologous hematopoietic stem cell transplantation in neuromyelitis optica: A registry study of the EBMT Autoimmune Diseases Working Party (2015) (52)
- Neuroimaging findings in frontotemporal lobar degeneration spectrum of disorders (2012) (52)
- In vivo signatures of nonfluent/agrammatic primary progressive aphasia caused by FTLD pathology (2014) (51)
- Spectral analysis of heart rate variability signal and respiration in diabetic subjects (1990) (51)
- Grading cervical cord damage in neuromyelitis optica and MS by diffusion tensor MRI (2006) (51)
- Occult tissue damage in patients with primary progressive multiple sclerosis is independent of T2-visible lesions (2003) (51)
- Safety of the first dose of fingolimod for multiple sclerosis: results of an open-label clinical trial (2014) (51)
- Magnetization transfer ratios of multiple sclerosis lesions with variable durations of enhancement (1998) (51)
- Preserved brain adaptive properties in patients with benign multiple sclerosis (2010) (51)
- Therapy with interferon-β modulates endogenous catecholamines in lymphocytes of patients with multiple sclerosis (2008) (50)
- Recurrent disease-activity rebound in a patient with multiple sclerosis after natalizumab discontinuations for pregnancy planning (2016) (50)
- Brain and cord imaging features in neuromyelitis optica spectrum disorders (2019) (50)
- Structural and metabolic changes in the brain of patients with upper motor neuron disorders: A multiparametric MRI study (2009) (50)
- White Matter Degeneration in Atypical Alzheimer Disease. (2015) (50)
- Effect of a long‐term oral l‐arginine supplementation on glucose metabolism: a randomized, double‐blind, placebo‐controlled trial (2012) (50)
- Magnetization transfer and diffusion tensor MR imaging of basal ganglia from patients with multiple sclerosis (2001) (49)
- Prognostic value of serum neurofilaments in patients with clinically isolated syndromes (2019) (49)
- Safety and efficacy of nabiximols on spasticity symptoms in patients with motor neuron disease (CANALS): a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial (2019) (49)
- Central nervous system dysregulation extends beyond the pain-matrix network in cluster headache (2010) (49)
- Multimodal structural MRI in the diagnosis of motor neuron diseases (2017) (48)
- A multiparametric MRI study of frontal lobe dementia in multiple sclerosis (1999) (48)
- Structural and functional brain signatures of C9orf72 in motor neuron disease (2017) (48)
- Shifting the paradigm toward earlier treatment of multiple sclerosis with interferon beta. (2009) (48)
- COVID-19 in people with multiple sclerosis: A global data sharing initiative (2020) (48)
- Evoked potentials in diabetes mellitus. (1997) (48)
- Abnormal adaptation over time of motor network recruitment in multiple sclerosis patients with fatigue (2016) (48)
- Riboflavin and migraine: the bridge over troubled mitochondria (2014) (48)
- MRI to Monitor Treatment Efficacy in Multiple Sclerosis (2007) (48)
- Ocular surface injury induces inflammation in the brain: in vivo and ex vivo evidence of a corneal-trigeminal axis. (2014) (48)
- Pharmacogenomics in Alzheimer's disease: a genome-wide association study of response to cholinesterase inhibitors (2013) (48)
- The effect of imprecise repositioning on lesion volume measurements in patients with multiple sclerosis (1997) (47)
- Intra-voxel and inter-voxel coherence in patients with multiple sclerosis assessed using diffusion tensor MRI (2002) (47)
- Guidelines from The Italian Neurological and Neuroradiological Societies for the use of magnetic resonance imaging in daily life clinical practice of multiple sclerosis patients (2013) (47)
- A Longitudinal Magnetic Resonance Imaging Study of the Cervical Cord in Multiple Sclerosis (1997) (47)
- Analyzing histopathological features of rare charcot-marie-tooth neuropathies to unravel their pathogenesis. (2010) (47)
- Pyramidal tract lesions and movement-associated cortical recruitment in patients with MS (2004) (47)
- Sensitivity and reproducibility of volume change measurements of different brain portions on magnetic resonance imaging in patients with multiple sclerosis (2000) (47)
- Determinants of disability in multiple sclerosis at various disease stages: a multiparametric magnetic resonance study. (2007) (47)
- Sativex® and clinical–neurophysiological measures of spasticity in progressive multiple sclerosis (2015) (47)
- Therapy of primary headaches: the role of antidepressants (2004) (46)
- Gray matter trophism, cognitive impairment, and depression in patients with multiple sclerosis (2017) (46)
- A high‐resolution three‐dimensional T1‐weighted gradient echo sequence improves the detection of disease activity in multiple sclerosis (1996) (46)
- Sensitivities and predictive values of paraclinical tests for diagnosing multiple sclerosis (2004) (46)
- International consensus statement on the use of disease-modifying agents in multiple sclerosis (2002) (46)
- Interhemispheric Balance in Parkinson's Disease: A Transcranial Magnetic Stimulation Study (2013) (46)
- Observational case-control study of the prevalence of chronic cerebrospinal venous insufficiency in multiple sclerosis: results from the CoSMo study (2013) (46)
- White matter damage in frontotemporal lobar degeneration spectrum (2011) (46)
- Long-term disability progression in primary progressive multiple sclerosis: a 15-year study (2017) (45)
- Real-time assessment of COVID-19 prevalence among multiple sclerosis patients: a multicenter European study (2020) (45)
- Laquinimod prevents inflammation-induced synaptic alterations occurring in experimental autoimmune encephalomyelitis (2013) (45)
- Triple dose of gadolinium-DTPA and delayed MRI in patients with benign multiple sclerosis. (1996) (45)
- Central Nervous System Delivery of Interleukin 4 by a Nonreplicative Herpes Simplex Type 1 Viral Vector Ameliorates Autoimmune Demyelination (1998) (45)
- Randomized study of once-weekly interferon β-1a therapy in relapsing multiple sclerosis: three-year data from the OWIMS study (2005) (45)
- Rituximab in the treatment of Neuromyelitis optica: a multicentre Italian observational study (2016) (45)
- Intra-observer reproducibility in measuring new putative MR markers of demyelination and axonal loss in multiple sclerosis: a comparison with conventional T2-weighted images (1997) (45)
- Tumor necrosis factor α and its receptors in relapsing-remitting multiple sclerosis (1997) (45)
- Sativex in resistant multiple sclerosis spasticity: Discontinuation study in a large population of Italian patients (SA.FE. study) (2017) (45)
- Multiple sclerosis: pseudotumoral forms (2004) (45)
- Psychosocial issue in children and adolescents with multiple sclerosis (2010) (45)
- Copaxone’s effect on MRI-monitored disease in relapsing MS is reproducible and sustained (2002) (44)
- Interleukin 4 modulates microglia homeostasis and attenuates the early slowly progressive phase of amyotrophic lateral sclerosis (2018) (44)
- Noninvasive Neuromodulation in Poststroke Gait Disorders (2016) (44)
- Regional cervical cord atrophy and disability in multiple sclerosis: a voxel-based analysis. (2013) (44)
- Short-term correlations between clinical and MR imaging findings in relapsing-remitting multiple sclerosis. (2003) (44)
- APOE ε2-4 and -491 polymorphisms are not associated with MS (1999) (44)
- Diffusion tensor MRI contributes to differentiate Richardson's syndrome from PSP-parkinsonism (2012) (44)
- White matter microstructural damage in Alzheimer's disease at different ages of onset (2013) (43)
- Immunological patterns identifying disease course and evolution in multiple sclerosis patients (2005) (43)
- Neuroimaging in amyotrophic lateral sclerosis (1999) (43)
- A multiparametric evaluation of regional brain damage in patients with primary progressive multiple sclerosis (2009) (43)
- MRI outcomes with cladribine tablets for multiple sclerosis in the CLARITY study (2013) (43)
- Long-term effects of cladribine tablets on MRI activity outcomes in patients with relapsing–remitting multiple sclerosis: the CLARITY Extension study (2018) (43)
- Intranetwork and internetwork functional connectivity abnormalities in pediatric multiple sclerosis (2014) (42)
- Vaccinations in patients with multiple sclerosis: A Delphi consensus statement (2020) (42)
- The apparently milder course of multiple sclerosis: changes in the diagnostic criteria, therapy and natural history. (2020) (42)
- Quantitative EEG and LORETA: valuable tools in discerning FTD from AD? (2012) (42)
- Presence of carpal tunnel syndrome in diabetics: Effect of age, sex, diabetes duration and polyneuropathy (1985) (42)
- Cytokine therapy in immune-mediated demyelinating diseases of the central nervous system: a novel gene therapy approach (2000) (42)
- Incidence and course of depression in multiple sclerosis in the multinational BEYOND trial (2016) (42)
- Interferon beta-1 a for brain tissue loss in patients at presentation with syndromes suggestive of multiple sclerosis : a randomised , double-blind , placebo-controlled trial (2004) (42)
- Age-Related Changes in Motor Cortical Representation and Interhemispheric Interactions: A Transcranial Magnetic Stimulation Study (2014) (41)
- Benefit–Risk Profile of Sphingosine-1-Phosphate Receptor Modulators in Relapsing and Secondary Progressive Multiple Sclerosis (2017) (41)
- Neurophysiological investigations in multiple sclerosis. (2000) (41)
- Allogeneic hematopoietic stem cell transplantation for neuromyelitis optica (2014) (41)
- No evidence of disease activity (NEDA) analysis by epochs in patients with relapsing multiple sclerosis treated with ocrelizumab vs interferon beta-1a (2018) (41)
- Considerations on discontinuing natalizumab for the treatment of multiple sclerosis (2010) (41)
- Microstructural magnetic resonance imaging of cortical lesions in multiple sclerosis (2013) (41)
- Efficacy of fingolimod and interferon beta-1b on cognitive, MRI, and clinical outcomes in relapsing–remitting multiple sclerosis: an 18-month, open-label, rater-blinded, randomised, multicentre study (the GOLDEN study) (2017) (40)
- MiR-30e and miR-181d control Radial Glia cell proliferation via HtrA1 modulation (2012) (40)
- Abnormal functional connectivity of thalamic sub-regions contributes to fatigue in multiple sclerosis (2018) (40)
- Safety and efficacy of MD1003 (high-dose biotin) in patients with progressive multiple sclerosis (SPI2): a randomised, double-blind, placebo-controlled, phase 3 trial (2020) (40)
- Development of oral cladribine for the treatment of multiple sclerosis (2010) (40)
- Cxcl10 enhances blood cells migration in the sub-ventricular zone of mice affected by experimental autoimmune encephalomyelitis (2010) (40)
- Behavioural and EEG effects of chronic rapamycin treatment in a mouse model of Tuberous Sclerosis Complex (2013) (40)
- Structural brain abnormalities in patients with vestibular migraine (2017) (40)
- Brain white matter lesions in migraine: what’s the meaning? (2011) (40)
- Efficacy of fingolimod and interferon beta-1b on cognitive, MRI, and clinical outcomes in relapsing–remitting multiple sclerosis: an 18-month, open-label, rater-blinded, randomised, multicentre study (the GOLDEN study) (2017) (40)
- Dopaminergic Modulation of CD4+CD25high Regulatory T Lymphocytes in Multiple Sclerosis Patients during Interferon-β Therapy (2012) (40)
- Computational classifiers for predicting the short-term course of Multiple sclerosis (2011) (39)
- An MT MRI study of the cervical cord in clinically isolated syndromes suggestive of MS (2004) (39)
- MRI signatures of the frontotemporal lobar degeneration continuum (2015) (39)
- Wnt signaling has opposing roles in the developing and the adult brain that are modulated by Hipk1. (2012) (39)
- Induction vs. escalating therapy in Multiple Sclerosis: practical implications (2008) (39)
- Acute effects of L-dopa on event-related desynchronization in Parkinson's disease (2002) (39)
- Structural and functional magnetic resonance imaging correlates of motor network dysfunction in primary progressive multiple sclerosis (2010) (39)
- Contribution of abnormal insulin secretion and insulin resistance to the pathogenesis of type 2 diabetes in myotonic dystrophy. (2003) (39)
- Resting state functional connectivity alterations in primary lateral sclerosis (2014) (39)
- Cord damage elicits brain functional reorganization after a single episode of myelitis (2003) (39)
- The “mirror-neuron system” in MS (2008) (39)
- Teriflunomide reduces relapse-related neurological sequelae, hospitalizations and steroid use (2013) (39)
- Assessment of Opicinumab in Acute Optic Neuritis Using Multifocal Visual Evoked Potential (2018) (38)
- Abnormal pattern of cortical activation associated with voluntary movement in obsessive-compulsive disorder: an EEG study. (2001) (38)
- Progressive MS: from pathophysiology to drug discovery (2015) (38)
- Blood neurofilament light chain and total tau levels at admission predict death in COVID-19 patients (2021) (38)
- Correlation between brain MRI lesion volume and disability in patients with multiple sclerosis (1996) (38)
- Visual evoked potentials may be recorded simultaneously with fMRI scanning: A validation study (2005) (38)
- Mapping Early Changes of Cortical Motor Output after Subcortical Stroke: A Transcranial Magnetic Stimulation Study (2013) (38)
- Deep repetitive transcranial magnetic stimulation with H-coil on lower limb motor function in chronic stroke: a pilot study. (2014) (38)
- Efficacy of Cladribine Tablets in high disease activity subgroups of patients with relapsing multiple sclerosis: A post hoc analysis of the CLARITY study (2018) (37)
- A reassessment of the plateauing relationship between T2 lesion load and disability in MS (2009) (37)
- Flash visual evoked potentials in mice can be modulated by transcranial direct current stimulation (2011) (37)
- Associations of DMT therapies with COVID-19 severity in multiple sclerosis (2020) (37)
- Siponimod (BAF312) Activates Nrf2 While Hampering NFκB in Human Astrocytes, and Protects From Astrocyte-Induced Neurodegeneration (2020) (37)
- A 3-year diffusion tensor MRI study of grey matter damage progression during the earliest clinical stage of MS (2008) (37)
- Paths of cognitive and language development in healthy preterm infants. (2016) (37)
- Efficacy and safety of nabiximols (Sativex®) on multiple sclerosis spasticity in a real-life Italian monocentric study (2016) (37)
- Potassium depletion myopathy: A clinical and morphological study of six cases (1985) (37)
- Excitatory Deep Repetitive Transcranial Magnetic Stimulation With H-coil as Add-on Treatment of Motor Symptoms in Parkinson's Disease: An Open Label, Pilot Study (2014) (37)
- Motor nerve biopsy: Clinical usefulness and histopathological criteria (2011) (37)
- Cervical Cord T1-weighted Hypointense Lesions at MR Imaging in Multiple Sclerosis: Relationship to Cord Atrophy and Disability. (2018) (37)
- White matter microstructure abnormalities in pediatric migraine patients (2015) (37)
- Extramotor Damage Is Associated with Cognition in Primary Lateral Sclerosis Patients (2013) (37)
- Workshop on Neurobehavioral Disorders in Multiple Sclerosis. Diagnosis, underlying disease, natural history, and therapeutic intervention, Bergamo, Italy, June 25-27, 1992. (1993) (37)
- TBK1 mutations in Italian patients with amyotrophic lateral sclerosis: genetic and functional characterisation (2017) (37)
- Functional MR Imaging Correlates of Neuropsychological Impairment in Primary-Progressive Multiple Sclerosis (2010) (37)
- A systems biology approach uncovers cell-specific gene regulatory effects of genetic associations in multiple sclerosis (2019) (36)
- Interleukin 17F level and interferon β response in patients with multiple sclerosis. (2013) (36)
- No evidence of disease activity is associated with reduced rate of axonal retinal atrophy in MS (2017) (36)
- Relationship between corpus callosum atrophy and cerebral metabolic asymmetries in multiple sclerosis (1992) (36)
- Evaluation of an optimized [18F]fluoro‐deoxy‐glucose positron emission tomography voxel‐wise method to early support differential diagnosis in atypical Parkinsonian disorders (2017) (35)
- A Three-Year Study of Brain Atrophy after Autologous Hematopoietic Stem Cell Transplantation in Rapidly Evolving Secondary Progressive Multiple Sclerosis (2007) (35)
- Disease-modifying drugs can reduce disability progression in relapsing multiple sclerosis. (2020) (35)
- Peripheral neuropathy in scleroderma. (1993) (35)
- Neural precursor cell–secreted TGF-&bgr;2 redirects inflammatory monocyte-derived cells in CNS autoimmunity (2017) (35)
- Disease reactivation after fingolimod discontinuation in two multiple sclerosis patients (2012) (35)
- Neutralizing antibodies to interferon beta-1b multiple sclerosis: a clinico-radiographic paradox in the BEYOND trial (2012) (35)
- Why treat early multiple sclerosis patients? (2000) (35)
- Somatosensory evoked potentials and sensory involvement in multiple sclerosis: comparison with clinical findings and quantitative sensory tests (2003) (35)
- Cognitive reserve, cognition, and regional brain damage in MS: A 2 -year longitudinal study (2019) (35)
- Subcutaneous immunoglobulin therapy for the treatment of multifocal motor neuropathy: a case report (2010) (35)
- A pharmacogenetic study implicates SLC9a9 in multiple sclerosis disease activity (2015) (34)
- Fast progressive lower motor neuron disease is an ALS variant: A two-centre tract of interest-based MRI data analysis (2017) (34)
- Spectral analysis of short-term heart rate variability in diabetic patients. (1990) (34)
- Subclinical neurodegeneration in multiple sclerosis and neuromyelitis optica spectrum disorder revealed by optical coherence tomography (2020) (34)
- Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis Risk (2018) (33)
- Long-term management of natalizumab discontinuation in a large monocentric cohort of multiple sclerosis patients. (2014) (33)
- Genome sequencing uncovers phenocopies in primary progressive multiple sclerosis (2018) (33)
- An fMRI study of the motor system in patients with neuropsychiatric systemic lupus erythematosus (2006) (33)
- Association of Genetic Markers with CSF Oligoclonal Bands in Multiple Sclerosis Patients (2013) (33)
- Clinical, morphological and immunological evaluation of six patients with dysferlin deficiency (2003) (33)
- Characterization of immune cell subsets during the active phase of multiple sclerosis reveals disease and c-Jun N-terminal kinase pathway biomarkers (2011) (33)
- Peripheral nerve morphogenesis induced by scaffold micropatterning. (2014) (33)
- Alterations in the brain adenosine metabolism cause behavioral and neurological impairment in ADA-deficient mice and patients (2017) (32)
- THE RELATIONSHIP BETWEEN PERIPHERAL AND AUTONOMIC NEUROPATHY IN INSULIN DEPENDENT DIABETES: A CLINICAL AND INSTRUMENTAL EVALUATION (1978) (32)
- Structural connectivity‐defined thalamic subregions have different functional connectivity abnormalities in multiple sclerosis patients: Implications for clinical correlations (2017) (32)
- The extracellular matrix affects axonal regeneration in peripheral neuropathies (2008) (32)
- Axonal injury and overall tissue loss are not related in primary progressive multiple sclerosis. (2005) (32)
- The apolipoprotein E epsilon4 allele causes a faster decline of cognitive performances in Down's syndrome subjects. (1997) (32)
- Peripheral neuropathy associated with Crohn's disease (1987) (32)
- Differentiation between Subtypes of Primary Progressive Aphasia by Using Cortical Thickness and Diffusion-Tensor MR Imaging Measures. (2015) (32)
- Brain MR Imaging in Patients with Lower Motor Neuron-Predominant Disease. (2016) (32)
- Lymphocyte pharmacodynamics are not associated with autoimmunity or efficacy after alemtuzumab (2019) (32)
- Ceruloplasmin functional changes in Parkinson’s disease-cerebrospinal fluid (2015) (32)
- Efficacy and safety of ozanimod in multiple sclerosis: Dose-blinded extension of a randomized phase II study (2018) (32)
- P2X7 receptor is expressed in human vessels and might play a role in atherosclerosis. (2013) (32)
- Imaging patterns of gray and white matter abnormalities associated with PASAT and SDMT performance in relapsing-remitting multiple sclerosis (2019) (31)
- SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study (2021) (31)
- Differential cerebellar functional interactions during an interference task across multiple sclerosis phenotypes. (2012) (31)
- Clinical and genetic variability of glycogen storage disease type IIIa: seven novel AGL gene mutations in the Mediterranean area. (2002) (31)
- Autologous Bone Marrow Transplantation for the Treatment of Multiple Sclerosis (2014) (31)
- Paternal therapy with disease modifying drugs in multiple sclerosis and pregnancy outcomes: a prospective observational multicentric study (2014) (31)
- Comparative study of mitoxantrone efficacy profile in patients with relapsing—remitting and secondary progressive multiple sclerosis (2010) (31)
- Abnormalities of the executive control network in multiple sclerosis phenotypes: An fMRI effective connectivity study (2016) (30)
- A double blind, placebo-controlled, phase II, add-on study of cyclophosphamide (CTX) for 24 months in patients affected by multiple sclerosis on a background therapy with interferon-beta study denomination: CYCLIN (2004) (30)
- Management of pregnancy-related issues in multiple sclerosis patients: the need for an interdisciplinary approach (2017) (30)
- Prognostic indicators in pediatric clinically isolated syndrome (2017) (30)
- MRI and neurophysiological measures to predict course, disability and treatment response in multiple sclerosis. (2016) (30)
- Abnormal cervical cord function contributes to fatigue in multiple sclerosis (2012) (30)
- Subcutaneous interferon β-1a in the treatment of clinically isolated syndromes: 3-year and 5-year results of the phase III dosing frequency-blind multicentre REFLEXION study (2016) (30)
- Cerebrospinal Fluid Amyloid-β 42, Total Tau and Phosphorylated Tau are Low in Patients with Normal Pressure Hydrocephalus: Analogies and Differences with Alzheimer's Disease. (2017) (30)
- Gamma interferon activates a previously undescribed Ca2+ influx in T lymphocytes from patients with multiple sclerosis. (1994) (30)
- The efficacy of cladribine tablets in CIS patients retrospectively assigned the diagnosis of MS using modern criteria: Results from the ORACLE-MS study (2017) (29)
- Pediatric versus adult MS: similar or different? (2017) (29)
- Serum neurofilaments increase at progressive multifocal leukoencephalopathy onset in natalizumab‐treated multiple sclerosis patients (2019) (29)
- Interferon-beta treatment in multiple sclerosis patients decreases the number of circulating T cells producing interferon-gamma and interleukin-4. (2000) (29)
- White matter abnormalities in Parkinson's disease patients with glucocerebrosidase gene mutations (2013) (29)
- A composite score to predict short-term disease activity in patients with relapsing-remitting MS (2007) (29)
- Effects of seasons on magnetic resonance imaging–measured disease activity in patients with multiple sclerosis (2001) (29)
- MR Imaging of Brachial Plexus and Limb-Girdle Muscles in Patients with Amyotrophic Lateral Sclerosis. (2016) (29)
- Long-term disability trajectories in relapsing multiple sclerosis patients treated with early intensive or escalation treatment strategies (2021) (29)
- Visual Evoked Potentials as a Biomarker in Multiple Sclerosis and Associated Optic Neuritis (2018) (29)
- Fluid biomarker and electrophysiological outcome measures for progressive MS trials (2017) (29)
- Retromer stabilization results in neuroprotection in a model of Amyotrophic Lateral Sclerosis (2020) (29)
- Treatment of multiple sclerosis: role of natalizumab (2009) (29)
- Hereditary Spastic Paraplegia: Beyond Clinical Phenotypes toward a Unified Pattern of Central Nervous System Damage. (2015) (28)
- In vivo structural and functional assessment of optic nerve damage in neuromyelitis optica spectrum disorders and multiple sclerosis (2019) (28)
- Muscle glucose-6-phosphate dehydrogenase deficiency (1989) (28)
- Imaging cortical damage and dysfunction in multiple sclerosis. (2013) (28)
- Neurophysiological and cognitive markers of disease evolution in multiple sclerosis (1998) (28)
- Free Light Chains and Intrathecal B Cells Activity in Multiple Sclerosis: A Prospective Study and Meta-Analysis (2016) (28)
- Cortical control of unilateral simple movement in healthy aging (2011) (28)
- Post-marketing of disease modifying drugs in multiple sclerosis: An exploratory analysis of gender effect in interferon beta treatment (2009) (28)
- Cladribine tablets for relapsing-remitting multiple sclerosis: Efficacy across patient subgroups from the phase III CLARITY study. (2012) (28)
- Long-term follow-up of pediatric MS patients starting treatment with injectable first-line agents: A multicentre, Italian, retrospective, observational study (2019) (28)
- Multiple sclerosis relapses are associated with increased fatigue and reduced health-related quality of life - A post hoc analysis of the TEMSO and TOWER studies. (2016) (28)
- Transcranial magnetic stimulation and silent period in spasmodic torticollis. (2000) (28)
- Safety and tolerability of fingolimod in patients with relapsing-remitting multiple sclerosis: results of an open-label clinical trial in Italy (2016) (28)
- Glucose-6-phosphate dehydrogenase Lodi844C: a study on its expression in blood cells and muscle. (1991) (28)
- A nitric oxide releasing derivative of flurbiprofen inhibits experimental autoimmune encephalomyelitis (2004) (28)
- Motor evoked potentials in a mouse model of chronic multiple sclerosis (2006) (27)
- Evidence of subtle gray-matter pathologic changes in healthy elderly individuals with nonspecific white-matter hyperintensities. (2003) (27)
- Involvement of cortico-subcortical circuits in normoacousic chronic tinnitus: A source localization EEG study (2015) (27)
- Nonfluent/Agrammatic PPA with In-Vivo Cortical Amyloidosis and Pick’s Disease Pathology (2013) (27)
- Characterization of new arylsulfatase A gene mutations reinforces genotype‐phenotype correlation in metachromatic leukodystrophy (2009) (27)
- Long-term safety and tolerability of glatiramer acetate 20 mg/ml in the treatment of relapsing forms of multiple sclerosis (2016) (27)
- A widespread pattern of cortical activations in patients at presentation with clinically isolated symptoms is associated with evolution to definite multiple sclerosis. (2005) (27)
- The risk of infection in patients with multiple sclerosis treated with disease-modifying therapies: A Delphi consensus statement (2020) (27)
- Cladribine tablets for the treatment of relapsing–remitting multiple sclerosis (2013) (27)
- Cervical cord FMRI abnormalities differ between the progressive forms of multiple sclerosis (2012) (27)
- Brain macro- and microscopic damage in patients with paediatric MS (2010) (27)
- Patterns of white matter diffusivity abnormalities in Leber’s hereditary optic neuropathy: a tract-based spatial statistics study (2012) (27)
- Clinical Pregenetic Screening for Stroke Monogenic Diseases: Results From Lombardia GENS Registry (2016) (27)
- Engaging across dimensions of diversity: A cross-national perspective on mHealth tools for managing relapsing remitting and progressive multiple sclerosis. (2019) (27)
- Beta-endorphin concentrations in peripheral blood mononuclear cells of patients with multiple sclerosis: effects of treatment with interferon beta. (2000) (27)
- Brain MRI correlates of magnetization transfer imaging metrics in patients with multiple sclerosis (1999) (27)
- Clinically relevant cranio-caudal patterns of cervical cord atrophy evolution in MS (2019) (27)
- Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology (2021) (26)
- Cortical activation to voluntary movement in amyotrophic lateral sclerosis is related to corticospinal damage: Electrophysiological evidence (2012) (26)
- The cognitive reserve theory in the setting of pediatric-onset multiple sclerosis (2013) (26)
- Clinical and MRI predictors of response to interferon‐beta and glatiramer acetate in relapsing–remitting multiple sclerosis patients (2013) (26)
- A one year study of new lesions in multiple sclerosis using monthly gadolinium enhanced MRI: Correlations with changes of T2 and magnetization transfer lesion loads (1998) (26)
- Computer-assisted EEG monitoring during carotid endarterectomy. (2000) (26)
- Sporadic failure of botulinum toxin treatment in usually responsive patients with adductor spasmodic dysphonia (2001) (26)
- Normal tissue plasminogen activator and plasminogen activator inhibitor activity in plasma from patients with type 1 diabetes mellitus. (1992) (26)
- Relapses in patients treated with fingolimod after previous exposure to natalizumab (2015) (26)
- The Italian Multiple Sclerosis Database Network (MSDN): the risk of worsening according to IFNβ exposure in multiple sclerosis (2006) (26)
- Deep grey matter T2 hypo-intensity in patients with paediatric multiple sclerosis (2011) (26)
- Chronic cerebro-spinal venous insufficiency (CCSVI) and multiple sclerosis (2011) (26)
- Multispectral MRI with Dual Fluorinated Probes to Track Mononuclear Cell Activity in Mice. (2019) (26)
- COVID-19 Severity in Multiple Sclerosis (2021) (26)
- Functional and structural plasticity following action observation training in multiple sclerosis (2018) (25)
- Expanding the spectrum of genes responsible for hereditary motor neuropathies (2019) (25)
- The mirror‐neuron system and handedness: A “right” world? (2008) (25)
- Effect of glatiramer acetate on MS lesions enhancing at different gadolinium doses (2002) (25)
- Excitatory Deep Transcranial Magnetic Stimulation With H-Coil Over the Right Homologous Broca’s Region Improves Naming in Chronic Post-stroke Aphasia (2014) (25)
- Analysis of genes, pathways and networks involved in disease severity and age at onset in primary-progressive multiple sclerosis (2015) (25)
- Animal Models of Ischemic Stroke. Part One: Modeling Risk Factors (2010) (25)
- Response to interferon-beta treatment in multiple sclerosis patients: a genome-wide association study (2016) (25)
- Risk for Major Bleeding in Patients Receiving Ticagrelor Compared With Aspirin After Transient Ischemic Attack or Acute Ischemic Stroke in the SOCRATES Study (Acute Stroke or Transient Ischemic Attack Treated With Aspirin or Ticagrelor and Patient Outcomes) (2017) (25)
- Axonal neuropathy associated with interferon-α treatment for hepatitis C: HLA-DR immunoreactivity in Schwann cells (1997) (25)
- Smart watch, smarter EDSS: Improving disability assessment in multiple sclerosis clinical practice (2017) (25)
- Leukocyte Counts and Ratios Are Predictive of Stroke Outcome and Hemorrhagic Complications Independently of Infections (2020) (25)
- Regional hippocampal involvement and cognitive impairment in pediatric multiple sclerosis (2016) (25)
- Brain and spinal cord MR in benign multiple sclerosis: a follow-up study (1996) (25)
- Administration of a monomeric CCL2 variant to EAE mice inhibits inflammatory cell recruitment and protects from demyelination and axonal loss (2009) (25)
- Movement preparation is affected by tissue damage in multiple sclerosis: Evidence from EEG event-related desynchronization (2005) (25)
- Pharmacogenetic study of long-term response to interferon-β treatment in multiple sclerosis (2015) (25)
- Dysregulation of MS risk genes and pathways at distinct stages of disease (2017) (25)
- Movement-related event-related desynchronization in neuropsychiatric disorders. (2006) (25)
- In vivo evidence of hippocampal dentate gyrus expansion in multiple sclerosis (2015) (24)
- Response competition and response inhibition during different choice-discrimination tasks: evidence from ERP measured inside MRI scanner. (2013) (24)
- Down-sizing of neuronal network activity and density of presynaptic terminals by pathological acidosis are efficiently prevented by Diminazene Aceturate (2015) (24)
- Schwann cell overexpression of the GPR7 receptor in inflammatory and painful neuropathies (2005) (24)
- Endovascular treatment of CCSVI in patients with multiple sclerosis: clinical outcome of 462 cases (2013) (24)
- Brain stem magnetic resonance imaging and evoked potential studies of symptomatic multiple sclerosis patients. (1993) (24)
- Cerebrospinal fluid biomarkers can play a pivotal role in the diagnostic work up of primary progressive aphasia. (2014) (24)
- Efficacy and Safety of Alemtuzumab Through 9 Years of Follow-up in Patients with Highly Active Disease: Post Hoc Analysis of CARE-MS I and II Patients in the TOPAZ Extension Study (2020) (24)
- Action-related semantic content and negation polarity modulate motor areas during sentence reading: An event-related desynchronization study (2012) (24)
- Early treatment of multiple sclerosis (1998) (24)
- Italian Multiple Sclerosis Database Network (2006) (23)
- Dizziness, migrainous vertigo and psychiatric disorders (2009) (23)
- The prognosis of idiopathic optic neuritis (2000) (23)
- Structural connectivity in multiple sclerosis and modeling of disconnection (2020) (23)
- Clinical, neurophysiological, and magnetic resonance imaging correlations in multiple sclerosis. (1998) (23)
- Cognitive impairment in paediatric multiple sclerosis patients is not related to cortical lesions (2015) (23)
- The level of spinal cord involvement influences the pattern of movement-associated cortical recruitment in patients with isolated myelitis (2006) (23)
- A global immune deficit in Alzheimer's disease and mild cognitive impairment disclosed by a novel data mining process. (2014) (23)
- Extra-Visual Functional and Structural Connection Abnormalities in Leber's Hereditary Optic Neuropathy (2011) (23)
- Fixed combination of cinnarizine and dimenhydrinate in the prophylactic therapy of vestibular migraine: an observational study (2015) (23)
- Interferon-gamma and interferon-beta affect endogenous catecholamines in human peripheral blood mononuclear cells: implications for multiple sclerosis. (2005) (23)
- Immunological markers in multiple sclerosis (2000) (23)
- Clinical trials in multiple sclerosis: methodological issues (2005) (23)
- Effects of Natalizumab and Fingolimod on Clinical, Cognitive, and Magnetic Resonance Imaging Measures in Multiple Sclerosis (2019) (23)
- Following the Spreading of Brain Structural Changes in Alzheimer's Disease: A Longitudinal, Multimodal MRI Study. (2015) (23)
- Cognitive impairment and EEG background activity in adults with Down's syndrome: A topographic study (2011) (23)
- Quantitative brain volumetric analysis from patients with multiple sclerosis: a follow-up study (1999) (23)
- Long-term Clinical Outcomes of Hematopoietic Stem Cell Transplantation in Multiple Sclerosis (2021) (23)
- Efficacy of subcutaneous interferon β-1a on MRI outcomes in a randomised controlled trial of patients with clinically isolated syndromes (2013) (23)
- Cognitive function and neurophysiological evaluation in early-treated hypothyroid children (2000) (23)
- Interferon β treatment for multiple sclerosis has a graduated effect on MRI enhancing lesions according to their size and pathology (1999) (23)
- Cytokine gene therapy of autoimmune demyelination revisited using herpes simplex virus type-1-derived vectors (2000) (23)
- Efficacy and safety of ocrelizumab in relapsing multiple sclerosis: Results of the IFN-β-1a-controlled, double-blind, Phase III OPERA I and II studies (2016) (22)
- Regression of ventral striatum hypometabolism after calcium/calcitriol therapy in paroxysmal kinesigenic choreoathetosis due to idiopathic primary hypoparathyroidism (2001) (22)
- Rituximab in refractory chronic inflammatory demyelinating polyradiculoneuropathy: report of four cases (2017) (22)
- Impact of fatigue on the efficacy of rehabilitation in multiple sclerosis (2011) (22)
- Autoimmunity in the peripheral nervous system. (1996) (22)
- Assessment of the damage of the cerebral hemispheres in MS using neuroimaging techniques (2000) (22)
- Human-Centered Design Strategies for Device Selection in mHealth Programs: Development of a Novel Framework and Case Study (2020) (22)
- Combining Cerebrospinal Fluid Biomarkers and Neuropsychological Assessment: A Simple and Cost-Effective Algorithm to Predict the Progression from Mild Cognitive Impairment to Alzheimer's Disease Dementia. (2016) (22)
- Neurophysiological correlates of cognitive disturbances in multiple sclerosis (2010) (22)
- Effects of disease modifying treatments on cognitive dysfunction in multiple sclerosis (2010) (22)
- Myeloid cells as target of fingolimod action in multiple sclerosis (2015) (22)
- Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating neuropathy not responsive to other treatments. (1994) (22)
- Long-term safety data from the cladribine tablets clinical development program in multiple sclerosis. (2020) (22)
- Recurrent acute transverse myelopathy associated with anticardiolipin antibodies. (1998) (22)
- COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context (2021) (22)
- Pattern visual evoked potential mapping in Alzheimer's disease: correlations with visuospatial impairment. (1996) (22)
- A multimodal neuroimaging study of a case of crossed nonfluent/agrammatic primary progressive aphasia (2015) (21)
- Quantification of brain damage in cerebrotendinous xanthomatosis with magnetization transfer MR imaging. (2003) (21)
- The distribution of the magnetic resonance imaging response to glatiramer acetate in multiple sclerosis (2005) (21)
- Effects of pancreatic transplantation on diabetic polyneuropathy. (1991) (21)
- Working memory network dysfunction in relapse-onset multiple sclerosis phenotypes: A clinical-imaging evaluation (2017) (21)
- Italian multicentre observational study of the prevalence of CCSVI in multiple sclerosis (CoSMo study): rationale, design, and methodology (2013) (21)
- A magnetization transfer study of white matter in siblings of multiple sclerosis patients (1997) (21)
- Serum phosphorylated neurofilament heavy-chain levels reflect phenotypic heterogeneity and are an independent predictor of survival in motor neuron disease (2020) (21)
- Sensory tricks and brain excitability in cervical dystonia: A transcranial magnetic stimulation study (2014) (21)
- In Vivo Fate Analysis Reveals the Multipotent and Self-Renewal Features of Embryonic AspM Expressing Cells (2011) (21)
- The role of clinical and neuroimaging features in the diagnosis of CADASIL (2018) (21)
- Neurophysiological evaluation in detrusor instability (1993) (20)
- Can rate of brain atrophy in multiple sclerosis be explained by clinical and MRI characteristics? (2009) (20)
- Clinically isolated syndrome: the rationale for early treatment (2008) (20)
- Weight gain after subthalamic nucleus deep brain stimulation in Parkinson’s disease is influenced by dyskinesias’ reduction and electrodes’ position (2017) (20)
- Unraveling gene expression profiles in peripheral motor nerve from amyotrophic lateral sclerosis patients: insights into pathogenesis (2016) (20)
- Clinical significance of the number of oligoclonal bands in patients with clinically isolated syndromes (2015) (20)
- Reading, writing, and reserve: Literacy activities are linked to hippocampal volume and memory in multiple sclerosis (2016) (19)
- Evoked potentials in monitoring multiple sclerosis (2000) (19)
- Teriflunomide Efficacy and Safety in Patients with Relapsing Multiple Sclerosis: Results from TOWER, a Second, Pivotal, Phase 3 Placebo-Controlled Study (S01.004) (2013) (19)
- Neurophysiologic Studies and Cognitive Function in Congenital Hypothyroid Children (1995) (19)
- Tumor necrosis factor alpha and its receptors in relapsing-remitting multiple sclerosis. (1997) (19)
- Magnetic Resonance Spectroscopy in Multiple Sclerosis (2001) (19)
- EEG coherence in alzheimer and multi-infarct dementia (1997) (19)
- Endocrine involvement in mitochondrial encephalomyopathy with partial cytochrome c oxidase deficiency. (1989) (19)
- The window of opportunity for treatment of progressive multiple sclerosis. (2020) (19)
- The first year after diagnosis: psychological impact on people with multiple sclerosis (2017) (19)
- Further evidence about the crucial role of CSF biomarkers in diagnosis of posterior cortical atrophy (2014) (19)
- A whole genome screen for linkage disequilibrium in multiple sclerosis performed in a continental Italian population (2003) (19)
- Elevated body temperature is linked to fatigue in an Italian sample of relapsing–remitting multiple sclerosis patients (2015) (19)
- Teriflunomide reduces relapses with sequelae and relapses leading to hospitalizations: results from the TOWER study (2014) (19)
- Characterizing lymphocyte counts and infection rates with long-term teriflunomide treatment: Pooled analysis of clinical trials (2019) (19)
- Source model and scalp topography of pattern reversal visual evoked potentials to altitudinal stimuli suggest that infoldings of calcarine fissure are not part of VEP generators (2005) (19)
- Parry Romberg Syndrome associated with chronic facial pain (2013) (19)
- Defining peripheral nervous system dysfunction in the SOD-1G93A transgenic rat model of amyotrophic lateral sclerosis. (2014) (19)
- Defining Minor Symptoms in Acute Ischemic Stroke (2015) (19)
- Adverse events after endovascular treatment of chronic cerebro-spinal venous insufficiency (CCSVI) in patients with multiple sclerosis (2013) (19)
- A brain magnetization transfer MRI study with a clinical follow up of about four years in patients with clinically isolated syndromes suggestive of multiple sclerosis (2007) (19)
- APOE epsilon2-4 and -491 polymorphisms are not associated with MS. (1999) (18)
- Abnormal cerebellar functional MRI connectivity in patients with paediatric multiple sclerosis (2016) (18)
- The use of magnetic resonance imaging in multiple sclerosis: lessons learned from clinical trials (2004) (18)
- Clinical and radiologic correlates of a novel T lymphocyte γ‐interferon‐activated Ca2+ influx in patients with relapsing remitting multiple sclerosis (1996) (18)
- Impact of MS genetic loci on familial aggregation, clinical phenotype, and disease prediction (2015) (18)
- Monoclonal Antibodies Conjugated with Superparamagnetic Iron Oxide Particles Allow Magnetic Resonance Imaging Detection of Lymphocytes in the Mouse Brain (2012) (18)
- Association study of a new polymorphism in the PECAM-1 gene in multiple sclerosis (2000) (18)
- Half-dose fingolimod for treating relapsing-remitting multiple sclerosis: Observational study (2018) (18)
- Refractory chronic migraine: is drug withdrawal necessary before starting a therapy with onabotulinum toxin type A? (2016) (18)
- The Neurophysiologist Perspective into MS Plasticity (2015) (17)
- Fitbeat: COVID-19 estimation based on wristband heart rate using a contrastive convolutional auto-encoder (2021) (17)
- Absence of an intrathecal immune reaction to a helper-dependent adenoviral vector delivered into the cerebrospinal fluid of non-human primates (2008) (17)
- Cardiac autonomic function during sleep and wakefulness in multiple sclerosis (1995) (17)
- Progressive visual function impairment as the predominant symptom of the transition phase to secondary progressive multiple sclerosis: A case report. (2018) (17)
- Click-evoked otoacoustic emissions recorded from untreated congenital hypothyroid newborns (2002) (17)
- The role of non-conventional MR techniques to study multiple sclerosis patients (2001) (17)
- Pre-targeted immunodetection in glioma patients: tumour localization and single-photon emission tomography imaging of [99mTc]PnAO-biotin (1994) (17)
- A PET study with [11-C]raclopride in Parkinson's disease: preliminary results on the effect of amantadine on the dopaminergic system (2001) (17)
- β endorphin concentrations in PBMC of patients with different clinical phenotypes of multiple sclerosis (2003) (17)
- Italian consensus on treatment of spasticity in multiple sclerosis (2019) (17)
- Temporal evolution of neurophysiological and behavioral features of synapsin I/II/III triple knock-out mice (2013) (17)
- Natalizumab therapy of multiple sclerosis: recommendations of the Multiple Sclerosis Study Group—Italian Neurological Society (2011) (17)
- Multicenter trial with ubidecarenone: treatment of 44 patients with mitochondrial myopathies. (1991) (16)
- Neurophysiological markers (2008) (16)
- Proteomic identification of aldolase A as an autoantibody target in patients with atypical movement disorders (2013) (16)
- Electroencephalographic background desynchronization during cerebral blood flow reduction (2005) (16)
- Absence of oligoclonally restricted immunoglobulins in tears from multiple sclerosis patients (1993) (16)
- Chronic motor axonal neuropathy (2011) (16)
- Transition to secondary progression in relapsing-onset multiple sclerosis: Definitions and risk factors (2020) (16)
- Foot Pad Skin Biopsy in Mouse Models of Hereditary Neuropathy (2010) (16)
- The CSF p-tau181/Aβ42 Ratio Offers a Good Accuracy "in Vivo" in the Differential Diagnosis of Alzheimer's Dementia. (2019) (16)
- Motor Cortical Plasticity to Training Started in Childhood: The Example of Piano Players (2016) (16)
- Clinical and MRI correlates of disease progression in a case of nonfluent/agrammatic variant of primary progressive aphasia due to progranulin (GRN) Cys157LysfsX97 mutation (2014) (16)
- Absence of diffuse cervical cord tissue damage in early, non-disabling relapsing-remitting MS: a preliminary study (2008) (16)
- Survival prediction models in motor neuron disease (2019) (16)
- Correlation between multimodal evoked potentials and magnetic resonance imaging in multiple sclerosis (2004) (16)
- Pre-targeted immunodetection in glioma patients: tumour localization and single-photon emission tomography imaging of [99mTc]PnAO-biotin (2004) (16)
- Compensatory movement-related recruitment in amyotrophic lateral sclerosis patients with dominant upper motor neuron signs: An EEG source analysis study (2011) (16)
- Acquired haemophilia A as a secondary autoimmune disease after alemtuzumab treatment in multiple sclerosis: A case report. (2019) (16)
- The role of transcranial Doppler in carotid artery surgery. (1992) (16)
- Efficacy of alemtuzumab in relapsing-remitting MS patients who received additional courses after the initial two courses: Pooled analysis of the CARE-MS, extension, and TOPAZ studies (2019) (16)
- Motor area localization using fMRI-constrained cortical current density reconstruction of movement-related cortical potentials, a comparison with fMRI and TMS mapping (2010) (16)
- Effects of long-lasting antiepileptic therapy on brainstem auditory evoked potentials. (1988) (16)
- Effect of prior treatment status and reasons for discontinuation on the efficacy and safety of fingolimod vs. interferon β-1a intramuscular: Subgroup analyses of the Trial Assessing Injectable Interferon vs. Fingolimod Oral in Relapsing-Remitting Multiple Sclerosis (TRANSFORMS). (2014) (16)
- Practice of yoga may cause damage of both sciatic nerves: a case report (2013) (16)
- Laquinimod Safety Profile: Pooled Analyses from the ALLEGRO and BRAVO Trials. (2017) (15)
- Association between DPP6 polymorphism and the risk of progressive multiple sclerosis in Northern and Southern Europeans (2012) (15)
- CHRNA7 Gene and Response to Cholinesterase Inhibitors in an Italian Cohort of Alzheimer's Disease Patients. (2016) (15)
- Long-term results from a phase 2 extension study of fingolimod at high and approved dose in relapsing multiple sclerosis (2015) (15)
- Predictors of effectiveness of multidisciplinary rehabilitation treatment on motor dysfunction in multiple sclerosis (2014) (15)
- High tumor necrosis factor-alpha [corrected] levels in cerebrospinal fluid of cobalamin-deficient patients. (2004) (15)
- Cumulative effect of a weekly low dose of interferon beta 1a on standard and triple dose contrast-enhanced MRI from multiple sclerosis patients (1999) (15)
- Transcriptional dysregulation of Interferome in experimental and human Multiple Sclerosis (2017) (15)
- Selective killing of spinal cord neural stem cells impairs locomotor recovery in a mouse model of spinal cord injury (2018) (15)
- Short-term evolution of new multiple sclerosis lesions enhancing on standard and triple dose gadolinium-enhanced brain MRI scans (1999) (15)
- Validation of 1‐year predictive score of long‐term response to interferon‐β in everyday clinical practice multiple sclerosis patients (2015) (15)
- Delayed Diagnosis in Pediatric Headache: An Outpatient Italian Survey (2011) (15)
- Interferon-γ induces T lymphocyte proliferation in multiple sclerosis via a Ca2+-dependent mechanism (1995) (15)
- Multiple biomarkers improve the prediction of multiple sclerosis in clinically isolated syndromes (2017) (15)
- Stroke Care in Young Patients (2013) (15)
- Association of stiff-man syndrome and type I diabetes with islet cell and other autoantibodies. (1988) (15)
- Ocrelizumab No Evidence of Disease Activity (NEDA) Status at 96 Weeks in Patients with Relapsing Multiple Sclerosis: Analysis of the Phase III Double-Blind, Double-Dummy, Interferon beta-1a-Controlled OPERA I and OPERA II Studies (PL02.004) (2016) (15)
- Cognitive impairment in progressive supranuclear palsy-Richardson's syndrome is related to white matter damage. (2016) (15)
- Metallothioneins as dynamic markers for brain disease in lysosomal disorders (2014) (15)
- The heritage of glatiramer acetate and its use in multiple sclerosis (2016) (15)
- Pregnancy Outcomes During the Clinical Development Program of Cladribine in Multiple Sclerosis: An Integrated Analysis of Safety (2020) (15)
- A gene therapy approach to treat demyelinating diseases using nonreplicative herpetic vectors engineered to produce cytokines (1998) (15)
- Clinical and MRI assessment of brain damage in MS (2001) (15)
- Patient subgroup analyses of the treatment effect of subcutaneous interferon β-1a on development of multiple sclerosis in the randomized controlled REFLEX study (2014) (14)
- Clinical Features of Headache in Patients With Diagnosis of Definite Vestibular Migraine: The VM-Phenotypes Projects (2018) (14)
- Clinical response to Nabiximols correlates with the downregulation of immune pathways in multiple sclerosis (2018) (14)
- Urokinase Plasminogen Receptor and the Fibrinolytic Complex Play a Role in Nerve Repair after Nerve Crush in Mice, and in Human Neuropathies (2012) (14)
- Neurophysiological imaging techniques in dementia (1999) (14)
- Risk of Getting COVID-19 in People With Multiple Sclerosis (2022) (14)
- MUSCLE G6PD DEFICIENCY (1987) (14)
- Progressive MS Alliance Industry Forum: Maximizing Collective Impact To Enable Drug Development. (2016) (14)
- Hippocampal-related memory network in multiple sclerosis: A structural connectivity analysis (2015) (14)
- Early treatment of multiple sclerosis with Rebif (recombinant human interferon beta): design of the study. (1995) (14)
- The Communication of Multiple Sclerosis Diagnosis: The Patients' Perspective (2015) (14)
- Reproducibility of Brain MRI Lesion Volume Measurements in Multiple Sclerosis Using a Local Thresholding Technique: Effects of Formal Operator Training (1999) (14)
- Teriflunomide Increases the Proportion of Patients Free from Disease Activity in the TEMSO Phase III Study (PD5.007) (2012) (14)
- Changes in brain glucose metabolism in subthalamic nucleus deep brain stimulation for advanced Parkinson's disease. (2012) (14)
- Imaging correlates of hand motor performance in multiple sclerosis: A multiparametric structural and functional MRI study (2020) (14)
- Association of Vitamin D LevelsWithMultiple Sclerosis Activity and Progression in Patients Receiving Interferon Beta-1 b (2015) (14)
- MxA mRNA Quantification and Disability Progression in Interferon Beta-Treated Multiple Sclerosis Patients (2014) (14)
- Emotional outcomes in clinically isolated syndrome and early phase multiple sclerosis: a systematic review and meta-analysis. (2019) (13)
- Fingolimod Treatment Increases the Proportion of Patients Who Are Free from Disease Activity in Multiple Sclerosis Compared to IFN-b1a: Results from a Phase 3, Active-Controlled Study (TRANSFORMS) (PD5.006) (2012) (13)
- Transplacental injection of somite-derived cells in mdx mouse embryos for the correction of dystrophin deficiency. (2000) (13)
- Visual evoked potentials in diabetic teen-agers: influence of metabolic control and relationship with peripheral neuropathy. (1986) (13)
- Added value of multimodal MRI to the clinical diagnosis of primary progressive aphasia variants (2019) (13)
- Semi-invasive and non-invasive recording of visual evoked potentials in mice (2019) (13)
- Cerebral thrombi of cardioembolic etiology have an increased content of neutrophil extracellular traps (2021) (13)
- Genetic burden of common variants in progressive and bout-onset multiple sclerosis (2014) (13)
- Evoked potentials in diagnosis and monitoring of multiple sclerosis. (1999) (13)
- Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis Risk (2020) (13)
- Action observation training modifies brain gray matter structure in healthy adult individuals (2017) (13)
- Giant Anterior Arachnoid Cyst Associated With Syringomyelia: Implications for Treatment and Follow-up (2010) (13)
- Assessment, pathophysiology and treatment of fatigue in multiple sclerosis (2002) (13)
- Risk of Persistent Disability in Patients With Pediatric-Onset Multiple Sclerosis. (2021) (13)
- Inverse correlation of genetic risk score with age at onset in bout-onset and progressive-onset multiple sclerosis (2015) (13)
- Correlation between MRI and Short-Term Clinical Activity in Multiple Sclerosis: Comparison between Standard- and Triple-Dose Gd-Enhanced MRI (1999) (13)
- Persistence of congenital mirror movements after hemiplegic stroke. (2005) (13)
- Clinical Efficacy of Cladribine Tablets in Patients with Relapsing-Remitting Multiple Sclerosis (RRMS): Final Results from the 120-Week Phase IIIb Extension Trial to the CLARITY Study (P3.028) (2016) (13)
- Cortical Motor Circuits after Piano Training in Adulthood: Neurophysiologic Evidence (2016) (12)
- Magnetization transfer and diffusion tensor MR imaging of the optic radiations and calcarine cortex from patients with Leber's hereditary optic neuropathy (2001) (12)
- Intensive immunosuppression in multiple sclerosis (2006) (12)
- Lack of association betweenIL-1A and IL-1Bpromoter polymorphisms and multiple sclerosis (2000) (12)
- Effectiveness and baseline factors associated to fingolimod response in a real-world study on multiple sclerosis patients (2018) (12)
- Disease control and safety in relapsing remitting multiple sclerosis (RRMS) patients switching from natalizumab to fingolimod: a 32-week, rater- and patient-blind, randomized, parallel-group study (TOFINGO) (2013) (12)
- Brain connectivity abnormalities extend beyond the sensorimotor network in peripheral neuropathy (2014) (12)
- Clinical neurophysiology of multiple sclerosis. (2014) (12)
- Apparatus design and behavioural testing protocol for the evaluation of spatial working memory in mice through the spontaneous alternation T-maze (2021) (12)
- The efficacy of teriflunomide in patients who received prior disease-modifying treatments: Subgroup analyses of the teriflunomide phase 3 TEMSO and TOWER studies (2017) (12)
- Ozanimod in relapsing multiple sclerosis: Pooled safety results from the clinical development program. (2021) (12)
- Prognosis-modifying therapy in multiple sclerosis (2000) (12)
- MGAT5 and disease severity in progressive multiple sclerosis (2011) (12)
- Different Frontal Involvement in ALS and PLS Revealed by Stroop Event-Related Potentials and Reaction Times (2013) (12)
- The burden of multiple sclerosis variants in continental Italians and Sardinians (2015) (12)
- Magnetization transfer ratio changes in a symptomatic lesion of a patient at presentation with possible multiple sclerosis (1997) (12)
- Inferring Multiple Sclerosis Stages from the Blood Transcriptome via Machine Learning (2020) (12)
- Intravenous immunoglobulin treatment in multifocal motor neuropathy and other chronic immune-mediated neuropathies (1997) (12)
- Normal-appearing White and Grey Matter Damage in Multiple Sclerosis (2004) (12)
- Disease-modifying treatments modulate myeloid cells in multiple sclerosis patients (2018) (12)
- Balance exercise in patients with chronic sensory ataxic neuropathy: a pilot study (2014) (12)
- Electrophysiological studies of brain plasticity of the motor system (2006) (12)
- Ganglioside treatment in diabetic peripheral neuropathy: A multicenter trial (1983) (12)
- Non‐invasive visual evoked potentials to assess optic nerve involvement in the dark agouti rat model of experimental autoimmune encephalomyelitis induced by myelin oligodendrocyte glycoprotein (2020) (11)
- Dysregulated copper transport in multiple sclerosis may cause demyelination via astrocytes (2021) (11)
- Vocal cord paralysis in Charcot–Marie–Tooth type 4b1 disease associated with a novel mutation in the myotubularin-related protein 2 gene: A case report and review of the literature (2017) (11)
- P300 and EEG mapping in Down's syndrome (1997) (11)
- Correlation between enhancing lesion number and volume on standard and triple dose gadolinium-enhanced brain MRI scans from patients with multiple sclerosis. (1999) (11)
- Effects of cladribine tablets on peripheral lymphocyte subtypes implicated in multiple sclerosis immunopathogenesis: surface marker analysis for a subset of patients from the 96-week, phase III, double-blind, placebo-controlled CLARITY study (2009) (11)
- Effect of Ozanimod on Symbol Digit Modalities Test Performance in Relapsing MS. (2020) (11)
- CSF metabolites in the differential diagnosis of Alzheimer’s disease from frontal variant of frontotemporal dementia (2012) (11)
- Occurrence of thyroid autoimmunity in relapsing remitting multiple sclerosis patients undergoing interferon-β treatment (1998) (11)
- Upper limb motor evoked potentials as outcome measure in progressive multiple sclerosis (2019) (11)
- MS treatment: New perspectives (2006) (11)
- A Comparison Between the Sensitivities of 3‐mm and 5‐mm Thick Serial Brain MRI for Detecting Lesion Volume Changes in Patients with Multiple Sclerosis (1998) (11)
- Cortical function abnormalities in migraine: neurophysiological and neuropsychological evidence from reaction times and event-related potentials to the Stroop Test (2004) (11)
- Variability in detection and quantification of interferon β-1b–induced neutralizing antibodies (2012) (11)
- Neurophysiological study of the effect of combined kidney and pancreas transplantation on diabetic neuropathy: a 2-year follow-up evaluation (1991) (11)
- Stopping disease-modifying therapy in relapsing and progressive multiple sclerosis (2021) (11)
- Peripheral nerve abnormalities in newly-diagnosed diabetic children (2007) (11)
- Churg Strauss syndrome presenting as acute neuropathy resembling Guillain Barré syndrome (2008) (11)
- Anton’s Syndrome following Callosal Disconnection (2007) (11)
- Laser capture microdissection for transcriptomic profiles in human skin biopsies (2018) (11)
- Electrophysiological investigations in multiple sclerosis dementia. (1999) (10)
- Treatment of Wernicke’s encephalopathy with high dose of thiamine in a patient with pyloric sub-stenosis: description of a case (2010) (10)
- Long term follow-up in advanced Parkinson’s disease treated with DBS of the subthalamic nucleus (2021) (10)
- Acute myelopathy selectively involving lumbar anterior horns following intranasal insufflation of ecstasy and heroin (2007) (10)
- A comparison of the sensitivity of monthly unenhanced and enhanced MRI techniques in detecting new multiple sclerosis lesions (1999) (10)
- From neuroimaging to clinical setting: what have we learned from migraine pain? (2012) (10)
- Basal vitamin D levels and disease activity in multiple sclerosis patients treated with fingolimod (2018) (10)
- Treatment Challenges of a Primary Vertebral Artery Aneurysm Causing Recurrent Ischemic Strokes (2017) (10)
- NLRP3 polymorphisms and response to interferon-beta in multiple sclerosis patients (2018) (10)
- Striatal hand in Parkinson’s disease: the re-evaluation of an old clinical sign (2013) (10)
- Long-term outcomes with teriflunomide in patients with clinically isolated syndrome: Results of the TOPIC extension study★★. (2019) (10)
- DT MRI microstructural cortical lesion damage does not explain cognitive impairment in MS (2017) (10)
- Neurodegeneration in Multiple Sclerosis (2008) (10)
- Reduction in Healthcare and Societal Resource Utilization Associated with Cladribine Tablets in Patients with Relapsing-Remitting Multiple Sclerosis (2012) (10)
- Peripheral neuropathy associated with mycosis fungoides. (1989) (10)
- The progranulin (GRN) Cys157LysfsX97 mutation is associated with nonfluent variant of primary progressive aphasia clinical phenotype. (2012) (10)
- Functioning and quality of life in patients with neuropathy associated with anti-MAG antibodies (2018) (10)
- Performance of the 2017 and 2010 Revised McDonald Criteria in Predicting MS Diagnosis After a Clinically Isolated Syndrome (2021) (9)
- Multiple sclerosis progression: time for a new mechanism-driven framework (2022) (9)
- Plasma neurofilament light chain concentrations as a biomarker of clinical and radiologic outcomes in relapsing multiple sclerosis: Post hoc analysis of Phase 3 ozanimod trials (2021) (9)
- Frequency of Infections during Treatment with Teriflunomide: Pooled Data from Three Placebo-Controlled Teriflunomide Studies (P01.171) (2013) (9)
- Can evoked potentials be useful in monitoring multiple sclerosis evolution? (1997) (9)
- Caesarean section and infant formula feeding are associated with an earlier age of onset of multiple sclerosis. (2019) (9)
- Lambert-Eaton myasthenic syndrome and polyneuropathy in a patient with epidermoid carcinoma of the lung. (1993) (9)
- Haematological profiles in patients treated with cladribine tablets for relapsing-remitting multiple sclerosis (RRMS): results from the CLARITY study, a 96 week, phase III, double-blind, placebo-controlled trial (2009) (9)
- Interferon-γ induced increases in intracellular calcium in T lymphocytes from patients with multiple sclerosis precede clinical exacerbations and detection of active lesions on MRI (1997) (9)
- Pharmacogenetic influence of eNOS gene variant on endothelial and glucose metabolism responses to L-arginine supplementation: Post hoc analysis of the L-arginine trial. (2015) (9)
- Disclosing the diagnosis of multiple sclerosis: The Profile Project (2012) (9)
- Deep magnetic stimulation in a progressive supranuclear palsy patient with speech involvement (2013) (9)
- Recurrence of disease activity after repeated Natalizumab withdrawals (2015) (9)
- Extracorporeal Circulation as a New Experimental Pathway for Myoblast Implantation in mdx Mice (1999) (9)
- Southern Egypt Stroke Study: Case Fatality Rates in a Hospital-Based Setting (2009) (9)
- Pregnancy in multiple sclerosis women with relapses in the year before conception increases the risk of long-term disability worsening (2021) (9)
- Serial immunoprecipitation assays for interferon--(IFN)-beta antibodies in multiple sclerosis patients. (2003) (9)
- Can pharmacological manipulation of LTP favor the effects of motor rehabilitation in multiple sclerosis? (2018) (9)
- Language Disturbances in a Group of Participants Suffering from Duchenne Muscular Dystrophy: A Pilot Study (2007) (9)
- Pediatric sporadic hemiplegic migraine (ATP1A2 gene): a case report and brief literature review (2018) (9)
- Long-term safety and efficacy of teriflunomide in patients with relapsing multiple sclerosis: Results from the TOWER extension study. (2020) (9)
- Visual evoked potentials can be reliably recorded using noninvasive epidermal electrodes in the anesthetized rat (2018) (9)
- MRI substrates of sustained attention system and cognitive impairment in pediatric MS patients (2017) (9)
- Spontaneous intracerebral hemorrhage in Urbach-Wiethe disease (2012) (9)
- No evidence of ATP1A2 involvement in 12 multiplex Italian families with benign familial infantile seizures (2005) (9)
- Oral Fingolimod (FTY720) Treatment Improves the Performance of Daily Activities Compared with Intramuscular Interferon beta-1a: Patient-Reported Indices for Multiple Sclerosis (PRIMUS)-Activities Results from a Phase III Study (TRANSFORMS) (2010) (9)
- Bilateral Repetitive Transcranial Magnetic Stimulation With the H-Coil in Parkinson's Disease: A Randomized, Sham-Controlled Study (2021) (9)
- Corpus Callosum Damage and Motor Function in Parkinson’s Disease (P2.006) (2014) (8)
- Long-Term (7-Year) Data from a Phase 2 Extension Study of Fingolimod in Relapsing Multiple Sclerosis (P01.129) (2012) (8)
- Optical Coherence Tomography and Visual Evoked Potentials as Prognostic and Monitoring Tools in Progressive Multiple Sclerosis (2021) (8)
- The brachial plexus branches to the pectoral muscles in adult rats: morphological aspects and morphometric normative data (2012) (8)
- Induction and add-on therapy with Mitoxantrone and Interferon beta in multiple sclerosis (2008) (8)
- Can glatiramer acetate reduce brain atrophy development in multiple sclerosis? (2005) (8)
- Lombardia GENS: a collaborative registry for monogenic diseases associated with stroke. (2012) (8)
- Effectiveness of fingolimod in real-world relapsing-remitting multiple sclerosis Italian patients: the GENIUS study (2020) (8)
- Efficacy of Ocrelizumab in Patients with Relapsing Multiple Sclerosis: Pooled Analysis of Two Identical Phase III, Double-Blind, Double-Dummy, Interferon Beta-1a-Controlled Studies (S49.003) (2016) (8)
- Is it clinically relevant to repair focal multiple sclerosis lesions? (2008) (8)
- A fatal case of Churg–Strauss syndrome presenting with acute polyneuropathy mimicking Guillain–Barré syndrome (2011) (8)
- Neuro-Retina Might Reflect Alzheimer's Disease Stage. (2020) (8)
- Alemtuzumab Maintains Efficacy on Clinical and MRI Disease Activity Outcomes, Including Slowing of Brain Volume Loss, Over 9 Years in RRMS Patients: CARE-MS II Follow-up (TOPAZ Study) (2020) (8)
- From primary progressive aphasia to corticobasal syndrome: two clinical and rCBF functional reports (2013) (8)
- Clinical deterioration due to co-occurrence of multiple sclerosis and glioblastoma: report of two cases (2017) (8)
- Cross-modal plasticity among sensory networks in neuromyelitis optica spectrum disorders (2016) (8)
- Effect of HLA-DRB1 alleles and genetic variants on the development of neutralizing antibodies to interferon beta in the BEYOND and BENEFIT trials (2019) (8)
- Ozanimod Demonstrates Efficacy and Safety in a Multicenter, Randomized, Double-Blind, Double-Dummy, Active-Controlled Phase 3 Trial of Relapsing Multiple Sclerosis (SUNBEAM) (P3.396) (2018) (8)
- Loss of Circulating CD8+ CD161high T Cells in Primary Progressive Multiple Sclerosis (2019) (8)
- Delayed hyperbaric oxygen treatment after acute carbon monoxide poisoning (2011) (8)
- The “vegetarian brain”: chatting with monkeys and pigs? (2013) (8)
- Vaccination with amyloid-b peptide induces autoimmune encephalomyelitis in C 57 / BL 6 mice (8)
- CONCERTO: A randomized, placebo-controlled trial of oral laquinimod in relapsing-remitting multiple sclerosis (2021) (8)
- Teriflunomide Reduces Relapse-Related Sequelae, Hospitalizations and Corticosteroid Use: A Post-Hoc Analysis of the Phase 3 TOWER Study (P07.109) (2013) (7)
- Understanding fatigue in multiple sclerosis: new insights in causes and assessment (2006) (7)
- P19.19 Effects of high-frequency repetitive transcranial magnetic stimulation (rTMS) applied with H-coil for chronic migraine prophylaxis (2011) (7)
- Aldose reductase inhibitors: pharmacological data and therapeutic perspectives (1985) (7)
- Correlations between Measures of Multiple Sclerosis Pathology Derived from T2, T1, Magnetization Transfer and Diffusion Tensor MR Imaging (2001) (7)
- Clinical Efficacy of Laquinimod for the Treatment of Multiple Sclerosis; Pooled Analyses from the ALLEGRO and BRAVO Phase III Trials (S01.007) (2012) (7)
- Familial clustering in Italian progressive-onset and bout-onset multiple sclerosis (2014) (7)
- Does hemispheric dominance influence brain lesion distribution in multiple sclerosis? (1995) (7)
- MEAN DIFFUSIVITY AND FRACTIONAL ANISOTROPY HISTOGRAM ANALYSIS OF THE CERVICAL CORD IN PATIENTS WITH MULTIPLE SCLEROSIS. (2004) (7)
- Sturge-Weber syndrome with an unusual onset in the sixth decade: a case report (2012) (7)
- Evaluation of central nervous conduction by visual evoked potentials in insulin-dependent diabetic children. metabolic and clinical correlations (1987) (7)
- Results from the CLARITY Study: a Phase III, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Oral Cladribine in Relapsing-Remitting Multiple Sclerosis (RRMS) (2009) (7)
- Safety and tolerability of cladribine tablets in relapsing-remitting multiple sclerosis during the 96-week, phase III, double-blind, placebo-controlled CLARITY study (2009) (7)
- Acute myelopathy selectively involving lumbar anterior horns following intranasal insufflation of ecstasy and heroin (2009) (7)
- Microbial Risk Factors of Cardiovascular and Cerebrovascular Diseases: Potential Therapeutical Options (2008) (7)
- Pharmacokinetics and pharmacodynamics of natalizumab in pediatric patients with RRMS (2019) (7)
- Efficacy and safety of interferon beta-1b sc in older RRMS patients—a posthoc analysis of the BEYOND study (2013) (7)
- Distributed abnormalities of brain white matter architecture in patients with dominant optic atrophy and OPA1 mutations (2015) (7)
- Efficacy Results of the Phase 2 Portion of the RADIANCE Trial: A Randomized, Double-blind, Placebo-controlled Trial of Oral RPC1063 in Adults with Relapsing Multiple Sclerosis (P7.198) (2015) (7)
- Pooled Analyses from the ALLEGRO and BRAVO Trials on the Safety and Tolerability of Laquinimod as a Multiple Sclerosis Treatment (P04.132) (2012) (7)
- Magnetic Resonance Techniques in Multiple Sclerosis (2016) (7)
- Understanding Factors Associated With Psychomotor Subtypes of Delirium in Older Inpatients With Dementia. (2020) (7)
- Changes in Migraine Patients With T 2-Visible Lesions A 3T MRI Study (2006) (7)
- Magnetic Resonance Techniques in Clinical Trials in Multiple Sclerosis (2012) (7)
- MRI AND MT 1 CHANGES IN THE BRAIN AND CERVICAL CORD FROM PATIENTS WITH DEVIC ’ S NEUROMYELITIS OPTICA (1999) (7)
- A real world experience with fingolimod in active RRMS patients naïve to second-line agents: a 2 years, intention-to-treat, observational, single center study (2016) (7)
- Copolymer 1 (1997) (7)
- Subclinical anterior optic pathway involvement in early multiple sclerosis and clinically isolated syndromes. (2021) (7)
- Deep rTMS with H-Coil Associated with Rehabilitation Enhances Improvement of Walking Abilities in Patients with Progressive Multiple Sclerosis: Randomized, Controlled, Double Blind Study (S49.007) (2012) (7)
- Effect of carotid stenosis on the prognostic value of admission blood pressure in patients with acute ischemic stroke. (2009) (7)
- Teriflunomide added to interferon-β in relapsing multiple sclerosis (2012) (6)
- Erratum: Delayed postischaemicneuroprotection following systemic neural stem cell transplantation involves multiple mechanisms (Brain (2009) 132:PART 8 (2239-2251) DOI: 10.1093/brain/awp174) (2010) (6)
- Efficacy and safety of ocrelizumab in patients with relapsing‐remitting multiple sclerosis with suboptimal response to prior disease‐modifying therapies: A primary analysis from the phase 3b CASTING single‐arm, open‐label trial (2021) (6)
- Functional evolution of visual involvement in experimental autoimmune encephalomyelitis (2020) (6)
- A complex case of anti-GAD antibody-related syndrome treated with Rituximab (2013) (6)
- Pooled Safety Analyses from Teriflunomide Clinical Studies (P7.268) (2015) (6)
- Long-term disease stability assessed by the expanded disability status scale in patients treated with cladribine tablets in the clarity and clarity extension studies (2019) (6)
- Bilateral intracavernous carotid artery occlusion caused by invasive lymphocytic hypophysitis. (2012) (6)
- A randomized trial of teriflunomide added to glatiramer acetate in relapsing multiple sclerosis (2015) (6)
- Reduction in Healthcare and Societal Resource Utilization Associated with Cladribine Tablets in Patients with Relapsing-Remitting Multiple Sclerosis : Analysis of Economic Data from the CLARITY Study. (2012) (6)
- Interferon-gamma induces T lymphocyte proliferation in multiple sclerosis via a Ca(2+)-dependent mechanism. (1995) (6)
- Long-Term Disease Stability Assessed by the Expanded Disability Status Scale in Patients Treated with Cladribine Tablets 3.5 mg/kg for Relapsing Multiple Sclerosis: An Exploratory Post Hoc Analysis of the CLARITY and CLARITY Extension Studies (2021) (6)
- TOPIC: Efficacy and Safety of Once-Daily Oral Teriflunomide in Patients with First Clinical Episode Consistent With Multiple Sclerosis (PL2.002) (2014) (6)
- Auditory P300 in multiple sclerosis (MS): Correlations with neuroradiological and neuropsychological findings (1993) (6)
- Position and practical use of fingolimod in Europe (2014) (6)
- Ofatumumab versus teriflunomide in relapsing MS: adaptive design of two Phase 3 studies (ASCLEPIOS I and ASCLEPIOS II) (S16.005) (2017) (6)
- CSF extracellular vesicles and risk of disease activity after a first demyelinating event (2021) (6)
- The Use of Immunosuppressant Therapy for Multiple Sclerosis in Italy: A Multicenter Retroprospective Study (2016) (6)
- From inflammation to degeneration: the lessons of clinical trials (2003) (6)
- Discontinuos distribution of IgG oligoclonal bands in cerebrospinal fluid from multiple sclerosis patients (1990) (6)
- ECTRIMS-EAN clinical practice guideline on pharmacological management of multiple sclerosis. (2016) (5)
- Autoimmunity and long-term safety and efficacy of alemtuzumab for multiple sclerosis: Benefit/risk following review of trial and post-marketing data (2021) (5)
- Neurodegeneration in the course of Langerhans cell histiocytosis (2012) (5)
- Neural stem cell transplantation in patients with progressive multiple sclerosis: an open-label, phase 1 study (2023) (5)
- Autologous mesenchymal stem cells applied on the pressure ulcers had produced a surprising outcome in a severe case of neuromyelitis optica (2015) (5)
- Multiple Sclerosis Data Alliance - A global multi-stakeholder collaboration to scale-up real world data research. (2020) (5)
- Durable efficacy of cladribine tablets in patients with multiple sclerosis: analysis of relapse rates and relapse-free patients in the CLARITY and CLARITY Extension studies (P6.353) (2017) (5)
- Relapse Outcomes in Fingolimod-Treated Patients Previously Exposed to Natalizumab: Post-Hoc Analysis from the 4-Month, Open-Label FIRST Study (P07.103) (2013) (5)
- Optic nerve involvement in experimental autoimmune encephalomyelitis to homologous spinal cord homogenate immunization in the dark agouti rat (2018) (5)
- Baseline Demographics and Disease Characteristics from OPERA I and II, Two Phase III Trials Evaluating Ocrelizumab in Patients with Relapsing Multiple Sclerosis (P7.201) (2015) (5)
- Oral corticosteroids for multiple sclerosis relapse (2015) (5)
- Thrombolysis in elderly stroke patients in Italy (TESPI) trial and updated meta-analysis of randomized controlled trials (2019) (5)
- Assessing the role of innovative therapeutic paradigm on multiple sclerosis treatment response (2018) (5)
- Effect of Teriflunomide on Relapses with Sequelae and Relapse Leading to Hospitalization in a Population with Relapsing Forms of Multiple Sclerosis: Results from the TEMSO Study (S30.003) (2012) (5)
- MULTIPLE sclerosis. (1948) (5)
- Overcoming recruitment challenges in patients with multiple sclerosis: Results from an Italian survey (2014) (5)
- The Peripheral Network between Oxidative Stress and Inflammation in Multiple Sclerosis (2014) (5)
- Serial gadolinium-enhanced MRI in patients with multiple sclerosis of varying levels of disability (1997) (5)
- A pharmacogenetic study implicates NINJ2 in the response to Interferon-β in multiple sclerosis (2020) (5)
- Anti-GAD antibody-positive myoclonic leg jerks (2015) (5)
- Chronic cerebro-spinal venous insufficiency (CCSVI) and global venous haemodynamics in multiple sclerosis: the CoSMo study (2012) (5)
- Early evidence of disease activity during fingolimod predicts medium-term inefficacy in relapsing-remitting multiple sclerosis (2020) (5)
- Neuropathic cranial pain (2003) (5)
- Animal models of ischemic stroke. Part one: modeling risk factors. (2010) (5)
- Oral teriflunomide in patients with relapsing multiple sclerosis: baseline clinical features of patients in the TEMSO phase III trial (2008) (5)
- Headache in cerebral venous thrombosis associated with extracranial tumors: a clinical series (2015) (5)
- Teriflunomide Treatment Is Not Associated With Increased Risk of Infections: Pooled Data From the Teriflunomide Development Program (P2.194) (2014) (5)
- Updated Results of the COVID-19 in MS Global Data Sharing Initiative (2022) (5)
- Discontinuous distribution of IgG oligoclonal bands in cerebrospinal fluid from multiple sclerosis patients. (1990) (5)
- Safety and Efficacy of Oral Cladribine in Patients with Relapsing-Remitting Multiple Sclerosis: Results from the 96 Week Phase IIIb Extension Trial to the CLARITY Study (P07.119) (2013) (5)
- Results of the Phase 3 SPI2 Study of MD1003 (high dose Pharmaceutical grade Biotin) in Progressive MS (680) (2020) (5)
- Newly approved agents for relapsing remitting multiple sclerosis: how real-world evidence compares with randomized clinical trials? (2020) (5)
- ‘Progressive MS – macro views’: The need for novel clinical trial paradigms to enable drug development for progressive MS (2017) (5)
- Adrenergic mechanisms in multiple sclerosis: the neuro-immune connection? (2004) (5)
- Early onset of effect of treatment with cladribine tablets for relapsing-remitting multiple sclerosis in the 96-week, phase III, double-blind, placebo-controlled CLARITY study (2009) (5)
- Spinal Fluid Myeloid Microvesicles Predict Disease Course in Multiple Sclerosis (2021) (5)
- Safety and tolerability of fingolimod 0.5 mg during the first 4 months of administration in patients with relapsing forms of multiple sclerosis. Results from the open-label, multicentre FIRST study (2012) (4)
- The 4‐Hole‐Board Test for Assessment of Long‐Term Spatial Memory in Mice (2021) (4)
- Safety of Ozanimod Versus Interferon β-1a in Two Multicenter, Randomized, Double-Blind, Parallel-Group, Active-Controlled, Double-Dummy Phase 3 Studies in Relapsing Multiple Sclerosis (SUNBEAM and RADIANCE Part B) (S36.006) (2018) (4)
- Erratum to: Cross-validation of biomarkers for the early differential diagnosis and prognosis of dementia in a clinical setting (2015) (4)
- Quality of Life Improves with Alemtuzumab Over 6 Years in Relapsing-Remitting Multiple Sclerosis Patients with or without Autoimmune Thyroid Adverse Events: Post Hoc Analysis of the CARE-MS Studies (2020) (4)
- Multiple Sclerosis and Neurodegenerative Diseases (2016) (4)
- Quantitative EMG of external urethral sphincter in neurologically healthy men with prostate pathology (2014) (4)
- Neuromyelitis optica spectrum disorder and multiple sclerosis in a Sardinian family. (2018) (4)
- Long-term follow-up (up to 11 years) of an Italian pediatric MS cohort treated with Natalizumab: a multicenter, observational study (2022) (4)
- Headache therapy with neuronal stabilising drugs (2008) (4)
- Functional end-plate recovery in long-term botulinum toxin therapy of hemifacial spasm: a nerve conduction study (2013) (4)
- Triple dose of gadolinium-DTPA and delayed MRI scanning in benign multiple sclerosis (1995) (4)
- Cranio-caudal patterns of cervical cord atrophy progression in MS according to disease phenotype and clinical worsening: a multicenter study. (2018) (4)
- P300 and PET in cortical and subcortical dementia (1996) (4)
- The effect of cross-talk on MRI lesion numbers and volumes in multiple sclerosis using conventional and turbo spin-echo (1998) (4)
- Digital epidemiology confirms a latitude gradient of MS in France. (2018) (4)
- Cladribine tablets in the ORACLE-MS study open-label maintenance period: analysis of efficacy in patients after conversion to clinically definite multiple sclerosis (CDMS) (P6.349) (2017) (4)
- Immunoglobulins in chronic inflammatory demyelinating polyneuropathy (2003) (4)
- Frequency of the Chromosome 9 C9ORF72 Hexanucleotide Repeats in Italian Patients with Frontotemporal Lobar Degeneration (2012) (4)
- PO10-TU-39 Safety and tolerability of short-course oral treatment with cladribine tablets for relapsing-remitting multiple sclerosis (RRMS) in the 96-week, phase III, double-blind, placebo-controlled CLARITY study (2009) (4)
- Repetitive Transcranial Magnetic Stimulation With H‐Coil Coupled With Cycling for Improving Lower Limb Motor Function After Stroke: An Exploratory Study (2020) (4)
- Pooled Safety Data From Four Placebo-Controlled Teriflunomide Studies (P2.203) (2014) (4)
- Migralepsy: a new case confirming the existence of this migraine complication and proposing therapy (2013) (4)
- Ocular pain: a neurological perspective (2010) (4)
- A longitudinal study comparing the sensitivity of CSE and RARE sequences in detecting new multiple sclerosis lesions. (1999) (4)
- Alemtuzumab Improves Clinical and MRI Disease Activity Outcomes, Including Slowing of Brain Volume Loss, in RRMS Patients Over 8 Years: CARE-MS I Follow-up (TOPAZ Study) (2019) (4)
- International consensus statement on the use of disease-modifying agents in multiple sclerosis (2002) (4)
- A multicenter Italian randomised study on early treatment of Parkinson disease: comparison of 1-dopa, 1-deprenyl and dopaminoagonists. Study design and short term results (1992) (4)
- Reductions in MRI activity in relapsing-remitting multiple sclerosis achieved with cladribine tablets in the 96-week, phase III, double-blind, placebo-controlled CLARITY study (2009) (4)
- 2014 Joint ACTRIMS-ECTRIMS Meeting (MSBoston 2014): Oral Presentations (2014) (4)
- Demyelination and cortical reorganization: functional MRI data from a case of subacute combined degeneration (2003) (4)
- A comparison of multimodal evoked potentials, nuclear magnetic resonance imaging and CSF profile for the diagnosis of multiple sclerosis (1989) (4)
- Cost-Effectiveness Analysis of Cannabinoid Oromucosal Spray Use for the Management of Spasticity in Subjects with Multiple Sclerosis (2020) (4)
- The CLARITY study (CLAdRIbine tablets Treating multiple sclerosis orallY): design of a Phase III trial of oral cladribine in relapsing multiple sclerosis (2007) (4)
- A strange case of waitress headache (2011) (4)
- Burden of rare coding variants in an Italian cohort of familial multiple sclerosis (2021) (4)
- Connecting real-world digital mobility assessment to clinical outcomes for regulatory and clinical endorsement–the Mobilise-D study protocol (2022) (4)
- Transcriptomic Analysis of Peripheral Monocytes upon Fingolimod Treatment in Relapsing Remitting Multiple Sclerosis Patients (2021) (4)
- Predictors of disease activity in 857 patients with MS treated with interferon beta-1b (2015) (4)
- An Investigation of the Role of Common and Rare Variants in a Large Italian Multiplex Family of Multiple Sclerosis Patients (2021) (4)
- Treatment of chronic inflammatory demyelinating polyneuropathy (1998) (4)
- Structural and functional disconnections convey the pathology progression along the Alzheimer’s continuum (2019) (4)
- Updated Safety of Cladribine Tablets in the Treatment of Patients with Multiple Sclerosis: Integrated Safety Analysis and Post-Approval Data (2020) (4)
- DOP53 Pregnancy outcomes in the ozanimod clinical development program in relapsing multiple sclerosis, Ulcerative Colitis, and Crohn’s Disease (2021) (4)
- Todd’s post-epileptic paresis and Takotsubo cardiomyopathy: unusual combination of neurological and cardiac disorder. Trigger or triggered? (2015) (4)
- Refractory migraine: the role of the physician in assessment and treatment of a problematic disease (2013) (4)
- Gray Matter Damage Predicts the Accumulation of Disability and Cognitive Impairment 13 Years Later in Patients with Multiple Sclerosis (S51.005) (2012) (4)
- Clinical outcomes with cladribine tablets in the 96-week, phase III, double-blind, placebo-controlled CLARITY study in patients with relapsing-remitting multiple sclerosis (2009) (4)
- Incidence of multiple sclerosis in Italy: A multicenter study (1989) (4)
- Effects of tDCS in modulating the after-effect of prismatic lenses training in stroke patients with neglect (2019) (4)
- T-antigen regulated expression reduces apoptosis of Tag-transformed human myoblasts (2001) (4)
- Multiple sclerosis associated with pembrolizumab in a patient with non-small cell lung cancer (2019) (4)
- Early Indicators Early Treatments Neuroprotection in Multiple Sclerosis (2004) (4)
- Centronuclear myopathy with unusual mitochondrial abnormalities. (1985) (4)
- Thrombus hallmarks reveal atherothrombotic stroke aetiology (2019) (4)
- The introduction of new medications in pediatric multiple sclerosis: Open issues and challenges (2020) (3)
- Laquinimod Modulates Human Astrocyte Function and Dampens Astrocyte-Induced Neurotoxicity during Inflammation (2020) (3)
- Magnetic resonance imaging (MRI) outcomes in patients with relapsing-remitting multiple sclerosis (RRMS) treated with cladribine tablets: results from the CLARITY study, a 96-week, phase III, double-blind, placebo-controlled trial (2009) (3)
- 71. Repetitive Transcranial Magnetic Stimulation (rTMS) applied with H-coil in Alzheimer’s disease: A placebo-controlled, double-blind, pilot study (2016) (3)
- Natalizumab treatment and pregnancy in multiple sclerosis: A reappraisal of maternal and infant outcomes after 6 years (2022) (3)
- Evolution from a first clinical demyelinating event to multiple sclerosis in the REFLEX trial: Regional susceptibility in the conversion to multiple sclerosis at disease onset and its amenability to subcutaneous interferon beta‐1a (2022) (3)
- Changes in cortical motor outputs after a motor relapse of multiple sclerosis (2019) (3)
- Functional Network Connectivity in the Behavioral Variant of Frontotemporal Dementia (P04.216) (2012) (3)
- Biopsychosocial Response to the COVID-19 Lockdown in People with Major Depressive Disorder and Multiple Sclerosis (2022) (3)
- Limitations in daily activities and general perception of quality of life: Long term follow‐up in patients with anti‐myelin‐glycoprotein antibody polyneuropathy (2019) (3)
- Clinical and biochemical evidence of skeletal muscle involvement in galactose-1-phosphate uridyl transferase deficiency (1993) (3)
- Effect of Ocrelizumab on MRI Inflammatory and Neurodegenerative Markers of Disease in Patients with Relapsing Multiple Sclerosis: Analysis of the Phase III, Double-Blind, Double-Dummy, Interferon Beta-1a-Controlled OPERA I and OPERA II Studies (S49.002) (2016) (3)
- Safety and Efficacy of Teriflunomide for up to 9 Years in Relapsing Forms of Multiple Sclerosis: Update of the TEMSO Extension Trial (P3.150) (2014) (3)
- Robot-assisted assessment of sensorimotor control: A case study (2009) (3)
- A multiparametric score for assessing the individual risk of severe Covid-19 among patients with Multiple Sclerosis (2022) (3)
- Bi-hemispheric repetitive transcranial magnetic stimulation for upper limb motor recovery in chronic stroke: A feasibility study (2018) (3)
- Stroop event-related potentials as a bioelectrical correlate of frontal lobe dysfunction in multiple sclerosis (2016) (3)
- Consistent Decreased Functional Connectivity Among the Main Cortical and Subcortical Functional Networks in MS: Relationship With Disability and Cognitive Impairment (P6.133) (2015) (3)
- Repetitive Transcranial Magnetic Stimulation (rTMS) as Preventive Treatment of Chronic Migraine: A Safe Approach with a Promising Effect (S59.005) (2013) (3)
- Comparing Natural History of Early and Late Onset Pediatric Multiple Sclerosis (2022) (3)
- Early (≤1-h) vs. late (>1-h) administration of frovatriptan plus dexketoprofen combination vs. frovatriptan monotherapy in the acute treatment of migraine attacks with or without aura: a post hoc analysis of a double-blind, randomized, parallel group study (2015) (3)
- Comparison of Early and Delayed Oral Laquinimod in Patients with Relapsing-Remitting Multiple Sclerosis: Effects on Disability Progression at 36 Months in the ALLEGRO Trial (S41.004) (2013) (3)
- Interferon-gamma activated calcium influx in peripheral blood lymphocytes from patients with primary and secondary progressive multiple sclerosis. (1996) (3)
- The agenda of the global patient reported outcomes for multiple sclerosis (PROMS) initiative: Progresses and open questions. (2022) (3)
- Erratum: A multi-centre longitudinal study comparing the sensitivity of monthly MRI after standard and triple dose gadolinium-DTPA for monitoring disease activity in multiple sclerosis. Implications for phase II clinical trials (Brain, Journal of Neurology (1998) 121, Part 10) (1998) (3)
- Quantified electroencephalogram in adult patients with Down's syndrome (1996) (3)
- MRI and Multiple Sclerosis: What Happened in the Last 10 Years? (2007) (3)
- Intracortical motor conduction is associated with hand dexterity in progressive multiple sclerosis (2020) (3)
- Safety of cladribine tablets in the treatment of relapsing-remitting multiple sclerosis (RRMS): results from the CLARITY study, a 96-week, phase III, double-blind, placebo-controlled trial (2009) (3)
- PML risk is the main factor driving the choice of discontinuing natalizumab in a large multiple sclerosis population: results from an Italian multicenter retrospective study (2021) (3)
- Author Correction: A systems biology approach uncovers cell-specific gene regulatory effects of genetic associations in multiple sclerosis (2019) (3)
- Clinical and Magnetic Resonance Imaging Results From RADIANCE Part B, a Multicenter, Randomized, Double-Blind, Phase 3 Trial of Ozanimod Versus Intramuscular Interferon β-1a in Relapsing Multiple Sclerosis (RMS) (P3.410) (2018) (3)
- LYMPHOMATOUS NEUROPATHY IN COLD AGGLUTININ DISEASE (2008) (3)
- Assessing seasonal dynamics of Guillain-Barré syndrome with search engine query data (2019) (3)
- Contribution of Rare and Low-Frequency Variants to Multiple Sclerosis Susceptibility in the Italian Continental Population (2022) (3)
- The Italian multicentre study on the prevalence of distal symmetric polyneuropathy: correlation between clinical variables and nerve conduction parameters. Italian Diabetic Neuropathy Committee. (1999) (3)
- Towards a European Network for Multiple Sclerosis Trials (ENMST) (2003) (3)
- Safety and Tolerability Results of the Phase 2 Portion of the RADIANCE Trial: A Randomized, Double-blind, Placebo-controlled Trial of Oral RPC1063 in Relapsing Multiple Sclerosis (P7.199) (2015) (3)
- Absence of central nervous system pathology in severe combined immunodeficiency mice intraperitoneally injected with peripheral blood lymphocytes from multiple sclerosis patients (1994) (3)
- Efficacy of Cladribine Tablets in ORACLE Study Patients Who Retrospectively Met 2010 McDonald Multiple Sclerosis (MS) Criteria at Baseline (P3.035) (2016) (3)
- EEG band centroid modifications in HIV patients. (1996) (3)
- Frontotemporal dementia with parkinsonism presenting as posterior cortical atrophy (2011) (3)
- FP39-WE-05 High incidence of acute leukaemia in multiple sclerosis patients treated with mitoxantrone: a retrospective multicentre Italian study (2009) (3)
- 040 An analysis of malignancy risk in the clinical development programme of cladribine tablets in patients with relapsing multiple sclerosis (2018) (3)
- Dynamic pattern of clinical and MRI findings in a tumefactive demyelinating lesion: A case report (2016) (3)
- Comparison of triple dose vs standard dose gadolinium-DTPA for detection of MRI enhancing lesions in patients with primary progressive multiple sclerosis (1995) (3)
- Amyloid- b deposition and regional grey matter atrophy rates in dementia with Lewy bodies (2016) (3)
- Effect of Ocrelizumab on Disability Progression in Patients with Relapsing Multiple Sclerosis: Analysis of the Phase III, Double-Blind, Double-Dummy, Interferon Beta-1a-Controlled OPERA I and OPERA II Studies (S49.008) (2016) (3)
- Repetitive Transcranial Magnetic Stimulation With H-Coil in Alzheimer's Disease: A Double-Blind, Placebo-Controlled Pilot Study (2021) (3)
- What To Expect after Natalizumab in Every-Day Clinical Practice (P06.169) (2012) (3)
- Effects of cyclandelate on diabetic peripheral neuropathy. (1984) (3)
- Charting a global research strategy for progressive MS—An international progressive MS Alliance proposal (2021) (3)
- Diffuse intraneural leiomyoma in a case of sensorimotor neuropathy (2009) (3)
- Disease-free status achieved with cladribine tablets in the 96-week, phase III, double-blind, placebo-controlled CLARITY study in patients with relapsing-remitting multiple sclerosis (2009) (3)
- Reproducibility of cardiovascular autonomic tests in diabetics with and without autonomic dysfunction and in normal controls (1986) (3)
- Mapping face encoding using functional MRI in multiple sclerosis across disease phenotypes (2017) (3)
- Outcomes of the TOPIC Extension Study of Teriflunomide in Patients With Early Multiple Sclerosis: Up to 7 Years of Clinical Results (P2.103) (2017) (3)
- Visual Evoked Potentials to Monitor Myelin Cuprizone-Induced Functional Changes (2022) (3)
- Topographic mapping of single-sweep evoked potentials as a picture of the spatio-temporal dynamics in the brain (1989) (3)
- How does brain MRI lesion volume change on serial scans in patients with multiple sclerosis? (1998) (3)
- Pregnancy Outcomes During the Clinical Development of Cladribine in Multiple Sclerosis: An Integrated Analysis of Safety (2018) (3)
- Immunological and biochemical studies and pilot therapeutic trial with ubidecarenone in Kearns-Sayre patients. (1988) (3)
- Secondary cervical dystonic tremor after Japanese encephalitis (2014) (3)
- Partial recovery after severe immune reconstitution inflammatory syndrome in a multiple sclerosis patient with progressive multifocal leukoencephalopathy. (2014) (3)
- Safety and Tolerability of Cladribine Tablets in Patients with Relapsing-Remitting Multiple Sclerosis (RRMS): Final Results from the 120-Week Phase IIIb Extension Trial to the CLARITY Study (P3.095) (2016) (3)
- FFT approximation in Alzheimer’s disease (1998) (3)
- Opinion & Special Articles: Professionalism in neurology (2014) (3)
- A functional magnetic resonance imaging study in multiple sclerosis patients with fatigue (2001) (2)
- Cardiac safety of fingolimod 0.5 mg during the first-dose observation in a 4-month, open-label, multicentre FIRST study in relapsing multiple sclerosis patients (2012) (2)
- Electrophysiological correlates of dementia. (2000) (2)
- A new electrophysiological non-invasive method to assess retinocortical conduction time in the Dark Agouti rat through the simultaneous recording of electroretinogram and visual evoked potential (2019) (2)
- Functional Connectome Architecture of Alzheimer’s Disease, Mild Cognitive Impairment and Behavioral Variant of Frontotemporal Dementia: A Graph Analysis Study (P4.028) (2016) (2)
- Evaluation of No Evidence of Progression or Active Disease (NEPAD) in Patients with Relapsing Multiple Sclerosis in the OPERA I and OPERA II Trials (2018) (2)
- Abnormalities of the Brain Functional Connectome in Pediatric Patients with Multiple Sclerosis (P3.336) (2014) (2)
- RENEWED: Long-Term Electrophysiological and Clinical Outcomes in Participants Previously Enrolled in the Opicinumab Phase 2 Study RENEW (1599) (2020) (2)
- Processing Face Encoding in Multiple Sclerosis: A fMRI Investigation (P6.134) (2015) (2)
- Intensive immunosuppression in multiple sclerosis FUTURE THERAPIES IN MULTIPLE (2006) (2)
- The Danger of Walking with Socks: Evidence from Kinematic Analysis in People with Progressive Multiple Sclerosis (2020) (2)
- Regional hippocampal involvement differs across multiple sclerosis clinical phenotypes : a radial mapping MR-based study (2012) (2)
- Mediation of the Effect of Laquinimod on Disability Progression in Relapsing-Remitting Multiple Sclerosis (RRMS) (P3.195) (2014) (2)
- Early MRI outcomes in participants with a first clinical demyelinating event at risk of multiple sclerosis in the ORACLE-MS study (2021) (2)
- Multiple sclerosis progression is not associated with birth timing in Italy (2014) (2)
- Moyamoya disease mimicking the first attack of multiple sclerosis (2017) (2)
- Correction to: The Italian multiple sclerosis register (2019) (2)
- Clinical utility of evoked potentials in patients infected with human immunodeficiency virus. (1996) (2)
- Concurrence of NMOSD and ALS in a patient with hexanucleotide repeat expansions of C9orf72 (2019) (2)
- Brain structural and functional abnormalities in Fahr’s disease : a report of two cases (2013) (2)
- Multiple Sclerosis and other demyelinating disorders (2018) (2)
- Severe disease activity in a patient with multiple sclerosis after daclizumab discontinuation. (2019) (2)
- Thalamic Dysfunction Is Associated with Fatigue in Patients with Multiple Sclerosis: A Graph Theory Study (S13.003) (2014) (2)
- State of the Art and Future Challenges in Multiple Sclerosis Research and Medical Management: An Insight into the 5th International Porto Congress of Multiple Sclerosis (2020) (2)
- Using Smartphones and Wearable Devices to Monitor Behavioral Changes During COVID-19 (Preprint) (2020) (2)
- Optimisation of immunomodulatory therapies (2005) (2)
- Time-frequency analysis of event-related brain potentials (1998) (2)
- Brain Structural And Functional Changes After Action Observation Therapy In Parkinson’s Disease Patients With Freezing Of Gait (S21.003) (2014) (2)
- Extracorporeal phototherapy in multiple sclerosis (2006) (2)
- EEG correlates of cognitive impairment in MS (1998) (2)
- Cardiac Improvement after Coenzyme Q10 Treatment in Patients with Kearns-Sayre Syndrome (1987) (2)
- Functional and structural disruption of the precuneus contributes to cognitive impairment in pediatric multiple sclerosis (2013) (2)
- Subacute visual loss and bilateral fixed mydriasis: an atypical case of giant cell arteritis (2014) (2)
- A parametric method for the analysis of temporal and spatial variability in the interictal EEG signal (1994) (2)
- Non-invasive visual evoked potentials under sevoflurane versus ketamine-xylazine in rats (2021) (2)
- The effect of air pollution on COVID‐19 severity in a sample of patients with multiple sclerosis (2021) (2)
- Brain structural and functional abnormalities in Parkinson’s disease patients with freezing of gait (P6.072) (2015) (2)
- Large vessel occlusion stroke due to dislodged aortic valve calcification revealed by imaging and histopathology (2019) (2)
- Efficacy of cladribine tablets for relapsing-remitting multiple sclerosis in patients with high disease activity: results from the phase III, 96-week CLARITY study (2011) (2)
- Brain adaptive changes following tissue damage in PPMS: a multiparametric study using F-MRI, MTI and DTI (2001) (2)
- Long-term remission of tumefactive relapsing multiple sclerosis after alemtuzumab rescue treatment in an adolescent patient. (2020) (2)
- Electrophysiological correlates of cognitive dysfunction in multiple sclerosis (1997) (2)
- Neurofilament Light Chains as a Marker of Concurrent and Future Active Disease in Relapsing Multiple Sclerosis: An Analysis of Baseline Data From the Phase 3 Ozanimod Clinical Trials (S56.006) (2019) (2)
- P349 EEG coherence analysis in multiple sclerosis: Correlation with clinical, neuropsychological and MRI findings (1997) (2)
- FP36-WE-03 MRI outcomes of short-course oral treatment with cladribine tablets for relapsing-remitting multiple sclerosis (RRMS) in the 96-week, phase III, double-blind, placebo-controlled CLARITY study (2009) (2)
- Primary progressive multiple sclerosis presenting with severe predominant cognitive impairment and psychiatric symptoms: A challenging case (2017) (2)
- Tolerability Profile of Cladribine Tablets Therapy for Patients with Relapsing-Remitting Multiple Sclerosis: Factors Contributing to Treatment Completion in the Double-Blind, 96-Week, Placebo-Controlled CLARITY Study (2011) (2)
- ID 278 – Motor cortical disinhibition is more pronounced in Progressive Supranuclear Palsy than in Parkinson’s disease: Evidence from TMS (2016) (2)
- The physiopathology of multiple sclerosis (2010) (2)
- Slower progression of Parkinson’s disease in patients treated with ropinirole compared with L-dopa: REAL-PET – a randomised controlled 18F-dopa PET study (2002) (2)
- A functional MRI study of the motor system in patients with primary progressive multiple sclerosis (2000) (2)
- P6.6 Effect of sensory tricks on brain excitability in cervical dystonia: TMS study (2011) (2)
- Lymphocyte Counts in Patients Treated With Teriflunomide: Observations From Phase 3 Clinical Trials and the Real-World Teri-PRO Study (P5.376) (2018) (2)
- P573: Optical coherence tomography and visual evoked potentials in monitoring neural damage in multiple sclerosis (2014) (2)
- A multicenter study of the incidence of multiple sclerosis in Italy: design of the study. (1987) (2)
- Disease-Modifying Treatments and Time to Loss of Ambulatory Function in Patients With Primary Progressive Multiple Sclerosis. (2022) (2)
- Necrotic-hemorrhagic myelitis: A rare malignant variant of parainfectious acute disseminated encephalomyelitis in childhood (2018) (2)
- Efficacy and safety of ocrelizumab in patients with relapsing-remitting multiple sclerosis with a suboptimal response to previous disease-modifying therapies (1‑year interim results) (2019) (1)
- Reconstitution of circulating lymphocyte subsets after treatment with cladribine tablets in the 96-week CLARITY study in relapsing-remitting multiple sclerosis (2010) (1)
- A multicentre longitudinal study comparing the sensitivity of monthly enhanced MRI after single and triple dose gd-DTPA injection for monitoring disease activity in multiple sclerosis (1997) (1)
- B-cell Depletion and Efficacy Outcomes with Ofatumumab: Subgroup Analysis From the Pooled Phase 3 ASCLEPIOS I and II Trials (2356) (2020) (1)
- Prognostic value of the nervous system involvement in HIV patients. (1990) (1)
- Surrogate Markers in Multiple Sclerosis: The Role of Magnetic Resonance Imaging (2016) (1)
- Reply to “Serum Neurofilaments as Candidate Biomarkers of Natalizumab Progressive Multifocal Leukoencephalopathy” (2019) (1)
- New Insights on the Pathophysiology of Fatigue in MS: A fMRI Study of the Motor Network (P6.141) (2015) (1)
- Assessing Functional Decline in Neurological Diseases Clinical Trials: Duration of Follow-Up - The Case of Multiple Sclerosis. (2016) (1)
- Definition of responder: introduction (2008) (1)
- Mapping Regional Grey and White Matter Damage in Patients with Progressive Supranuclear Palsy Syndrome (S57.007) (2014) (1)
- Assessing Brain System Dysfunction In Amnesic Mild Cognitve Impairment Through MRI-Based Connectomics (P4.012) (2014) (1)
- Alemtuzumab Reduced MRI Lesions and the Rate of Brain Volume Loss in CARE-MS II Patients Switching From SC IFNB-1a: 5-Year Follow-up (TOPAZ Study) (P5.031) (2018) (1)
- 101. Functional changes of cortical motor circuits after piano training in adults: TMS and EEG evidence (2016) (1)
- Neuromyotonia, systemic lupus erythematosus and acetylcholine-receptor antibodies (1998) (1)
- Baseline characteristics of patients enrolled in CONCERTO - a study of 0.6 and 1.2 mg/day oral laquinimod for relapsing-remitting multiple sclerosis (P7.216) (2015) (1)
- Abnormalities of the Brain Connectome in Patients with Multiple Sclerosis (PD6.009) (2013) (1)
- Oculomotor focal dystonia (1997) (1)
- Lower Socioeconomic Status Is Linked to Worse Disability in Persons with Multiple Sclerosis (P2.197) (2016) (1)
- CIDP associated with lung cancer: a paraneoplastic disease? (2004) (1)
- Characterization of ZFP36L1 in the context of multiple sclerosis and functional immunological consequences associated with the susceptibility to the disease (2014) (1)
- Patients Free of Clinical MS Activity in TEMSO and TOWER: Pooled Analyses of Two Phase 3 Placebo-Controlled Trials (P3.164) (2014) (1)
- Author Correction: Transcriptional dysregulation of Interferome in experimental and human Multiple Sclerosis (2018) (1)
- Evaluation of the Treatment Effect of Cladribine Tablets in the Cohort of Patients Who Had Failed Prior Treatment with Injectable Disease-Modifying Drugs: The CLARITY Relapsing-Remitting Multiple Sclerosis Study (2011) (1)
- Grey matter and white matter MRI markers of cognitive progression in early and late onset variants of Alzheimer’s disease (P4.090) (2015) (1)
- No evidence of disease activity status in patients treated with early vs. delayed subcutaneous interferon β-1a. (2019) (1)
- Botulinum Toxin A and physiotherapy in multiple sclerosis spasticity: Patient-tailored goal setting and the measurement of its achievement (2019) (1)
- Variability in detection and quantification of interferon β-1b–induced neutralizing antibodies (2012) (1)
- Improved Clinical and MRI Disease Activity Outcomes, Including Slowing of Brain Volume Loss, in Alemtuzumab-Treated RRMS Patients: 8-Year Follow-up of CARE-MS I (TOPAZ Study) (2019) (1)
- Genetic modification of 25(OH)D levels in MS (2014) (1)
- The utility of wearable devices in assessing ambulatory impairments of people with multiple sclerosis in free-living conditions (2021) (1)
- Retrospectively acquired cohort study to evaluate the long-term impact of two different treatment strategies on disability outcomes in patients with relapsing multiple sclerosis (RE.LO.DI.MS): data from the Italian MS Register (2019) (1)
- Cognitive impairment in multiple sclerosis: Correlations between neuropsychological tests, brain MRI, long-latency SEPs and PET (1990) (1)
- Transcranial direct current stimulation as a preventive treatment in multiple sclerosis? Preclinical evidence (2022) (1)
- Efficacy of Ozanimod Versus Interferon β-1a by Prior Treatment and Baseline Disability in Two Multicenter, Randomized, Double-Blind, Parallel-Group, Active-Controlled, Double-Dummy Phase 3 Studies in Relapsing Multiple Sclerosis (SUNBEAM and RADIANCE Part B) (S36.005) (2018) (1)
- Transcriptional dysregulation of Interferome in experimental and human Multiple Sclerosis (2017) (1)
- The past and present of Italian neurology (2012) (1)
- FP36-WE-02 Clinical outcomes of short-course oral treatment with cladribine tablets for relapsing-remitting multiple sclerosis (RRMS) in the 96-week, phase III, double-blind, placebo-controlled CLARITY study (2009) (1)
- Human-Centered Design Strategies for Device Selection in mHealth Programs: Development of a Novel Framework and Case Study (Preprint) (2019) (1)
- PND10 - GENIUS RWE STUDY (FINGOLIMOD REAL WORLD EVIDENCE ITALIAN MULTICENTER OBSERVATIONAL STUDY IN MULTIPLE SCLEROSIS)PRELIMINARY RESULTS (2018) (1)
- Improved Naming after Excitatory Repetitive Deep Transcranial Magnetic Stimulation over the Right Homologous Broca's Region in Chronic Post-Stroke Aphasia (P03.156) (2013) (1)
- Consistent efficacy of cladribine tablets across multiple sclerosis and patient characteristics, in the double-blind, 96-week CLARITY study (2010) (1)
- [Tecfidera® (delayed-release dimethylfumarate) in the treatment of relapsing-remitting multiple sclerosis] (2017) (1)
- 039 Rates of lymphopenia in years 1–4 in patients with relapsing multiple sclerosis treated annually with cladribine tablets (2018) (1)
- Corrigendum: Clinical Features of Headache in Patients With Diagnosis of Definite Vestibular Migraine: The VM-Phenotypes Projects (2020) (1)
- 35. Visual evoked potentials and MRI in monitoring optic nerve involvement in a relapsing remitting model of EAE (2015) (1)
- The spatio-temporal relationship between white matter lesion volume changes and brain atrophy in clinically isolated syndrome and early multiple sclerosis (2022) (1)
- Alemtuzumab-Treated Patients Experienced Decreased MRI Disease Activity and Slowing of Brain Volume Loss Over 5 Years After Switching From SC IFNB-1a: Follow-up of Patients From CARE-MS I (TOPAZ Study) (S36.003) (2018) (1)
- Clinical Aspects and Treatment of Diabetic Peripheral and Autonomic Neuropathy (1987) (1)
- Rapid and sustained efficacy with cladribine tablet treatment in relapsing-remitting multiple sclerosis (RRMS): results from the CLARITY study, a 96-week, phase III, double-blind, placebo-controlled trial (2009) (1)
- Cognitive Rehabilitation Modifies Functional Connectivity of the Anterior Cingulate Cortex in Multiple Sclerosis (S51.003) (2012) (1)
- Efficacy of Cladribine Tablets 3.5 mg/kg in High Disease Activity (HDA) Subgroups of Patients with Relapsing Multiple Sclerosis (RMS) in the CLARITY Study (P6.360) (2017) (1)
- Comparison of fast-flair vs conventional SE sequences for measurement of brain mri lesion loads in patients with multiple sclerosis (1995) (1)
- Regional Patterns of Brain Gray and White Matter Abnormalities in Patients with Hereditary Optic Neuropathies: Dominant Optic Atrophy vs Leber Hereditary Optic Neuropathy (S48.006) (2016) (1)
- An SLC9A9 Variant Influences Treatment Response in Interferon beta Treated Multiple Sclerosis Patients (P05.141) (2013) (1)
- The Effects of Natalizumab and Fingolimod on Clinical and MRI Measures in Relapsing Remitting Multiple Sclerosis: A Two-Year Comparative Study (P2.073) (2017) (1)
- The Effect Of Age Of Onset On The Brain Functional Connectivity In Alzheimer’s Disease: A Graph Analysis Study (P6.312) (2014) (1)
- Erratum: High tumor necrosis factor-α in levels in cerebrospinal fluid of cobalamin-deficient patients (Annals of Neurology (2004) 56 (886-890)) (2005) (1)
- A Genetic Model To Predict Response to Glatiramer Acetate Developed from a Genome Wide Association Study (GWAS) (IN3-2.003) (2012) (1)
- Impact of multiple sclerosis risk loci in postinfectious neurological syndromes. (2020) (1)
- Clinical and instrumental diagnosis of autonomic neuropathy in insulin-dependent diabetes (1982) (1)
- Modulation of Cortico-Subcortical Functional Connectivity Occurs After Symptomatic Treatment of Fatigue in Patients with Multiple Sclerosis (P3.384) (2018) (1)
- P124: The value of VEP and OCT in multiple sclerosis (2014) (1)
- Combined VEPs and OCT Help Differentiating Multiple Sclerosis from NMOSD (P5.308) (2016) (1)
- Mitoxantrone for secondary progressive and progressive relapsing multiple sclerosis (2000) (1)
- Prescription of Complementary and Alternative Medicine (CAM) in an Italian Cohort of Pediatric Headache Patients (P03.115) (2013) (1)
- Cognitive Changes And White Matter Tract Damage In The Motor Neuron Disease Spectrum (P4.098) (2014) (1)
- The Potential Role of Optical Coherence Tomography as a Marker of Disease Severity in Alzheimer’s Dementia (P4.183) (2018) (1)
- EFFECT OF TERIFLUNOMIDE ON LYMPHOCYTE AND NEUTROPHIL COUNTS (2015) (1)
- Microbubbles as drug delivery systems in cerebrovascular diseases. (2009) (1)
- Genomic and functional evaluation of TNFSF14 in multiple sclerosis susceptibility. (2021) (1)
- Letter to the Editor Regarding: A Comprehensive Review on Copemyl® (2018) (1)
- Chapter 26 Multiple sclerosis and other demyelinating disorders (2005) (1)
- P360 ERPs and quantified EEG abnormalities in Down's syndrome (1996) (1)
- S8.3 EEG spectral analysis and low-resolution brain electromagnetic tomography (LORETA) in diagnosis of frontotemporal dementia and differences with Alzheimer's disease and healthy subjects (2011) (1)
- Alemtuzumab Decreased MRI Disease Activity Through 6 Years in Patients With Highly Active RRMS and an Inadequate Response to Prior Therapy: CARE-MS II Extension Study (S12.006) (2017) (1)
- Severity of COVID19 infection among patients with multiple sclerosis treated with interferon-β (2022) (1)
- Allogeneic Hematopoietic Stem Cell Transplantation For Severe Neuromyelitis Optica (2013) (1)
- P367: High frequency deep rTMS over the right homologous Broca’s region improves naming in chronic post-stroke aphasia: a pilot study (2014) (1)
- Falling too Fahr (2012) (1)
- Risk attitude and personality in people with multiple sclerosis facing the choice of different disease-modifying therapy scenarios (2020) (1)
- Do patients’ and referral centers’ characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register (2022) (1)
- Effect of Ocrelizumab on Visual Outcomes in Patients with Baseline Visual Impairment in the OPERA Studies in Relapsing Multiple Sclerosis (2018) (1)
- 067 Efficacy of cladribine tablets in patients with highly active relapsing-remitting multiple sclerosis: analysis of pooled double-blind data from the clarity and onward studies (2018) (1)
- Oral Cladribine Delays Time to Conversion to Clinically Definite MS in Patients with a First Demyelinating Event: Top Line Results from the Phase III ORACLE MS Study (P07.114) (2013) (1)
- Predicting multiple sclerosis: a large international multicentre study (2015) (1)
- The Role of Gut Immunity in Multiple Sclerosis Patients (P3.007) (2016) (1)
- 146. Excitatory deep transcranial magnetic stimulation with H-coil over the right homologous Broca’s region improves naming in chronic post-stroke aphasia (2013) (1)
- Long-term Cognitive Outcomes and Socioprofessional Attainment in People With Multiple Sclerosis With Childhood Onset (2022) (1)
- Pharmacokinetics and pharmacodynamics of natalizumab in pediatric patients with RRMS. (2019) (1)
- 73: Human herpesvirus 6 and multiple sclerosis: detection by quantitative real-time PCR and role of complement-mediated damage secondary to CD46 inactivation (2006) (1)
- Results from the 48-Week Blinded Extension of RADIANCE: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of Oral Ozanimod in Relapsing Multiple Sclerosis (P3.023) (2016) (1)
- Rethinking MS in Europe Prioritising Timely Integrated Services for People with Multiple Sclerosis (2020) (1)
- Pathophysiology of cognitive impairment in multiple sclerosis (1998) (1)
- Teaching Video NeuroImages: Speech-induced oromandibular dystonia relieved by singing (2012) (1)
- Towards a validated definition of the clinical transition to secondary progressive multiple sclerosis: A study from the Italian MS Register (2022) (1)
- Dose‐dependent effect of myelin oligodendrocyte glycoprotein on visual function and optic nerve damage in experimental autoimmune encephalomyelitis (2022) (1)
- Microstructural MR Imaging of Cortical Lesions in Multiple Sclerosis Phenotypes (S21.001) (2012) (1)
- Ventral and dorsal visual streams in posterior cortical atrophy (2011) (1)
- Anterior optic pathway pathology in CNS demyelinating diseases (2022) (1)
- Randomized controlled trial of IVIg versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) (2001) (1)
- Cladribine tablets in patients who had failed prior treatment with injectable disease-modifying drugs for relapsing-remitting multiple sclerosis: evaluation of treatment effect in the CLARITY study (2011) (1)
- A Genetic Model Predicts the Response to Glatiramer Acetate in Two Different Cohorts (P05.129) (2012) (1)
- Progressive ataxia in a natalizumab‐treated multiple sclerosis patient: the dark side of JC virus infection (2016) (1)
- Subarachnoid neurocysticercosis with spinal involvement presented with headache (2013) (1)
- Erratum to: Early (≤1-h) vs. late (>1-h) administration of frovatriptan plus dexketoprofen combination vs. frovatriptan monotherapy in the acute treatment of migraine attacks with or without aura: a post hoc analysis of a double-blind, randomized, parallel group study (2016) (1)
- Erratum: Assessment of cardiac safety during fingolimod treatment initiation in a real-world relapsing multiple sclerosis population: A phase 3b, open-label study (Journal of Neurology (2014) 261 (267-276) DOI: 10.1007/s00415-013-7115-8) (2014) (1)
- Intensive Neurorehabilitation and Gait Improvement in Progressive Multiple Sclerosis: Clinical, Kinematic and Electromyographic Analysis (2022) (1)
- Prior treatment status: impact on the efficacy and safety of teriflunomide in multiple sclerosis (2020) (1)
- Uhthoff's phenomena and brain MRI suggesting demyelinating lesions: RIS or CIS? A case report (2014) (1)
- Motor network rewiring in mild cognitive impairment and Alzheimer's disease (2009) (1)
- EBV and multiple sclerosis: Setting the research agenda. (2022) (1)
- Effect of extracellular vesicles derived from distinct brain cells on Aβ toxicity and assembly: focus on Microglia derived vesicles (2015) (1)
- Platelet glutamate uptake and Th1 cells inversely correlate in relapsing/remitting and in progressive multiple sclerosis. (2020) (1)
- Non Invasive Neuromodulation in Motor Recovery after Stroke: State of the Art, Open Questions and Future Perspectives (2013) (1)
- Preservation of auditory P300 in the minimal brain damage syndrome of hypothyroid children (1992) (1)
- Investigating the Effect of Teriflunomide on Diffuse Brain Tissue Damage in the Phase 3 TEMSO Study (2018) (1)
- A multi-step genomic approach prioritized TBKBP1 gene as relevant for multiple sclerosis susceptibility (2022) (1)
- Evaluacion patologica in vivo en la esclerosis multiple: Lugar que ocupan las tecnicas de neuroimagen (2000) (1)
- Exploring correlations between changes in lymphocyte counts and clinical/magnetic resonance imaging outcomes in cladribine-treated patients with relapsing-remitting multiple sclerosis: analyses from the double-blind, 96-week CLARITY study (2011) (1)
- Multimodality evoked potentials in the diagnosis of multiple sclerosis (1985) (0)
- 53. Sham repetitive transcranial magnetic stimulation with H-coil as symptomatic treatment in functional disorder (2017) (0)
- Defining Central Nervous System Involvement in Patients with Acquired Demyelinating Peripheral Neuropathies (S25.002) (2015) (0)
- γ-interferon activates a new Ca2+ influx in T-lymphocytes from multiple sclerosis patients (1994) (0)
- Mitoxantrone (MTX) therapy in secondary-progressive multiple sclerosis (SPMS) patients (2000) (0)
- Reappraisal of neurophysiological examinations and therapeutic neuromodulation (2017) (0)
- CHAPTER 9Neuroimaging in amyotrophic lateral sclerosis (2004) (0)
- Brain structural changes in primary focal dystonia (2013) (0)
- Ofatumumab subcutaneous injection for the treatment of relapsing forms of multiple sclerosis (2022) (0)
- Clinical characteristics, corse and prognosis of Devic’s neuromyelitis Optica (2004) (0)
- Connected speech production in the nonfluent variant of primary progressive aphasia and its relationship with white matter damage (P1.228) (2015) (0)
- Defining High Disease Activity (HDA) in Patients with Relapsing Multiple Sclerosis (RMS) Receiving Placebo in the CLARITY Study (P6.351) (2017) (0)
- 022 Updated safety of cladribine tablets in multiple sclerosis patients: integrated safety analysis and post-approval data (2022) (0)
- Magnetic Resonance Imaging Brachial Plexus Alterations In ALS Patients (P4.101) (2014) (0)
- The design of the CLARITY study (CLAdRIbine tablets Treating multiple sclerosis orallY) (2006) (0)
- Differential Contribution of Cerebellar Resting State Functional Connectivity Abnormalities to Cognitive Impairment in Pediatric and Adult Patients with Multiple Sclerosis (S35.004) (2015) (0)
- P37-S Quantification of walking patterns and muscle coactivations in multiple sclerosis with kinetic and electromyographic analyses (2019) (0)
- Correlation between multiple evoked potentials and disability in multiple sclerosis (1995) (0)
- ORIGINAL RESEARCH A Three-Year Study of Brain Atrophy after Autologous Hematopoietic Stem Cell Transplantation in Rapidly Evolving Secondary Progressive Multiple Sclerosis (2007) (0)
- Brain damage in primary-progressive MS assessed by diffusion tensor MRI (2001) (0)
- New abnormalities in the CSF of vitamin B12-deficient patients (2004) (0)
- Ventral and dorsal visual streams in posterior cortical atrophy (2011) (0)
- WO12 Neurophysiological study of botulinum toxin long-term effects in hemifacial spasm (2008) (0)
- Pupillometry for assessment of pupil motolity after botulinum toxin treatment (1993) (0)
- Structural MRI reveals distributed cortical thinning in patients with pure lower motor neuron disease variants (P6.091) (2015) (0)
- Comparative clinical efficacy of alemtuzumab and ocrelizumab in patients with relapsing-remitting multiple sclerosis: Number needed to treat analyses (2017) (0)
- Autologous Hematopoietic Stem Cell Transplantation In Neuromyelitis Optica: A Retrospective Study Of The EBMT Autoimmune Diseases Working Party In Collaboration With The University Of Sao Paulo, Ribeirao Preto, Brazil (2013) (0)
- Sensory Tricks Reverse Intracortical Facilitation Changes In Cervical Dystonia. A Transcranial Magnetic Stimulation Study (P2.047) (2014) (0)
- Effects of Natalizumab and Fingolimod on Clinical, Cognitive, and Magnetic Resonance Imaging Measures in Multiple Sclerosis (2019) (0)
- PROGETTO DI UN DATABASE MULTIMEDIALE PER LA SCLEROSI MULTIPLA (1994) (0)
- Neural Plasticity of Brain Motor Networks in Professional Fencers Studied with Functional MRI (IN6-1.001) (2012) (0)
- 132 Event-Related Desynchronization (ERD) in Parkinson's disease (1998) (0)
- Safety and Immunogenicity of Two Dosing Frequencies of Subcutaneous Interferon (scIFN) β-1a in Patients with a First Clinical Demyelinating Event (FCDE): 5-year Results of Phase III, Double-blind, Multicenter Trials (REFLEX/REFLEXION) (P7.211) (2015) (0)
- Cerebral venous thrombosis associated with extracranial tumours : a clinical series (2014) (0)
- Multicenter study of diabetic autonomic neuropathy with power spectrum analysis of heart rate variability (1993) (0)
- Editorial: Fatigue in multiple sclerosis—A current perspective (2023) (0)
- Retinal Atrophy Measured by Optical Coherence Tomography Predicts Disability Progression in Multiple Sclerosis (S45.007) (2016) (0)
- Clinical and Cognitive Correlates of White Matter Tract Damage in Progressive Supranuclear Palsy (P05.034) (2012) (0)
- Definition of sensory impairment in multiple sclerosis patients: diagnostic value of different tests (1995) (0)
- Maturational development of long-latency somatosensory evoked potentials in normal and hypothyroid children (1992) (0)
- Temporal and frequency analysis of click-evoked otoacoustic emissions recorded from untreated congenital hypothyroid newborns (2001) (0)
- Anatomical localization of EEG dipole sources using MRI images (1994) (0)
- S11.4 Action observation and motor imagery in motor learning: evidence from EEG and kinematic analysis (2011) (0)
- THUR 192 Yearly lymphopenia rates in cladribine tablets-treated rms patients (2018) (0)
- Is It Worth To Study Families With Multiple Sclerosis (MS)? The Case Of A Novel Rare Variant In A Novel Unexpected Interferon-Stimulated Gene. (P6.155) (2014) (0)
- Grey And White Matter Mri Signatures Of The Frontotemporal Lobar Degeneration Continuum (S49.006) (2015) (0)
- 56. Effects of deep repetitive transcranial magnetic stimulation (rTMS) on motor function of paretic lower limb in chronic sub-cortical stroke: A pilot study (2013) (0)
- Selective killing of spinal cord neural stem cells impairs locomotor recovery in a mouse model of spinal cord injury (2018) (0)
- An Investigation of White Matter Hyperintensities in Probable Dementia with Lewy Bodies (P6.235) (2016) (0)
- Clinical, radiological and laboratory comparison between autoantibody-negative and autoantibody-positive Autoimmune Encephalitis patients. (P2.2-006) (2019) (0)
- ID 275 – OCT and VEP in Multiple Sclerosis: Sensitivity and predictive value (2016) (0)
- Multiple sclerosis: Plate section (2010) (0)
- EEG evidence for central mechanism of fatigue in multiple sclerosis (2010) (0)
- The diagnosis of relapsing-remitting form (2004) (0)
- P569: Corticospinal reserve predicts the effect of deep repetitive brain stimulation with h-coil and neurorehabilitation on walking impairment in progressive multiple sclerosis: results from two randomized, double blind studies (2014) (0)
- PO137 Efficacy of cladribine tablets in high disease activity rms (2017) (0)
- Cognitive Reserve in Multiple Sclerosis Modulates Hippocampal Functional Connectivity and Protects from Memory Deficits (P6.124) (2014) (0)
- Immunogene therapy for autoimmune demyelination (2001) (0)
- 31. Retinal nerve fiber layer thinning as a mirror of neurodegeneration in Alzheimer’s disease (2015) (0)
- The Cortical Signature of Amyotrophic Lateral Sclerosis (P03.160) (2012) (0)
- Contribution of Global and Regional Damage of the Gray and White Matter to Fatigue in MS (P6.127) (2014) (0)
- S2.4 Time course of neural activity in different brain networks revealed by fMRI EEG integrated cortical source imaging (2011) (0)
- Cyclophosphamide pulses therapy after natalizumab discontinuation in Multiple Sclerosis patients (2015) (0)
- Additional Evidence for White Matter Damage in Never-Medicated Adults with Schizophrenia and Schizophreniform Disorder (P02.034) (2012) (0)
- IN34-TU-01 Disease modifying drugs: what and when (2009) (0)
- Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci | NOVA. The University of Newcastle's Digital Repository (2011) (0)
- Gray Matter Atrophy and Microstructural White Matter Abnormalities Underlying Cognitive Impairment in Benign MS (P3.352) (2018) (0)
- Multifocal VEP can be superior to full-field VEP in the assessment of neuromyelitis optica spectrum disorders and multiple sclerosis after optic neuritis (2015) (0)
- Multimodal EPs predict no evidence of disease activity at two years of first line multiple sclerosis treatment (P4.386) (2017) (0)
- Longitudinal Patterns Of Brain Atrophy In Frontotemporal Lobar Degeneration Clinical Syndromes Compared With Alzheimer’s Disease (P4.018) (2014) (0)
- The Lombardia Stroke Unit Registry: study protocol and preliminary data. (2007) (0)
- 96. Corticospinal reserve measured with the H-coil predicts walking impairment in progressive multiple sclerosis (2016) (0)
- COGNITIVE FUNCTIONING IN CHILDHOOD ANF JUVENILE MULTIPLE SCLEROSIS (2006) (0)
- Impaired functional integration in multiple sclerosis: a graph theory study (2014) (0)
- Surface Expansion of the Hippocampal Dentate Gyrus in Multiple Aclerosis: An In-Vivo Evidence of Neurogenesis? (P06.127) (2013) (0)
- ID 299 – Retinal involvement in fronto-temporal dementia: Role of optical coherence tomography and clinical implications (2016) (0)
- Introduction to the supplement (2001) (0)
- ACTRIMS-ECTRIMS MSBoston 2014: Late Breaking News Oral Presentations (2014) (0)
- Efficacy Outcomes in RRMS Patients Who Switched From SC IFNB-1a in CARE-MS I and II to Alemtuzumab in the Extension Studies: 7-Year Follow-up (2020) (0)
- Detection of brainstem involvement in multiple sclerosis: Superiority of MRI versus evoked potentials (1989) (0)
- Functional Correlates of Impaired Working Memory in MS Patients: A Multicentre Study (P6.123) (2014) (0)
- Thanks to Editorial Board of Arquivos de Neuro-Psiquiatria (2021) (0)
- Brain and spinal cord imaging features in neuromyelitis optica spectrum disorders (2018) (0)
- Rethinking MS in Europe: Prioritising Timely, Integrated Care for People with Multiple Sclerosis (2020) (0)
- Primary and Secondary Vasculitis of the Central Nervous System (2002) (0)
- Clinical Efficacy of Laquinimod 0.6 mg Once Daily in the Treatment of Worsening Relapsing-Remitting Multiple Sclerosis (Baseline EDSS >3) (P3.051) (2016) (0)
- O204 Simultaneous bi-hemispheric repetitive transcranial magnetic stimulation for upper limb motor recovery in chronic stroke: A double blind placebo controlled study (2017) (0)
- Correction to: A multi-step genomic approach prioritized TBKBP1 gene as relevant for multiple sclerosis susceptibility (2022) (0)
- Network analysis of intrinsic functional connectivity in the semantic variant of primary progressive aphasia (2013) (0)
- Safety and Efficacy of Excitatory Repetitive Deep Transcranial Magnetic Stimulation with H-Coil: An Open Study in 24 Patients with Parkinson's Disease (P04.185) (2013) (0)
- Influence of Depression and Fatigue on the Regional Distribution of Brain Damage in Patients with Multiple Sclerosis (P04.108) (2013) (0)
- Structural MRI Corrrelates of Cognitive Impairment in Patients with Multiple Sclerosis: A Multi Center Study (S33.002) (2014) (0)
- Cardiovascular autonomic function in idiopathic Parkinson's disease (1995) (0)
- Autonomic neuropathies. (1991) (0)
- 54. Early neurophysiological signs of disease in SOD1G93A mouse model: A stimulated single-fiber electromyography study (2016) (0)
- Microstructural Damage to NAWM and GM but Not to Cortical Lesions Contributes to Cognitive Impairment in Multiple Sclerosis: A Diffusion Tensor MRI Study (P6.129) (2014) (0)
- Axonal damage evolution in multiple sclerosis and neuromyelitis optica spectrum disorder: evaluation with optical coherence tomography (P6.400) (2018) (0)
- Neural stem cell transplantation promotes post-ischemic neuronal plasticity by regulating the expression of glutamate transporters (2014) (0)
- Effects of Deep Repetitive Transcranial Magnetic Stimulation (rTMS) on Motor Function of Paretic Lower Limb in Chronic Subcortical Stroke: A Study with H-Coil (S52.004) (2013) (0)
- Brain Functional Connectomics in Early Parkinson’s Disease (P2.005) (2014) (0)
- An Ipsilateral Silent Period Study in Relapsing Remitting Multiple Sclerosis during and after Motor Relapse (S59.006) (2013) (0)
- 88. Onabotulinumtoxin-A improves chronic migraine: An open label, single-center, post-marketing prospective study (2015) (0)
- ID 301 – Corticospinal reserve predicts walking ability in progressive multiple sclerosis (2016) (0)
- Evidence for Brain Reserve and Cognitive Reserve in Multiple Sclerosis: Lifetime Maximal Brain Growth and Early Life Cognitive Leisure Independently but Differentially Protect Against Disease-Related Cognitive Decline (P04.109) (2013) (0)
- Rationale For Advancing Laquinimod For Progressive MS: Evidence From Large Clinical Trials In RRMS (S4.001) (2014) (0)
- The Topography of Brain Damage at Different Stages of Parkinson's Disease (S22.006) (2012) (0)
- Evidence for Chlamydia pneumoniae infection in cerebrospinal fluid of patients with multiple sclerosis (2000) (0)
- Longitudinal assessment of frontal cognitive impairment in patients with motor neuron disease (P4.095) (2015) (0)
- The “vegetarian brain”: chatting with monkeys and pigs? (2012) (0)
- Abstracts of the 8th Meeting of the Italian Peripheral Nerve Study Group: 40 (2003) (0)
- Chapter 63 Event related desynchronization/synchronization in Parkinson's disease (2002) (0)
- A γ-interferon (-IFN)-activated calcium (Ca2+) influx in T-lymphocytes from multiple sclerosis (MS) patients influences immune activation during disease exacerbations (1995) (0)
- sclerosisdifferent clinical phenotypes of multiple ß endorphin concentrations in PBMC of patients (2005) (0)
- In Vivo Magnetic Resonance Imaging of Intravenously Injected Neural Stem Cells in a Mouse Model of Multiple Sclerosis (2006) (0)
- Extrapyramidal syndrome in a young man who reported repeated Ectsasy abuse (2000) (0)
- EEG modifications in children with congenital hypothyroidism (1997) (0)
- Mapping face encoding using functional MRI in multiple sclerosis across disease phenotypes (2016) (0)
- Structural and functional brain connectome architecture in Alzheimer’s disease and amnesic mild cognitive impairment patients (P4.091) (2017) (0)
- ID 214 – Optical coherence tomography and multifocal visual evoked potentials usefulness to detect visual pathway abnormalities in clinical practice (2016) (0)
- Identification of gene networks and pathways associated with Nabiximols treatment in Multiple Sclerosis patients. (S20.007) (2015) (0)
- Neurophysiological Studies In Metachromatic Leukodistrophy (2001) (0)
- 13. Optical coherence tomography and multifocal visual evoked potential clinical usefulness in identifying visual pathway involvement (2016) (0)
- Number Needed to Treat Analyses to Assess Clinical Outcomes in Patients With Relapsing-Remitting Multiple Sclerosis Treated With Alemtuzumab or Ocrelizumab (P6.384) (2017) (0)
- The effects of effort on visual and auditory potentials (1985) (0)
- Age at Disease Onset Influences Gray Matter and White Matter Damage in Adult Multiple Sclerosis Patients (P4.137) (2016) (0)
- Prestimus: Predictive estimates in muutple sclerosis a European multicentric prospective study (1995) (0)
- Larger intracranial volume affords reserve against disability in relapsing-remitting multiple sclerosis: Implications for clinical trial research (P6.130) (2015) (0)
- Longitudinal assessment of cervical cord atrophy across MS clinical phenotypes: a multicenter study (2016) (0)
- Focal spasticity in multiple sclerosis: Treatment-goal attainment evaluation after botulinum toxin type A therapy and physical rehabilitation (2018) (0)
- A case of Marchiafava-Bignami disease: Serial evaluation with MR and Proton MR spectroscopy (2000) (0)
- Highlights of the issue 7, 2020 (2020) (0)
- Alemtuzumab Decreased MRI Disease Activity Over 4 Years in Patients Who Switched From SC IFNB-1a: CARE-MS II Extension Study 4-Year Follow-up (S12.007) (2017) (0)
- P3.20 Spontaneous and odor-evoked seizures in synapsin I/II/III knockout mice: electrophysiological characterization (2011) (0)
- Brain structural changes in the course of Alzheimer’s disease (P6.214) (2015) (0)
- Diffusion tensor imaging of the brain from patients with primary progressive multiple sclerosis (2000) (0)
- 102. Enhanced cognitive control in healthy aging revealed by increased prefrontal bioelectrical activity to the Stroop task (2016) (0)
- Effect of Early Versus Delayed Subcutaneous Interferon (scIFN) β-1a to Achieve No Evidence of Disease Activity (NEDA) in Patients with Clinically Isolated Syndrome (CIS): A Post-hoc Analysis of REFLEXION (P3.111) (2016) (0)
- Brain White Matter Tract Microstructural Alterations in Multiple Sclerosis Patients with Depression and Fatigue: A Diffusion Tensor MRI Study (P6.126) (2014) (0)
- Intrathecal transplantation of neural precursor cells impairs the effector phase of experimental autoimmune encephalomyelitis (2014) (0)
- Metallothionein transcripts are dynamic markers for brain disease in lysosomal disorders (2014) (0)
- Ascending paralysis in AIDS patients: Guillain Barrè syndrome or cytomegalovirus (CMV) polyradiculopaty? (1996) (0)
- 77. Effect of sensory tricks on brain excitability in cervical dystonia: Sensory afferent inhibition study (2015) (0)
- 123. Visual evoked potential latencies are significantly delayed in a new model of experimental autoimmune encephalomyelitis rat (2013) (0)
- Pupillometry for assessment of pupillary motility after botulinum toxin treatment (1993) (0)
- The Effects of Natalizumab and Fingolimod on Clinical, Neuropsychological and MRI Measures in Relapsing Remitting Multiple Sclerosis: A One-Year Comparative Study (P6.152) (2015) (0)
- Optical coherence tomography and visual evoked potentials in monitoring MS evolution (P1.326) (2015) (0)
- P20.7 Safety and efficacy of deep repetitive transcranial magnetic stimulation (rTMS) with H-coil in Alzheimer disease (2011) (0)
- Magnetic stimulation of motor cortex in MS: Correlations with clinical, SEP and brain MRI findings (1989) (0)
- ID 295 – Deep repetitive transcranial magnetic stimulation with the H-coil in Alzheimer’s disease: A placebo-controlled, double-blind study (2016) (0)
- Introduction to the supplement (2000) (0)
- Evidence for an Early Treatment of Multiple Sclerosis (2004) (0)
- Results of the 48-Week Blinded Extension of RADIANCE: a Randomized, Placebo-controlled Phase 2 Trial of Oral Ozanimod in Relapsing Multiple Sclerosis (2016) (0)
- Drawing in Alzheimer-type dementia (2015) (0)
- Deficits in Memory and Spatial Cognition Correlate with Regional Hippocampal Atrophy in Multiple Sclerosis (P03.075) (2012) (0)
- A Whole-Genome Sequencing Study Implicates GRAMD1B in Multiple Sclerosis Susceptibility (2022) (0)
- Ceruloplasmin functional changes in Parkinson’s disease-cerebrospinal fluid (2015) (0)
- Comparison between magnetic resonance imaging and other techniques in 39 multiple sclerosis patients. (1987) (0)
- Diagnosis and treatment of multiple sclerosis: MENAC- TRIMS consensus guidelines (2014) (0)
- Influence of experimental autoimmune encephalomyelitis on the localization and viability of neural stem cells after intrathecal transplantation (2014) (0)
- Demyelination and Neurodegeneration along the Visual Pathway are more prominent in Secondary Progressive than Primary Progressive Multiple Sclerosis. (P2.391) (2018) (0)
- Brain Structural Changes In Primary Focal Dystonia (P2.045) (2014) (0)
- Laquinimod Disability Progression Effects Are Maintained with Increasingly Rigorous Confirmation Time Intervals (P3.069) (2016) (0)
- 33. Optical coherence tomography and visual evoked potentials combined use as monitoring tools in Multiple Sclerosis patients (2015) (0)
- Action Observation Training Modifies the Function and Structure of the Mirror Neuron System in Multiple Sclerosis Patients with Right Upper Limb Motor Deficits (S43.002) (2017) (0)
- Coronary atherosclerosis is characterized by more severe metabolic, inflammatory and endothelial alterations when compared to carotid atherosclerosis (2008) (0)
- [Following the harmony of the mind]. (2010) (0)
- AD-Related Pathology and Gray Matter Atrophy Rates in Probable Dementia with Lewy Bodies (P6.232) (2016) (0)
- Faculty Opinions recommendation of Dietary interventions for multiple sclerosis. (2013) (0)
- Giant infratentorial meningioma displacing the brainstem (2015) (0)
- ID 261 – Motor cortex plasticity after short-term piano training in adults (2016) (0)
- Monitoring of functional deficits: multiple sclerosis (2004) (0)
- Abstracts of the 8th Meeting of the Italian Peripheral Nerve Study Group: 79 (2003) (0)
- Erratum to: Assessment of cardiac safety during fingolimod treatment initiation in a real-world relapsing multiple sclerosis population: a phase 3b, open-label study (2014) (0)
- 066 Impact of long-term teriflunomide treatment on lymphocyte counts and infections in pooled temso and tower studies (2018) (0)
- 39. Usefulness of multifocal visual evoked potentials in compressive optic neuropathy: A case study (2015) (0)
- White matter degeneration in atypical Alzheimer’s disease (P6.215) (2015) (0)
- The RADIANCE and SUNBEAM phase 3 studies of ozanimod in relapsing multiple sclerosis: study design and baseline characteristics (P6.344) (2017) (0)
- Long-term Efficacy and Safety Outcomes of Teriflunomide Treatment in TEMSO and TOWER (P6.391) (2018) (0)
- European Society of Neuroradiology (ESNR) (2006) (0)
- Breastfeeding Is Not Related with the Risk of Post-Partum Relapses in Women with Multiple Sclerosis (2010) (0)
- Assessment of clinical disease activity and disability improvement by number-needed-to-treat analyses in patients with relapsing multiple sclerosis treated with alemtuzumab or ocrelizumab (2018) (0)
- Pathogenic role of microglia-derived microvesicles in neuroinflammation and neurodegeneration (2013) (0)
- [Evaluation of therapeutic efficacy in neurology]. (1990) (0)
- P10.9 Importance of video-EEG analysis in a conditional mutant mouse model of tuberous sclerosis complex (2011) (0)
- Efficacy of Alemtuzumab Retreatment in Patients Who Experienced Disease Activity after the Initial Two Courses: Results from the CARE-MS II Extension (2018) (0)
- Ischemic Stroke Safety and Efficacy of Transcranial Direct Current Stimulation in Acute Experimental (2013) (0)
- Pregnancy And Fetal Outcomes After Paternal Exposure To Disease Modifying Drugs For Multiple Sclerosis (P4.157) (2014) (0)
- Visual pathway damage in different subtipes of multiple sclerosis: an OCT, ffVEP and mfVEP study. (P6.398) (2017) (0)
- Functional Cognitive Control Load in Multiple Sclerosis (P4.127) (2016) (0)
- Long-term safety and efficacy of ozanimod in relapsing multiple sclerosis: Up to 5 years of follow-up in the DAYBREAK open-label extension trial (2022) (0)
- The use of immunosuppressants in multiple sclerosis: an Italian multicentre study (2010) (0)
- Combining Optical Coeherence Tomography, Full-Field and Multifocal Visual Evoked Potentials to Assess Multiple Sclerosis Patients (P2.146) (2016) (0)
- Cesarean delivery and artificial lactation are associated with an earlier age of disease onset in multiple sclerosis (P2.350) (2018) (0)
- Safety of the Concurrent Administration of Serotonergic Antidepressants and Ozanimod in Patients With Relapsing Multiple Sclerosis (P7-3.013) (2023) (0)
- 50. Clinical and neurophysiological effect of deep rTMS with H-COIL in Parkinson’s disease (2013) (0)
- Functional Connectivity Abnormalities and Cognitive Impairment in Relapse-Onset MS Patients: A Whole-Brain Functional Network Connectivity Analysis (P03.072) (2012) (0)
- Selective motor cortex activation in the pianist's brain during music listening: A combined EEG and TMS study (2012) (0)
- Deficits in memory and visuospatial learning correlate with regional hippocampal atrophy in MS (2013) (0)
- Gender ratio of multiple sclerosis in Italy: geographical distribution and trend over 60 years (2010) (0)
- Predictors of Disease Activity in 857 MS Patients Treated with IFNB-1b (PD5.009) (2012) (0)
- Contents, Vol 34, 1994 (2004) (0)
- 84. Atypical presentation of Guillain-Barré syndrome in childhood: A clinical case (2017) (0)
- Weight gain after subthalamic nucleus deep brain stimulation in PD: The role of electrodes position, hormonal setting and clinical outcome (2016) (0)
- Regional Hippocampal Involvement in Paediatric Multiple Sclerosis: A Radial Mapping MR Study (P2.336) (2014) (0)
- P030 Long-term cortical plasticity of interhemispheric inhibition in piano players: a transcranial magnetic stimulation study (2008) (0)
- Consistent reductions in MRI activity with cladribine tablets therapy for patients with relapsing-remitting multiple sclerosis in the CLARITY study (2010) (0)
- Peripheral neuropathy associated withmycosis fungoides (1989) (0)
- Visual system involvement in Alzheimer’s disease (2019) (0)
- 6th International Headache Seminary (2009) (0)
- Subject Index Vol. 34, 1994 (1994) (0)
- Autonomic response to walk tests is useful for assessing outcome measures in people with multiple sclerosis (2023) (0)
- Damage to the Optic Radiations in Multiple Sclerosis Studied Using DT MRI (P03.031) (2012) (0)
- A study of diffusion-weighted (DWI) and magnetization transfer imaging (MTI) in patients with Alzheimer's disease (AD) (2000) (0)
- Long-term MRI follow-up of patients in the ALLEGRO study: results from the yearly frequent MRI sub-cohort (P7.258) (2015) (0)
- White Matter Damage in Parkinson's Disease Patients with Glucocerebrosidase Gene Mutations: A Study Using Diffusion Tensor Imaging (P03.120) (2012) (0)
- pare the rates of enhancement and the changes in lesion burden between the two groups . Patients and Methods Patients (1997) (0)
- Time course of neural activity in different brain networks revealed by fMRI–EEG integrated cortical source imaging (2011) (0)
- Cortical thinning and white matter tract damage in relation to cognition in motor neuron diseases (P6.087) (2015) (0)
- Strategies for the prevention of Duchenne's muscular dystrophy in Lombardia (1987) (0)
- Optic neuritis in multiple sclerosis (2016) (0)
- P4.10 Paired pulse TMS for the assessment of fatigue in hereditary and acquired neuropathies (2011) (0)
- Intraoperative neurophysiologic monitoring in thoracoabdominal aortic aneurysm repair: A single-center prospective study (2019) (0)
- Tissue donations for multiple sclerosis research: current state and suggestions for improvement (2022) (0)
- Guidance concerning compensation for new therapies in multiple sclerosis patients (1997) (0)
- Psychomotor and executive functions in elite soccer players (2012) (0)
- Patterns of Regional Gray and White Matter Atrophy Are Associated to PASAT and SDMT Performances in Relapsing Remitting Multiple Sclerosis Patients (P03.035) (2012) (0)
- No Evidence of Cortical Lesions in Migraine Patients: A Double Inversion Recovery Study (S16.006) (2012) (0)
- 85. Deep repetitive transcranial magnetic stimulation with H-coil for motor symptoms in Parkinson’s disease: A randomized, double blind, placebo-controlled study (2015) (0)
- [Rationale for an early treatment of multiple sclerosis]. (2000) (0)
- Brain atrophy in MS: long-term prognostic value (2011) (0)
- Disease stability over five years in people with multiple sclerosis treated with cladribine tablets: a plain language summary. (2022) (0)
- The visual evoked potential N75 component: A cortical potential of foveal pathways? (1989) (0)
- Comparative evaluation of advanced eeg analysis techniques in aids dementia complex diagnosis (1997) (0)
- Combining Clinical and Genetic Data to Predict Response to Fingolimod Treatment in Relapsing Remitting Multiple Sclerosis Patients: A Precision Medicine Approach (2023) (0)
- Mild Cognitive Impairment in PD Is Associated with a Distributed Pattern of Brain White Matter Damage (S33.001) (2013) (0)
- Plasticity of Motor Cortex after Bimanual Piano Training: Towards Practice as a Preventive Strategy? (P06.077) (2013) (0)
- [In-vivo assessment of multiple sclerosis pathology: the role of neuroimaging techniques]. (2000) (0)
- ERPs in multiple sclerosis (1998) (0)
- 86. Efficacy of botulinum toxin on pain and spastic gait disorders in multiple sclerosis (2015) (0)
- 18F-FDG and PET metabolic study of visual cortex in multiple slecrosis patients (1995) (0)
- 61. Patients with progressive supranuclear palsy show abnormal response to conditioned and unconditioned TMS stimuli compared to patients with Parkinson’s disease and healthy subjects (2016) (0)
- P21.9 Evoked potential abnormalities predict disability progression at 5 years in patients with CIS (2011) (0)
- Autologous stem cell transplantation in multiple sclerosis: preliminary clinical results and future activities (2001) (0)
- Correction to: Management of pregnancy-related issues in multiple sclerosis patients: the need for an interdisciplinary approach (2017) (0)
- Action Observation Therapy Modifies Structural Brain Plasticity in Healthy Adult Individuals (P3.058) (2014) (0)
- Natalizumab: state of the art and open questions (2010) (0)
- Intravenous immunoglobulin treatmentin patients withchronic inflammatory demyelinating neuropathy notresponsive toother treatments (1994) (0)
- [Individualization of carriers of Duchenne's muscular dystrophy . Problems and prospectives]. (1986) (0)
- White and Gray Matter Damage Extends beyond the Visual Pathways in Patients with Autosomal Dominant Optic Atrophy and OPA1 Mutations (P07.265) (2012) (0)
- The combined use of 3D T1-and T2-weighted sequences improves cervical cord lesion detection in patients with multiple sclerosis: a multicenter study at 3T (2016) (0)
- Action observation training modifies brain gray matter structure in healthy adult individuals (2016) (0)
- The Guillain-Barrb Syndrome (GB Implementation of a register of the disease on basis s) a nationwide (1996) (0)
- ALPHA-ADDUCIN POLYMORPHISM'S INFLUENCE ON ISCHEMIC STROKES (2018) (0)
- P22.14 Selective modulation of the motor cortex excitability during listening to known melodic sequences in pianists (2011) (0)
- ORIGINAL RESEARCH Overcoming the ClinicalMR Imaging Paradox of Multiple Sclerosis: MR Imaging Data Assessed with a Random Forest Approach (2011) (0)
- P944: Mirror motor activation during music listening in professional pianists: a neurophysiological study (2014) (0)
- Microglial Microvesicles as Potential Biomarkers for Dementia (S14.003) (2012) (0)
- Comparison oftriple dose versusstandard dose gadolinium-DTPA fordetection ofMRI enhancing lesions inpatients withprimary progressive multiple sclerosis (1995) (0)
- Central nervous system delivery of interleukin-4 using herpetic vectors ameliorates experimental allergic encephalomyelitis (1998) (0)
- Multiple Sclerosis: The adult human oligodendrocyte precursor cell: a key player in myelin repair (2010) (0)
- Brain Gray Matter And White Matter Alterations In Patients With Myotonic Dystrophy 1 (P5.085) (2014) (0)
- Role of VEPS and OCT in demyelinating diseases (2021) (0)
- Fampridine Modulates Thalamic Resting State Functional Connectivity and Ameliorates Fatigue in Multiple Sclerosis Patients (P4.005) (2015) (0)
- Functional connectivity in patients with focal dystonia (2013) (0)
- Modifications of Functional Connectivity of the Anterior Cingulum Correlate with Medium-Term Effects of Cognitive Rehabilitation in Patients with Multiple Sclerosis (P04.030) (2013) (0)
- Isolated neurological syndrome suggestive of MS: MRI evidence of Wallerian degeneration of the corticospinal tract (2000) (0)
- Safety and tolerability of fingolimod in relapsing- remitting multiple sclerosis: resuls from a large open-label clinical trials. (2014) (0)
- Cardiac safety and tolerability of fingolimod in relapsing MS patients from the FIRST study who transitioned into the LONGTERMS study (2015) (0)
- Effects of Aging and Gender on Brain Intrinsic Functional Connectivity: A Resting State Study in a Large Cohort of Healthy Subjects (P06.023) (2013) (0)
- A Diffusion Tensor MRI Study OF Pediatric Patients With Severe Non-Traumatic Brain Injury (S35.001) (2015) (0)
- Design of two phase III open-label trials evaluating ocrelizumab in patients with relapsing-remitting multiple sclerosis and suboptimal response to disease-modifying treatment (2016) (0)
- An Integrated Model Of Risk Factors For Predicting The Early Occurrence Of A Second Attack In Patients With Clinically Isolated Syndromes (P1.224) (2014) (0)
- The motor nerve biopsy for early diagnosis and prognosis of motor neuron disease and motor neuropathies: proposal and validation of new histopathological criteria (2009) (0)
- Is gray matter atrophy a biomarker of migraine? A study in pediatric patients with migraine (2013) (0)
- White Matter Microstructure Abnormalities in Patients with Dominant Optic Atrophy and OPA1 Mutations (S39.002) (2014) (0)
- Interleukin 4 modulates microglia homeostasis and attenuates the early slowly progressive phase of amyotrophic lateral sclerosis (2018) (0)
- S7.1 Experimental neurophysiology for the understanding of mechanisms of neurological disease (2011) (0)
- Treatment with interferon reduces the appearance of lesions in clinically relevant white matter tracts in patients with clinically isolated syndrome (2016) (0)
- Intrathecally Transplanted Adult Neural Stem/Precursor Cells Crosstalk with Infiltrating Inflammatory Cells in Experimental Autoimmune Encephalomyelitis (P02.012) (2012) (0)
- W11.5 The effect of aging and ALS disease on the bereitschaftspotentials cortical generators (2011) (0)
- A Voxel-Based Assessment of Cervical Cord Atrophy in MS Patients (P03.061) (2012) (0)
- Functional and Structural Disruption of the Precuneus Contributes to Cognitive Impairment in Pediatric Multiple Sclerosis (S15.004) (2013) (0)
- Interleukin 12 is critical in the development of experimental autoimmune myasthenia gravis (1998) (0)
- Neurophysiological assessment of the effects of high-dose i.v. immunoglobulin treatment in 9 patients with chronic inflammatory demyelinating polyneuropathy (1995) (0)
- 62. Sensory Tricks in cervical dystonia: A neurophysiological study with short latency afferent inhibition (2016) (0)
- No Association Between Lymphocyte Pharmacodynamics and Disability Following Alemtuzumab Treatment in patients With Relapsing-Remitting Multiple Sclerosis (2019) (0)
- Brain and Spinal Cord Imaging Features in Neuromyelitis Optica Spectrum Disorders (S6.003) (2018) (0)
- Deep repetitive transcranial magnetic stimulation and cycling improve lower limb function in chronic stroke: a randomized, placebo-controlled, crossover study (I10-1G) (2015) (0)
- Faculty Opinions recommendation of Identification of risk factors for falls in multiple sclerosis: a systematic review and meta-analysis. (2013) (0)
- Defining breakthrough disease: When to escalate (2014) (0)
- Author Correction: Transcriptional dysregulation of Interferome in experimental and human Multiple Sclerosis (2018) (0)
- 5. Involvement of different cortico-subcortical circuits in chronic tinnitus: An Sloreta-based EEG study (2015) (0)
- Structural and Functional MRI Signatures of ALS Patients with C9ORF72 Hexanucleotide Repeat Expansion (P4.014) (2016) (0)
- Role of endogenous neural precursor cells in demyelination and remyelination after cuprizone-induced injury (2014) (0)
- No Increase in Malignancy Risk with Cladribine Tablets in Patients with Relapsing Multiple Sclerosis (2018) (0)
- Clinical and pharmacological characterization of anomalous metoclopramide-induced growth hormone secretion in insulin-dependent diabetes mellitus (1989) (0)
- Influence of 25(OH)D levels and genetic variants on disease severity in MS. (2016) (0)
- Evoked Potentials May Predict Response to Immunomodulating Treatment in Multiple Sclerosis (S39.003) (2013) (0)
- Outcome measures validation study for mesoangioblasts transplantation in children affected by Duchenne Muscular Dystrophy (2010) (0)
- Exploring the Relationship Between Serum GDF-15 and Disease Stability in Patients with a First Clinical Demyelinating Event Treated with Subcutaneous Interferon Β-1a Or Placebo in the REFLEX Study (2023) (0)
- Cerebellar Contribution to Motor and Cognitive Impairment in Multiple Sclerosis Patients: A Sub-Regional Structural MRI Analysis (P4.128) (2016) (0)
- P414: Involvement of different cortico-subcortical circuits in chronic tinnitus: an sLORETA-based study in normoacousic patients (2014) (0)
- SS-1-3 The validity of instrumental tests in monitoring interventions in diabetic neuropathy (1995) (0)
- 55. VEPS and OCT in acute and chronic optic neuritis associated with multiple sclerosis (2015) (0)
- TH-101. Smoldering inflammation and neurodegeneration in progressive Multiple Sclerosis revealed by sector-to-channel correlations between mfVEP and OCT (2022) (0)
- Diffusion Tensor Imaging Contributes To Differentiate Richardson's Syndrome from Progressive Supranuclear Palsy-Parkinsonism (P03.090) (2012) (0)
- Critical Review of Existing Trials (2007) (0)
- Retinal ganglion cell layer correlates with cognitive involvement in Alzheimer’s disease and mild cognitive impairment (2016) (0)
- Structural and functional brain connectome architecture in early onset Alzheimer’s disease and the behavioral variant of frontotemporal dementia (P2.084) (2017) (0)
- Long-Term Follow-Up of Laquinimod 0.6 mg in Patients with Relapsing-Remitting Multiple Sclerosis 2 (P3.087) (2016) (0)
- Optimal micro-patterning of a collagen scaffold coordinates the induction of morphogenetic pathways in adult nerve regeneration (2014) (0)
- Cortical Activation to Action Observation and Motor Imagery Corresponds to Motor Learning: An EEG Study (P04.022) (2012) (0)
- Patterns of Microstructural White Matter Damage in Early and Late Age of Onset Alzheimer's Disease Patients (P05.044) (2012) (0)
- Effect of Two Dosing Frequencies of Subcutaneous Interferon (scIFN) β-1a on Conversion to Multiple Sclerosis (MS) in Patients with a First Clinical Demyelinating Event (FCDE): 5-year Results of Phase III, Double-blind, Multicenter Trials (REFLEX/REFLEXION) (P7.206) (2015) (0)
- Neuroimaging-Methodology 4 November 1997, Tuesday (1997) (0)
- Altered Functional Brain Connectome in the Behavioral Variant of Frontotemporal Dementia (S54.004) (2013) (0)
- P308: Deep rTMS-induced clinical and neurophysiological effect in Parkinson’s disease (2014) (0)
- Myeloidcellsastargetoffingolimodaction in multiple sclerosis (2015) (0)
- The Importance of Stress as a Trigger Factor in Childhood Migraine: An Italian Study (P04.254) (2012) (0)
- Modifications of Gray Matter Volume in Migraine Patients Over Four Years: A Tensor-Based Morphometry Study (S26.005) (2016) (0)
- Vitamin D Metabolic Pathway Alterations and Risk of Multiple Sclerosis in Patients with Clinically Isolated Syndromes (P1.393) (2016) (0)
- Clinical and Paraclinical Outcomes for Treatment Trials in Multiple Sclerosis (1999) (0)
- PPA with in-vivo cortical amyloidosis and Pick ' s disease pathology (2012) (0)
- W10.3 Flash visual evoked potentials as neurophysiological marker of nervous damage in animal models of multiple sclerosis (2011) (0)
- The impact of white matter damage on cognition in PSP syndrome: a DT MRI study (P1.181) (2015) (0)
- P3.12 Long-term EEG monitoring in status epilepticus: automatic seizure detection (2011) (0)
- Chapter 5: Basic mechanisms of functional recovery (2010) (0)
- Reflection and Reaction (2005) (0)
- Peripheral transcriptional control in multiple sclerosis: Hepatocyte nuclear factor 4 alpha regulates immune cell activation and autoimmunity (2014) (0)
- Efficacy of Subcutaneous Interferon Β-1a in Patients with a First Clinical Demyelinating Event in REFLEX is Maintained After Application of the 2017 McDonald Criteria (2020) (0)
- WED 184 Cladribine tablets in clarity patients with high disease activity ms (2018) (0)
- Improving reproducibility of motor evoked potentials in mice (2021) (0)
- Clinical and radiologic correlates of a novel T lymphocyte gamma-interferon-activated Ca2+ influx in patients with relapsing-remitting multiple sclerosis. (1996) (0)
- Guillain-Barré syndrome in Castleman's lymphopathy. (1987) (0)
- Reply (2001) (0)
- 33. Effects of global proprioceptive resonance on resting state EEG in healthy subjects (2016) (0)
- Active RRMS Patients Treated with Alemtuzumab Experience Durable Reductions in MRI Disease Activity and Slowing of Brain Volume Loss: 7-Year Follow-up of CARE-MS II Patients (TOPAZ Study) (P6.367) (2018) (0)
- White Matter Microstructure Abnormalities in Paediatric Migraine Patients: In-Vivo Measures of Brain Hyperexcitability? (P6.201) (2014) (0)
- humansdecreases motor cortical excitability in Low-intensity repetitive transcranial magnetic (2015) (0)
- PO139 Integrated safety analysis; cladribine in multiple sclerosis (ms) (2017) (0)
- Functional Connectivity during Resting State Functional MR Imaging in the Semantic Variant of Primary Progressive Aphasia (P04.217) (2012) (0)
- Replication phase of a whole-genome association study in progressive forms of multiple sclerosis (2009) (0)
- Comprar Multiple Sclerosis | Jürg Kesselring | 9780521888325 | Cambridge University Press (2010) (0)
- P38-S Evaluating effects of neurorehabilitation on gait pattern in multiple sclerosis with kinetic and electromyographic analyses (2019) (0)
- Impact of treatment with dimethyl fumarate on sleep quality in patients with relapsing-remitting multiple sclerosis: A multicentre Italian wearable tracker study (2023) (0)
- P309: Motor planning improvement in Parkinson’s disease after excitatory deep repetitive transcranial magnetic stimulation with H-coil: evidence from sensorimotor rhythms event-related desynchronization (2014) (0)
- 44. Onabotulinumtoxin-a treatment in chronic migraine: A long-term prospective open label study (2016) (0)
- Paucintomaticità in una famiglia affetta da calpainopatia (2009) (0)
- The diagnostic value of cortical thickness measures and diffusion tensor MRI metrics in the clinical phenotypes of MND (P6.088) (2015) (0)
- 33 Event-related brain activity during color-word matching test (1998) (0)
- COMPARISON OF TRIPLE DOSE VERSUS STANDARD-DOSE OF GADOLINIUM-DTPA IN THE DETECTION OF ENHANCING LESIONS IN MULTIPLE-SCLEROSIS (1995) (0)
- Temporal evolution of new T1-weighted hypo-intense lesions and central brain atrophy in patients with a first clinical demyelinating event treated with subcutaneous interferon β-1a (2023) (0)
- Efficacy of Alemtuzumab in Patients With Active Relapsing-Remitting Multiple Sclerosis Who Received Retreatment Due to Disease Activity After the Initial Two Courses: Results From the CARE-MS II Extension (P6.363) (2018) (0)
- The role of Microglia and Inflammation in an animal model of ALS (2014) (0)
- [Expression of a defect in the respiratory chain in cultured human cells]. (1991) (0)
- Paucintomaticità in una famiglia affetta da calpainopatia (2009) (0)
- P1084: Motor effects of deep repetitive transcranial magnetic stimulation with H-coil in Parkinson’s disease: a randomized, double blind, placebo-controlled study (2014) (0)
- Journal of Neurology: Introduction (2005) (0)
- Signs and symptoms of COVID‐19 in patients with multiple sclerosis (2022) (0)
- Integration of MR images and EEG maps (1995) (0)
- ID 338 – Retinal Nerve Fibre Layer loss is associated with disease progression in Multiple Sclerosis (2016) (0)
- Resting State Functional Connectivity Abnormalities in Pediatric Patients with Migraine (S51.007) (2015) (0)
- BRAIN AND CORD MAGNETIZATION TRANSFER IMAGING HISTOGRAMS IN MULTIPLE SCLEROSIS PATIENTS (2000) (0)
- EEG and auditory P300 mapping in HIV + subjects: Preliminar results (1993) (0)
- MO14 Cortical activation to voluntary movement in Motor Neuron Disease is related to the extent of corticospinal damage (2008) (0)
- Selective Modulation of the Motor Cortex Excitability during Listening of Known Melodic Sequences in Pianists (P01.190) (2012) (0)
- Use of excitatory deep repetitive transcranial magnetic stimulation with the H-coil to improve motor planning in Parkinson ’ s disease : evidence from sensorimotor rhythms event-related desynchronization (2014) (0)
- Effects of gangliosides on the electroneurographic parameters in the diabetic neuropathy: A report of 140 cases (1983) (0)
- A Multidisciplinary Evaluation of Patients with DMD in An Italian Tertiary Care Center. (2020) (0)
- P18.5 Visual and sensorimotor pathways in primary and secondary progressive multiple sclerosis: neurophysiological differences? (2011) (0)
- Safety and efficacy of cladribine tablets in patients with relapsing-remitting multiple sclerosis (2018) (0)
- Thanks to Editorial Board of Arquivos de Neuro-Psiquiatria (2022) (0)
- Brain Structural and Functional Abnormalities in Fahr's Disease: Report of Two Cases (P06.159) (2013) (0)
- 566 Dipole source analysis of P300 component of the auditory evoked potentials (1998) (0)
- Multiple Sclerosis: Electrophysiological assessment in multiple sclerosis (2010) (0)
- Neurophysiology 4 November 1997, Tuesday (1997) (0)
- Baseline Characteristics of Patients with Relapsing Multiple Sclerosis in ASCLEPIOS Phase 3 Trials of Ofatumumab Versus Teriflunomide (P3.2-096) (2019) (0)
- EEG aspects during carotid endoarterectomy: Haemodynamic evaluation by means of transcranial doppler (TCD) (1990) (0)
- TH-220. Anti-inflammatory effects of transcranial direct current stimulation? evidence in experimental autoimmune encephalomyelitis (2022) (0)
- Thrombolysis with rt-PA for an ischemic stroke in boy treated with Fontan operation (2011) (0)
- Functional connectivity in early Parkinson disease: A resting-state FMRI study (2013) (0)
- White Matter Damage in Amyotrophic Lateral Sclerosis and Primary Lateral Sclerosis: A Tract-Based Spatial Statistics Study (P03.162) (2012) (0)
- Researching COVID-19 in progressive MS requires a globally coordinated, multi-disciplinary and multi-stakeholder approach—perspectives from the International Progressive MS Alliance (2022) (0)
- The overlap between the corticobasal degeneration syndrome and nonfluent aphasia (2011) (0)
- Effects of intravenous immunoglobulin therapy on neruophysiological features in 5 patients with multifocal motor neuropathy (1995) (0)
- The overlap between the corticobasal degeneration syndrome and nonfluent aphasia (2011) (0)
- Simultaneous rTMS and Piano Playing Improve Hand Dexterity and Cortical Motor Representation in a Professional Pianist with Multiple Sclerosis: A Case Report (IN11-1.010) (2013) (0)
- Alloalbumin in cerebrospinal fluid: Report of a case and remarks on physiopathology (1990) (0)
- PO138 High disease activity in relapsing multiple sclerosis (rms) (2017) (0)
- P6.20 Interhemispheric balance in Parkinson's disease (PD): a transcranial magnetic stimulation (TMS) study (2011) (0)
- Abnormalities of the Attentional Network Following Traumatic Brain Injury in Pediatric Patients: A fMRI Study (S42.002) (2014) (0)
- Regional thalamic damage and cognitive impairment in patients with multiple sclerosis: a multicenter study (2014) (0)
- 108. Corticospinal reserve predicts walking improvement after intensive rehabilitation and deep rTMS with H-coil in progressive multiple sclerosis (2015) (0)
- Spontaneous and odor-evoked seizures in Synapsin I/II/III knockout mice: Electrophysiological characterization (2011) (0)
- Ofatumumab Reduces Disability Progression Independent of Relapse Activity in Patients with Relapsing Multiple Sclerosis (1845) (2020) (0)
- Treatment of Inflammatory Demyelinating Polyneuropathy (1999) (0)
- 72. Corticospinal reserve and disability predict efficacy of repetitive transcranial stimulation on walking abilities in people with progressive multiple sclerosis undergoing rehabilitation (2016) (0)
- Serum neurofilament light chain levels are increased at the onset of PML in natalizumab treated MS patients (P1.383) (2018) (0)
- P940: Simultaneous rTMS and piano playing improve hand dexterity and induce changes in cortical excitability in a professional pianist affected by multiple sclerosis: a case report (2014) (0)
- Early use of fingolimod is associated with better clinical outcomes in relapsing–remitting multiple sclerosis patients (2022) (0)
- Functional and morphological changes of the retinal vessels in Alzheimer’s disease and mild cognitive impairment (2019) (0)
- Editorial introductions. (2020) (0)
- WED 185 Clarity: mri outcomes in high disease activity relapsing ms (2018) (0)
- Intrinsic damage to the cerebellar peduncles is associated to multiple sclerosis clinical disability (2013) (0)
- Interferon-y activated calcium influx inperipheral bloodlymphocytes frompatients withprimary andsecondary progressive multiple sclerosis (2012) (0)
- Late Breaking News (2007) (0)
- Influence of age-related blood brain barrier modifications on the outcome of experimental stroke in elderly mice (2014) (0)
- P10.3 Treating Krabbe disease: neurophysiological assessment of a mouse model (2011) (0)
- Brain structural and functional changes after action observation therapy addressed to freezing of gait of subjects with Parkinson's disease (2015) (0)
- 114. Physiological aging is associated with reorganization of map motor cortical representation and interhemispheric interactions: A TMS mapping study (2015) (0)
- Structural Brain MRI Abnormalities in Kennedy's Disease (P5.015) (2016) (0)
- In vivo structural and functional assessment of optic nerve damage in neuromyelitis optica spectrum disorders and multiple sclerosis (2019) (0)
- White matter microstructure abnormalities in pediatric migraine patients: In vivo measures of brain hyperexcitability? (2013) (0)
- Erratum to: Proteomic identification of aldolase A as an autoantibody target in patients with atypical movement disorders (2014) (0)
- Fatigue and Other Patient-Reported Outcomes in Patients With RRMS who Switched to Ocrelizumab: 4-Year Data From CASTING-LIBERTO (P6-3.010) (2023) (0)
- Efficacy and Safety of Ozanimod: Results From the 2-Year Blinded Extension of RADIANCE, a Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial in Relapsing Multiple Sclerosis (S24.008) (2017) (0)
- Alemtuzumab Improves Clinical and Radiological Outcomes in Patients with Relapsing-remitting Multiple Sclerosis Over 8 Years: Care-MS I Follow-up (topaz Study) (2018) (0)
- 52. Lower limbs motor evoked potentials intra-session reliability: A coil comparison study (2017) (0)
- Tournaments (2010) (0)
- O9 Early macular atrophy at optical coherence tomography is predicted by visual evoked potentials and precedes peripapillary neurodegeneration after acute optic neuritis (2017) (0)
- Clinical Response to Nabiximols (Sativex®) on Spasticity and Pain Is Paralleled by a Down-Regulation of Immune-Related Pathways in Multiple Sclerosis Patients (P2.169) (2016) (0)
- 35. Evoked potentials predict disease-modifying treatment response in multiple sclerosis (2013) (0)
- Quantification of Cortical Thickness and Cortical Surface Area Abnormalities in Patients Affected by Migraine (S16.005) (2012) (0)
- Exploring the Relationship between Regional Gray Matter Atrophy and Cognitive Impairment in Pediatric Multiple Sclerosis (P03.131) (2012) (0)
- 26. Excitatory deep repetitive transcranial magnetic stimulation with H-coil improves motor control in Parkinson’s disease: A pilot study (2013) (0)
- P.027 Efficacy of a fourth alemtuzumab course in RRMS patients from CARE-MS II who experienced disease activity after three prior courses (2018) (0)
- Tolerability profile of cladribine tablets therapy for patients with relapsing-remitting multiple sclerosis: factors contributing to treatment completion overall and in patients with high disease activity in the 96-week CLARITY study (2011) (0)
- Comparative effectiveness of early intensive or escalation treatment strategies on long term disability trajectories in relapsing multiple sclerosis patients (2021) (0)
- Pancreas and kidney transplantation: Effect on autonomic neuropathy (1993) (0)
- Durable Reduction in MRI Disease Activity and Slowing of Brain Volume Loss in Alemtuzumab-Treated Patients With Active RRMS: 7-Year Follow-up of CARE-MS I Patients (TOPAZ Study) (P6.375) (2018) (0)
- 27. Modulation of motor cortex excitability and brain activation in professional pianists during music listening: A combined EEG and TMS study (2013) (0)
- Prognostic Value of Vitamin D in Clinically Isolated Syndromes (CIS) (P05.104) (2012) (0)
- 067 Neurofilament light chain concentration predicts risk of relapse in participants with relapsing multiple sclerosis in phase 3 ozanimod trials (2021) (0)
- Teaching NeuroImages: Osteolytic intraosseous meningioma causing transcalvarial herniation (2020) (0)
- Effect of Two Dosing Frequencies of Subcutaneous Interferon (scIFN) β-1a on MRI Lesion and Brain Volume Changes in Patients with a First Clinical Demyelinating Event (FCDE): 5-year Results of Phase III REFLEX Study Extension (REFLEXION) (P7.250) (2015) (0)
- Impact of Gadolinium-enhancing (GD+) Lesions on No Evidence of Disease Activity (NEDA) Status in Subcutaneous Interferon Beta-1a (SC IFNβ-1a)-treated Patients (2018) (0)
- 2004 Lombardia Meeting of the Italian Neurological Society (SIN) and the Italian Society of Hospital Neurosciences (SNO) (2004) (0)
- Structural Cortical Brain Abnormalities in Patients with Vestibular Migraine (S51.005) (2015) (0)
- Effects of Ozanimod on Cognitive Processing Speed: Findings From the Phase 3 SUNBEAM and DAYBREAK Extension Trials (P6-3.001) (2023) (0)
- Persistent acidosis affects electrophysiological transmission and synaptic homeostasis of neuronal networks (2014) (0)
- 116. Comparative value of optical coherence tomography and visual evoked potentials in multiple sclerosis (2013) (0)
- Proceedings of the International Scientific Conference AIFI 2017. Therapeutic Exercise: Foundations, Evidences and Clinical Reasoning in Physiotherapy Practice (2019) (0)
- Effects of Bilateral Repetitive Transcranial Magnetic Stimulation with H-coil on Paretic Upper Limb Motor Function in Chronic Stroke (P3.304) (2016) (0)
- TERAPIA ANTICOAGULANTE E FIBRINOLITICA (1973) (0)
- P568: Multimodal evoked potentials in predicting response to immunomodulating treatment in multiple sclerosis (2014) (0)
- Evidence for use of glatiramer acetate in multiple sclerosis (2005) (0)
- Comparative study of the contrast sensitivity and the visual evoked potentials in multiple sclerosis patients (1986) (0)
- PD11-09 NEW APPROACH FOR THE MEASUREMENT OF QUANTITATIVE ELECTROMYOGRAPHY OF THE EXTERNAL URETHRAL SPHINCTER AND CORRELATION WITH URINARY SYMPTOMS AND PROSTATE MORPHOLOGY (2014) (0)
- Risk of a Second Clinical Attack in Pediatric Patients with a First Demyelinating Clinical Attack Suggestive of Multiple Sclerosis (P4.024) (2015) (0)
- Neurophysiological and neuroradiological correlates of fatigue in non-disabled multiple sclerosis patients (2000) (0)
- Headache and pain 1 (2002) (0)
- P033 Age-related decline in motor cortical specialization: a TMS study (2008) (0)
- [Diabetic neuropathy. Survey and case contribution]. (1979) (0)
- Effect on Functional Brain Plasticity of a Motor Dexterity Training Carried out with and without Musical Cues: An fMRI Study of the Mirror Neuron System in Healthy Individuals (P02.004) (2012) (0)
- FMRI Correlates of Sustained Attention in Pediatric Multiple Sclerosis (P2.250) (2015) (0)
- Reply to the letter by Dr R.B. Traycoff et al. (1995) (0)
- Visual function in Alzheimer's disease: A neurophysiological and pet study (1990) (0)
- P8.13 Tinnitus in normoacusic subjects is related to abnormal resting activity in cortical auditory brain networks: EEG evidence e/sLORETA (2011) (0)
- The spatio-temporal relationship between concurrent lesion and brain atrophy changes in early multiple sclerosis: A post-hoc analysis of the REFLEXION study (2023) (0)
- SMA THERAPIES II AND BIOMARKERS P.260A long-term, open-label, follow-up study of olesoxime in patients with type 2 or non-ambulatory type 3 SMA who participated in a placebo-controlled phase 2 trial (2018) (0)
- Demyelination Process Leading to Autoimmune Caspase-1 Regulates the Inflammatory (1999) (0)
- Effective Connectivity Differences During an Executive Control Task Between MS Subtypes and Healthy Individuals (P6.140) (2015) (0)
- Letter re: The contemporary spectrum of multiple sclerosis misdiagnosis: A multicenter study (2017) (0)
- Pattern reversal visual evoked potentials: dipole analysis and anatomical correlates (1995) (0)
- 45. Intraoperative neurophysiological monitoring during aortic aneurysm repair: A single center experience and focus on methodological aspects (2017) (0)
- P003 Aging effect over movement related cortical potentials. Correlation between movement duration and cortical activation (2008) (0)
- Diagnostic clues in primary angiitis of CNS: A case report (2000) (0)
- THUR 178 Infections during grade 3/4 lymphopenia with cladribine tablets (2018) (0)
- Microstructural Thalamic and Cortico-Thalamic Correlates of Cognitive Impairment in Pediatric Multiple Sclerosis (P6.267) (2015) (0)
- Effectiveness of Lymphocyte-based Re-treatment Criteria in Minimizing the Incidence of Severe Sustained Lymphopenia during Treatment with Cladribine Tablets 3.5mg/kg (P5.370) (2018) (0)
- Probing the Control Processes of the Motor System (2010) (0)
- Use of other disease-modifying therapies after or between alemtuzumab treatments: pooled results from the CAMMS223, and CARE-MS I and II studies over 8 years (2019) (0)
- 86. Onabotulinumtoxin-A treatment in chronic migraine with medication overuse: A two years Italian experience (2017) (0)
- Oral Cladribine Safety Profile in Patients with a First Demyelinating Event: Top Line Results from the Phase III ORACLE MS Study (P01.177) (2013) (0)
- Motor network rewiring in Mild Cognitive Impairment and Alzheimer's disease (2009) (0)
- Clinical Impairment in Multiple Sclerosis Is Related to the Damage of Clinically Eloquent White Matter Tracts (P03.059) (2012) (0)
- 12. Sensitivity and predictive value of OCT and VEP in multiple sclerosis (2016) (0)
- Alemtuzumab improves clinical and MRI outcomes, including slowing of brain volume loss, in RRMS patients over 8 years: CARE-MS I follow-up (TOPAZ Study) (2019) (0)
- A Novel Multiple Sclerosis Susceptibility Variant in GRAMD1B Gene (P05.136) (2013) (0)
- The Diagnostic Value Of Diffusion Tensor MRI Metrics In Relation To The MND Phenotype Heterogeneity (P7.007) (2014) (0)
- EEG connectivity in high-performance fencers (2012) (0)
- Triple doseofgadolinium-DTPA anddelayed MRI inpatients withbenign multiple sclerosis (1996) (0)
- PO136 Durable efficacy of cladribine tablets: clarity+extension (2017) (0)
- The integration of clinical and paraclinical measures in the diagnosis and staging of diabetic neuropathy: A multicentre Italian study (1997) (0)
- No correlation between lymphocyte repopulation kinetics and MS disease activity following alemtuzumab treatment in patients with relapsing-remitting multiple sclerosis (2018) (0)
- ORAL PRESENTATIONS; HUMAN NEURAL STEM CELLS AMELIORATE AUTOIMMUNE ENCEPHALOMYELITIS IN NON-HUMAN PRIMATES (2010) (0)
- S5.2 Mirror movements after cortical and lacunar stroke are related to interhemispheric inbalance: a TMS study (2011) (0)
- Resting State Functional Connectivity Abnormalities Are Associated with Cognitive Impairment in Patients with Pediatric Multiple Sclerosis (P03.130) (2012) (0)
- 106. Deep repetitive transcranial magnetic stimulation (rTMS) with H-coil coupled with cycling in chronic lower limb dysfuncion after stroke: A randomized, placebo-controlled, crossover study (2015) (0)
- Expanding the spectrum of lower motor neuron sindrome: chronic motor axonal neuropathy (2011) (0)
- White Matter Damage in Pure and Complicated Hereditary Spastic Paraparesis (P03.164) (2012) (0)
- A GENOMIC APPROACH TO IDENTIFY NEW GENES RESPONSIBLE FOR INHERITED MOTOR AND CMT2 NEUROPATHIES: A COLLABORATIVE STUDY (2016) (0)
- Multiple Sclerosis: Preface (2010) (0)
- PD11-03 NEW APPROACH AND SET OF REFERENCE VALUES FOR QUANTITATIVE ELECTROMYOGRAPHIC ANALYSIS OF THE EXTERNAL URETHRAL SPHINCTER IN MEN (2014) (0)
- SAFETY AND TOLERABILITY OF TERIFLUNOMIDE IN CLINICAL STUDIES (2015) (0)
- Association of genetic markers with the presence of cerebrospinal fluid oligoclonal bands in the Italian population (2012) (0)
- Emerging trends in multiple sclerosis research. (2022) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Giancarlo Comi?
Giancarlo Comi is affiliated with the following schools:
